<DOCUMENT>
<TYPE>EX-2.1
<SEQUENCE>2
<FILENAME>e59749ex2-1.htm
<DESCRIPTION>AGREEMENT AND PLAN OF MERGER
<TEXT>
<HTML>
<HEAD>
<TITLE></TITLE>
</HEAD>
<BODY>


<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 24pt 70%; text-align: right"><B>Exhibit 2.1</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 24pt 70%; text-align: left"><U>STRICTLY&nbsp;CONFIDENTIAL</U><BR>EXECUTION&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 24pt; text-align: center">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 24pt; text-align: center"><U>A<A NAME="a_Ref354688527"></A>GREEMENT
AND PLAN OF MERGER</U></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 24pt; text-align: center">by and among</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 24pt; text-align: center">IMB HOLDCO LLC,</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 24pt; text-align: center">CIT GROUP INC.,</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 24pt; text-align: center">CARBON MERGER SUB LLC</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 24pt; text-align: center">and</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 24pt; text-align: center">THE HOLDERS&rsquo; REPRESENTATIVE NAMED
HEREIN</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 30pt; text-align: center">_____________________</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 24pt; text-align: center">DATED AS OF JULY 21, 2014</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-top: 6pt; padding-bottom: 6pt; border-bottom: Black 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 24pt 70%; text-align: left"><U>STRICTLY&nbsp;CONFIDENTIAL</U><BR>EXECUTION&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-transform: uppercase; text-align: center">TABLE OF CONTENTS</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><FONT STYLE="text-transform: uppercase">Article
I</FONT><BR>
<BR>
THE MERGER</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center; color: blue"></P>

<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; border-collapse: collapse; font: 12pt Times New Roman, Times, Serif">
<tr style="vertical-align: middle">
    <TD STYLE="text-align: left; width: 5%; padding-right: 6pt">1.1</td>
    <TD>The Merger</td>
    <TD STYLE="text-align: right; width: 5%">6</td></tr>
<tr style="vertical-align: middle">
    <TD STYLE="text-align: left; padding-right: 6pt">1.2</td>
    <TD>Effective Time</td>
    <TD STYLE="text-align: right">6</td></tr>
<tr style="vertical-align: middle">
    <TD STYLE="text-align: left; padding-right: 6pt">1.3</td>
    <TD>Effects of the Merger</td>
    <TD STYLE="text-align: right">6</td></tr>
<tr style="vertical-align: middle">
    <TD STYLE="text-align: left; padding-right: 6pt">1.4</td>
    <TD>Conversion of Interests</td>
    <TD STYLE="text-align: right">6</td></tr>
<tr style="vertical-align: middle">
    <TD STYLE="text-align: left; padding-right: 6pt">1.5</td>
    <TD>Carbon Common Stock</td>
    <TD STYLE="text-align: right">8</td></tr>
<tr style="vertical-align: middle">
    <TD STYLE="text-align: left; padding-right: 6pt">1.6</td>
    <TD>Oxygen Options</td>
    <TD STYLE="text-align: right">8</td></tr>
<tr style="vertical-align: middle">
    <TD STYLE="text-align: left; padding-right: 6pt">1.7</td>
    <TD>Allocation of Merger Consideration</td>
    <TD STYLE="text-align: right">9</td></tr>
<tr style="vertical-align: middle">
    <TD STYLE="text-align: left; padding-right: 6pt">1.8</td>
    <TD>Organizational Documents of the Surviving Company</td>
    <TD STYLE="text-align: right">14</td></tr>
<tr style="vertical-align: middle">
    <TD STYLE="text-align: left; padding-right: 6pt">1.9</td>
    <TD>Directors and Officers of the Surviving Company</td>
    <TD STYLE="text-align: right">14</td></tr>
<tr style="vertical-align: middle">
    <TD STYLE="text-align: left; padding-right: 6pt">1.10</td>
    <TD>Certificate of Incorporation and Bylaws of Carbon</td>
    <TD STYLE="text-align: right">14</td></tr>
<tr style="vertical-align: middle">
    <TD STYLE="text-align: left; padding-right: 6pt">1.11</td>
    <TD>Directors and Officers of Carbon</td>
    <TD STYLE="text-align: right">14</td></tr>
<tr style="vertical-align: middle">
    <TD STYLE="text-align: left; padding-right: 6pt">1.12</td>
    <TD>Bank Merger</td>
    <TD STYLE="text-align: right">14</td></tr>
<tr style="vertical-align: middle">
    <TD STYLE="text-align: left; padding-right: 6pt">1.13</td>
    <TD>Tax Consequences</td>
    <TD STYLE="text-align: right">15</td></tr>

<TR STYLE="vertical-align: middle">
    <TD STYLE="text-align: left; padding-right: 6pt">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
<tr>
    <TD COLSPAN="3" STYLE="vertical-align: middle; text-align: center"><FONT STYLE="text-transform: uppercase">Article II</FONT></td></tr>
<tr>
    <TD STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; vertical-align: middle; text-align: left; padding-right: 6pt">&nbsp;</td>
    <TD STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; vertical-align: bottom">&nbsp;</td>
    <TD STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; vertical-align: bottom">&nbsp;</td></tr>
<tr>
    <TD COLSPAN="3" STYLE="vertical-align: middle; text-align: center">EXCHANGE OF EQUITY INTERESTS</td></tr>
<TR>
    <TD COLSPAN="3" STYLE="vertical-align: middle; text-align: center">&nbsp;</TD></TR>
<tr style="vertical-align: middle">
    <TD STYLE="text-align: left; padding-right: 6pt">2.1</td>
    <TD>Carbon to Make Shares and Cash Available</td>
    <TD STYLE="text-align: right">16</td></tr>
<tr style="vertical-align: middle">
    <TD STYLE="text-align: left; padding-right: 6pt">2.2</td>
    <TD>Exchange of Equity Interests</td>
    <TD STYLE="text-align: right">16</td></tr>
<tr style="vertical-align: middle">
    <TD STYLE="text-align: left; padding-right: 6pt">2.3</td>
    <TD>Holder Expense Fund</td>
    <TD STYLE="text-align: right">19</td></tr>
<TR STYLE="vertical-align: middle">
    <TD STYLE="text-align: left; padding-right: 6pt">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
<TR STYLE="vertical-align: middle">
    <TD STYLE="text-align: left; padding-right: 6pt">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
<tr>
    <TD COLSPAN="3" STYLE="vertical-align: middle; text-align: center"><FONT STYLE="text-transform: uppercase">Article III</FONT></td></tr>
<tr>
    <TD STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; vertical-align: middle; text-align: left; padding-right: 6pt">&nbsp;</td>
    <TD STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; vertical-align: bottom">&nbsp;</td>
    <TD STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; vertical-align: bottom">&nbsp;</td></tr>
<tr>
    <TD COLSPAN="3" STYLE="vertical-align: middle; text-align: center">REPRESENTATIONS AND WARRANTIES OF OXYGEN</td></tr>
<TR>
    <TD COLSPAN="3" STYLE="vertical-align: middle; text-align: center">&nbsp;</TD></TR>
<tr style="vertical-align: middle">
    <TD STYLE="text-align: left; padding-right: 6pt">3.1</td>
    <TD>Corporate Organization</td>
    <TD STYLE="text-align: right">20</td></tr>
<tr style="vertical-align: middle">
    <TD STYLE="text-align: left; padding-right: 6pt">3.2</td>
    <TD>Capitalization</td>
    <TD STYLE="text-align: right">21</td></tr>
<tr style="vertical-align: middle">
    <TD STYLE="text-align: left; padding-right: 6pt">3.3</td>
    <TD>Authority; No Violation</td>
    <TD STYLE="text-align: right">22</td></tr>
<tr style="vertical-align: middle">
    <TD STYLE="text-align: left; padding-right: 6pt">3.4</td>
    <TD>Consents and Approvals</td>
    <TD STYLE="text-align: right">23</td></tr>
<tr style="vertical-align: middle">
    <TD STYLE="text-align: left; padding-right: 6pt">3.5</td>
    <TD>Reports</td>
    <TD STYLE="text-align: right">23</td></tr>
<tr style="vertical-align: middle">
    <TD STYLE="text-align: left; padding-right: 6pt">3.6</td>
    <TD>Financial Statements</td>
    <TD STYLE="text-align: right">23</td></tr>
<tr style="vertical-align: middle">
    <TD STYLE="text-align: left; padding-right: 6pt">3.7</td>
    <TD>Broker&rsquo;s Fees</td>
    <TD STYLE="text-align: right">25</td></tr>
<tr style="vertical-align: middle">
    <TD STYLE="text-align: left; padding-right: 6pt">3.8</td>
    <TD>Absence of Certain Changes or Events</td>
    <TD STYLE="text-align: right">25</td></tr>
<tr style="vertical-align: middle">
    <TD STYLE="text-align: left; padding-right: 6pt">3.9</td>
    <TD>Legal Proceedings</td>
    <TD STYLE="text-align: right">25</td></tr>
<tr style="vertical-align: middle">
    <TD STYLE="text-align: left; padding-right: 6pt">3.10</td>
    <TD>Taxes and Tax Returns</td>
    <TD STYLE="text-align: right">26</td></tr>
<tr style="vertical-align: middle">
    <TD STYLE="text-align: left; padding-right: 6pt">3.11</td>
    <TD>Employee Benefit Matters</td>
    <TD STYLE="text-align: right">27</td></tr>
<tr style="vertical-align: middle">
    <TD STYLE="text-align: left; padding-right: 6pt">3.12</td>
    <TD>Compliance with Applicable Law.</td>
    <TD STYLE="text-align: right">29</td></tr>
<tr style="vertical-align: middle">
    <TD STYLE="text-align: left; padding-right: 6pt">3.13</td>
    <TD>Certain Contracts</td>
    <TD STYLE="text-align: right">31</td></tr>
<tr style="vertical-align: middle">
    <TD STYLE="text-align: left; padding-right: 6pt">3.14</td>
    <TD>Agreements with Regulatory Agencies</td>
    <TD STYLE="text-align: right">33</td></tr>
<tr style="vertical-align: middle">
    <TD STYLE="text-align: left; padding-right: 6pt">3.15</td>
    <TD>Risk Management Instruments</td>
    <TD STYLE="text-align: right">34</td></tr>
<tr style="vertical-align: middle">
    <TD STYLE="text-align: left; padding-right: 6pt"></TD></TR></TABLE>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-top: 6pt; padding-bottom: 6pt; border-bottom: Black 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 24pt 70%; text-align: left"><U>STRICTLY&nbsp;CONFIDENTIAL</U><BR>EXECUTION&nbsp;</P>


<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; border-collapse: collapse; font: 12pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: middle">
    <TD STYLE="text-align: left; padding-right: 6pt; width: 5%">3.16</td>
    <TD>Environmental Liability</td>
    <TD STYLE="text-align: right; width: 5%">34</td></tr>
<tr style="vertical-align: middle">
    <TD STYLE="text-align: left; padding-right: 6pt">3.17</td>
    <TD>Investment Securities and Commodities</td>
    <TD STYLE="text-align: right">35</td></tr>
<tr style="vertical-align: middle">
    <TD STYLE="text-align: left; padding-right: 6pt">3.18</td>
    <TD>Property</td>
    <TD STYLE="text-align: right">35</td></tr>
<tr style="vertical-align: middle">
    <TD STYLE="text-align: left; padding-right: 6pt">3.19</td>
    <TD>Intellectual Property</td>
    <TD STYLE="text-align: right">36</td></tr>
<tr style="vertical-align: middle">
    <TD STYLE="text-align: left; padding-right: 6pt">3.2</td>
    <TD>Related Party Transactions</td>
    <TD STYLE="text-align: right">37</td></tr>
<tr style="vertical-align: middle">
    <TD STYLE="text-align: left; padding-right: 6pt">3.21</td>
    <TD>State Takeover Laws</td>
    <TD STYLE="text-align: right">37</td></tr>
<tr style="vertical-align: middle">
    <TD STYLE="text-align: left; padding-right: 6pt">3.22</td>
    <TD>Oxygen Information</td>
    <TD STYLE="text-align: right">37</td></tr>
<tr style="vertical-align: middle">
    <TD STYLE="text-align: left; padding-right: 6pt">3.23</td>
    <TD>Loan Matters</td>
    <TD STYLE="text-align: right">37</td></tr>
<tr style="vertical-align: middle">
    <TD STYLE="text-align: left; padding-right: 6pt">3.24</td>
    <TD>Loan Portfolio</td>
    <TD STYLE="text-align: right">39</td></tr>
<tr style="vertical-align: middle">
    <TD STYLE="text-align: left; padding-right: 6pt">3.25</td>
    <TD>Insurance</td>
    <TD STYLE="text-align: right">40</td></tr>
<tr style="vertical-align: middle">
    <TD STYLE="text-align: left; padding-right: 6pt">3.26</td>
    <TD>Reorganization</td>
    <TD STYLE="text-align: right">40</td></tr>
<TR STYLE="vertical-align: middle">
    <TD STYLE="text-align: left; padding-right: 6pt">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
<tr>
    <TD COLSPAN="3" STYLE="vertical-align: middle; text-align: center"><FONT STYLE="text-transform: uppercase">Article IV</FONT></td></tr>
<tr>
    <TD STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; vertical-align: middle; text-align: left; padding-right: 6pt">&nbsp;</td>
    <TD STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; vertical-align: bottom">&nbsp;</td>
    <TD STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; vertical-align: bottom">&nbsp;</td></tr>
<tr>
    <TD COLSPAN="3" STYLE="vertical-align: middle; text-align: center">REPRESENTATIONS AND WARRANTIES OF CARBON AND MERGER SUB</td></tr>
<TR>
    <TD COLSPAN="3" STYLE="vertical-align: middle; text-align: center">&nbsp;</TD></TR>
<tr style="vertical-align: middle">
    <TD STYLE="text-align: left; padding-right: 6pt">4.1</td>
    <TD>Corporate Organization</td>
    <TD STYLE="text-align: right">40</td></tr>
<tr style="vertical-align: middle">
    <TD STYLE="text-align: left; padding-right: 6pt">4.2</td>
    <TD>Capitalization</td>
    <TD STYLE="text-align: right">41</td></tr>
<tr style="vertical-align: middle">
    <TD STYLE="text-align: left; padding-right: 6pt">4.3</td>
    <TD>Authority; No Violation</td>
    <TD STYLE="text-align: right">41</td></tr>
<tr style="vertical-align: middle">
    <TD STYLE="text-align: left; padding-right: 6pt">4.4</td>
    <TD>Consents and Approvals</td>
    <TD STYLE="text-align: right">42</td></tr>
<tr style="vertical-align: middle">
    <TD STYLE="text-align: left; padding-right: 6pt">4.5</td>
    <TD>Reports</td>
    <TD STYLE="text-align: right">42</td></tr>
<tr style="vertical-align: middle">
    <TD STYLE="text-align: left; padding-right: 6pt">4.6</td>
    <TD>Financial Statements</td>
    <TD STYLE="text-align: right">43</td></tr>
<tr style="vertical-align: middle">
    <TD STYLE="text-align: left; padding-right: 6pt">4.7</td>
    <TD>Broker&rsquo;s Fees</td>
    <TD STYLE="text-align: right">44</td></tr>
<tr style="vertical-align: middle">
    <TD STYLE="text-align: left; padding-right: 6pt">4.8</td>
    <TD>Absence of Certain Changes or Events</td>
    <TD STYLE="text-align: right">44</td></tr>
<tr style="vertical-align: middle">
    <TD STYLE="text-align: left; padding-right: 6pt">4.9</td>
    <TD>Legal Proceedings</td>
    <TD STYLE="text-align: right">44</td></tr>
<tr style="vertical-align: middle">
    <TD STYLE="text-align: left; padding-right: 6pt">4.10</td>
    <TD>Compliance with Applicable Law</td>
    <TD STYLE="text-align: right">45</td></tr>
<tr style="vertical-align: middle">
    <TD STYLE="text-align: left; padding-right: 6pt">4.11</td>
    <TD>Agreements with Regulatory Agencies</td>
    <TD STYLE="text-align: right">46</td></tr>
<tr style="vertical-align: middle">
    <TD STYLE="text-align: left; padding-right: 6pt">4.12</td>
    <TD>Available Funds</td>
    <TD STYLE="text-align: right">46</td></tr>
<tr style="vertical-align: middle">
    <TD STYLE="text-align: left; padding-right: 6pt">4.13</td>
    <TD>Reorganization</td>
    <TD STYLE="text-align: right">46</td></tr>
<tr style="vertical-align: middle">
    <TD STYLE="text-align: left; padding-right: 6pt">4.14</td>
    <TD>Carbon Information</td>
    <TD STYLE="text-align: right">46</td></tr>
<TR STYLE="vertical-align: middle">
    <TD STYLE="text-align: left; padding-right: 6pt">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
<tr>
    <TD COLSPAN="3" STYLE="vertical-align: middle; text-align: center"><FONT STYLE="text-transform: uppercase">Article V</FONT></td></tr>
<tr>
    <TD STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; vertical-align: middle; text-align: left; padding-right: 6pt">&nbsp;</td>
    <TD STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; vertical-align: bottom">&nbsp;</td>
    <TD STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; vertical-align: bottom">&nbsp;</td></tr>
<tr>
    <TD COLSPAN="3" STYLE="vertical-align: middle; text-align: center">COVENANTS RELATING TO CONDUCT OF BUSINESS</td></tr>
<TR>
    <TD COLSPAN="3" STYLE="vertical-align: middle; text-align: center">&nbsp;</TD></TR>
<tr style="vertical-align: middle">
    <TD STYLE="text-align: left; padding-right: 6pt">5.1</td>
    <TD>Conduct of Business Prior to the Effective Time</td>
    <TD STYLE="text-align: right">47</td></tr>
<tr style="vertical-align: middle">
    <TD STYLE="text-align: left; padding-right: 6pt">5.2</td>
    <TD>Oxygen Forbearances</td>
    <TD STYLE="text-align: right">47</td></tr>
<tr style="vertical-align: middle">
    <TD STYLE="text-align: left; padding-right: 6pt">5.3</td>
    <TD>Carbon Forbearances</td>
    <TD STYLE="text-align: right">51</td></tr>
<TR STYLE="vertical-align: middle">
    <TD STYLE="text-align: left; padding-right: 6pt">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
<tr>
    <TD COLSPAN="3" STYLE="vertical-align: middle; text-align: center"><FONT STYLE="text-transform: uppercase">Article VI</FONT></td></tr>
<tr>
    <TD STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; vertical-align: middle; text-align: left; padding-right: 6pt">&nbsp;</td>
    <TD STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; vertical-align: bottom">&nbsp;</td>
    <TD STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; vertical-align: bottom">&nbsp;</td></tr>
<tr>
    <TD COLSPAN="3" STYLE="vertical-align: middle; text-align: center">ADDITIONAL AGREEMENTS</td></tr>
<TR>
    <TD COLSPAN="3" STYLE="vertical-align: middle; text-align: center">&nbsp;</TD></TR>
<tr style="vertical-align: middle">
    <TD STYLE="text-align: left; padding-right: 6pt">6.1</td>
    <TD>Regulatory Matters; Third Party Consents</td>
    <TD STYLE="text-align: right">51</td></tr>
<tr style="vertical-align: middle">
    <TD STYLE="text-align: left; padding-right: 6pt">6.2</td>
    <TD>Access to Information</td>
    <TD STYLE="text-align: right">54</td></tr>
<tr style="vertical-align: middle">
    <TD STYLE="text-align: left; padding-right: 6pt">6.3</td>
    <TD>Employee Benefit Plans</td>
    <TD STYLE="text-align: right">55</td></tr>
<tr style="vertical-align: middle">
    <TD STYLE="text-align: left; padding-right: 6pt">6.4</td>
    <TD>Indemnification; Directors&rsquo; and Officers&rsquo; Insurance</td>
    <TD STYLE="text-align: right">57</td></tr>
<tr style="vertical-align: middle">
    <TD STYLE="text-align: left; padding-right: 6pt"></TD></TR></TABLE>

<!-- Field: Page; Sequence: 3; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-top: 6pt; padding-bottom: 6pt; border-bottom: Black 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 24pt 70%; text-align: left"><U>STRICTLY&nbsp;CONFIDENTIAL</U><BR>EXECUTION&nbsp;</P>


<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; border-collapse: collapse; font: 12pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: middle">
    <TD STYLE="text-align: left; padding-right: 6pt; width: 5%">6.5</td>
    <TD>Certain Oxygen Actions</td>
    <TD STYLE="text-align: right; width: 5%">59</td></tr>
<tr style="vertical-align: middle">
    <TD STYLE="text-align: left; padding-right: 6pt">6.6</td>
    <TD>Additional Agreements</td>
    <TD STYLE="text-align: right">59</td></tr>
<tr style="vertical-align: middle">
    <TD STYLE="text-align: left; padding-right: 6pt">6.7</td>
    <TD>Advice of Changes</td>
    <TD STYLE="text-align: right">59</td></tr>
<tr style="vertical-align: middle">
    <TD STYLE="text-align: left; padding-right: 6pt">6.8</td>
    <TD>Public Announcements</td>
    <TD STYLE="text-align: right">60</td></tr>
<tr style="vertical-align: middle">
    <TD STYLE="text-align: left; padding-right: 6pt">6.9</td>
    <TD>Takeover Statutes</td>
    <TD STYLE="text-align: right">60</td></tr>
<tr style="vertical-align: middle">
    <TD STYLE="text-align: left; padding-right: 6pt">6.10</td>
    <TD>No Solicitation of Alternative Transactions</td>
    <TD STYLE="text-align: right">61</td></tr>
<tr style="vertical-align: middle">
    <TD STYLE="text-align: left; padding-right: 6pt">6.11</td>
    <TD>NYSE Listing</td>
    <TD STYLE="text-align: right">61</td></tr>
<tr style="vertical-align: middle">
    <TD STYLE="text-align: left; padding-right: 6pt">6.12</td>
    <TD>Termination of Affiliate Arrangements</td>
    <TD STYLE="text-align: right">61</td></tr>
<tr style="vertical-align: middle">
    <TD STYLE="text-align: left; padding-right: 6pt">6.13</td>
    <TD>Rule 144</td>
    <TD STYLE="text-align: right">61</td></tr>
<tr style="vertical-align: middle">
    <TD STYLE="text-align: left; padding-right: 6pt">6.14</td>
    <TD>Transaction Expenses</td>
    <TD STYLE="text-align: right">62</td></tr>
<tr style="vertical-align: middle">
    <TD STYLE="text-align: left; padding-right: 6pt">6.15</td>
    <TD>Oxygen Dividends</td>
    <TD STYLE="text-align: right">63</td></tr>
<tr style="vertical-align: middle">
    <TD STYLE="text-align: left; padding-right: 6pt">6.16</td>
    <TD>Section 16 Matters</td>
    <TD STYLE="text-align: right">63</td></tr>
<tr style="vertical-align: middle">
    <TD STYLE="text-align: left; padding-right: 6pt">6.17</td>
    <TD>Holdback Amount</td>
    <TD STYLE="text-align: right">63</td></tr>
<tr style="vertical-align: middle">
    <TD STYLE="text-align: left; padding-right: 6pt">6.18</td>
    <TD>Holders&rsquo; Representative.</td>
    <TD STYLE="text-align: right">63</td></tr>
<TR STYLE="vertical-align: middle">
    <TD STYLE="text-align: left; padding-right: 6pt">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
<tr>
    <TD COLSPAN="3" STYLE="vertical-align: middle; text-align: center"><FONT STYLE="text-transform: uppercase">Article VII</FONT></td></tr>
<tr>
    <TD STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; vertical-align: middle; text-align: left; padding-right: 6pt">&nbsp;</td>
    <TD STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; vertical-align: bottom">&nbsp;</td>
    <TD STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; vertical-align: bottom">&nbsp;</td></tr>
<tr>
    <TD COLSPAN="3" STYLE="vertical-align: middle; text-align: center">CONDITIONS PRECEDENT</td></tr>
<TR>
    <TD COLSPAN="3" STYLE="vertical-align: middle; text-align: center">&nbsp;</TD></TR>
<tr style="vertical-align: middle">
    <TD STYLE="text-align: left; padding-right: 6pt">7.1</td>
    <TD>Conditions to Each Party&rsquo;s Obligation to Effect the Merger</td>
    <TD STYLE="text-align: right">65</td></tr>
<tr style="vertical-align: middle">
    <TD STYLE="text-align: left; padding-right: 6pt">7.2</td>
    <TD>Conditions to Obligations of Carbon and Merger Sub</td>
    <TD STYLE="text-align: right">66</td></tr>
<tr style="vertical-align: middle">
    <TD STYLE="text-align: left; padding-right: 6pt">7.3</td>
    <TD>Conditions to Obligations of Oxygen</td>
    <TD STYLE="text-align: right">68</td></tr>
<TR STYLE="vertical-align: middle">
    <TD STYLE="text-align: left; padding-right: 6pt">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
<tr>
    <TD COLSPAN="3" STYLE="vertical-align: middle; text-align: center"><FONT STYLE="text-transform: uppercase">Article VIII</FONT></td></tr>
<tr>
    <TD STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; vertical-align: middle; text-align: left; padding-right: 6pt">&nbsp;</td>
    <TD STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; vertical-align: bottom">&nbsp;</td>
    <TD STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; vertical-align: bottom">&nbsp;</td></tr>
<tr>
    <TD COLSPAN="3" STYLE="vertical-align: middle; text-align: center">TERMINATION AND AMENDMENT</td></tr>
<TR>
    <TD STYLE="color: blue; text-decoration: underline; vertical-align: middle; text-align: left; padding-right: 6pt">&nbsp;</TD>
    <TD STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; vertical-align: bottom">&nbsp;</TD></TR>
<tr style="vertical-align: middle">
    <TD STYLE="text-align: left; padding-right: 6pt">8.1</td>
    <TD>Termination</td>
    <TD STYLE="text-align: right">69</td></tr>
<tr style="vertical-align: middle">
    <TD STYLE="text-align: left; padding-right: 6pt">8.2</td>
    <TD>Effect of Termination</td>
    <TD STYLE="text-align: right">70</td></tr>
<tr style="vertical-align: middle">
    <TD STYLE="text-align: left; padding-right: 6pt">8.3</td>
    <TD>Amendment</td>
    <TD STYLE="text-align: right">70</td></tr>
<tr style="vertical-align: middle">
    <TD STYLE="text-align: left; padding-right: 6pt">8.4</td>
    <TD>Extension; Waiver</td>
    <TD STYLE="text-align: right">70</td></tr>
<TR STYLE="vertical-align: middle">
    <TD STYLE="text-align: left; padding-right: 6pt">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
<tr>
    <TD COLSPAN="3" STYLE="vertical-align: middle; text-align: center"><FONT STYLE="text-transform: uppercase">Article IX</FONT></td></tr>
<tr>
    <TD STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; vertical-align: middle; text-align: left; padding-right: 6pt">&nbsp;</td>
    <TD STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; vertical-align: bottom">&nbsp;</td>
    <TD STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; vertical-align: bottom">&nbsp;</td></tr>
<tr>
    <TD COLSPAN="3" STYLE="vertical-align: middle; text-align: center">GENERAL PROVISIONS</td></tr>
<TR>
    <TD COLSPAN="3" STYLE="vertical-align: middle; text-align: center">&nbsp;</TD></TR>
<tr style="vertical-align: middle">
    <TD STYLE="text-align: left; padding-right: 6pt">9.1</td>
    <TD>Closing</td>
    <TD STYLE="text-align: right">71</td></tr>
<tr style="vertical-align: middle">
    <TD STYLE="text-align: left; padding-right: 6pt">9.2</td>
    <TD>Nonsurvival of Representations, Warranties and Agreements</td>
    <TD STYLE="text-align: right">71</td></tr>
<tr style="vertical-align: middle">
    <TD STYLE="text-align: left; padding-right: 6pt">9.3</td>
    <TD>Expenses</td>
    <TD STYLE="text-align: right">71</td></tr>
<tr style="vertical-align: middle">
    <TD STYLE="text-align: left; padding-right: 6pt">9.4</td>
    <TD>Notices</td>
    <TD STYLE="text-align: right">71</td></tr>
<tr style="vertical-align: middle">
    <TD STYLE="text-align: left; padding-right: 6pt">9.5</td>
    <TD>Interpretation; Definitions</td>
    <TD STYLE="text-align: right">72</td></tr>
<tr style="vertical-align: middle">
    <TD STYLE="text-align: left; padding-right: 6pt">9.6</td>
    <TD>Disclosure Schedule</td>
    <TD STYLE="text-align: right">87</td></tr>
<tr style="vertical-align: middle">
    <TD STYLE="text-align: left; padding-right: 6pt">9.7</td>
    <TD>Counterparts</td>
    <TD STYLE="text-align: right">87</td></tr>
<tr style="vertical-align: middle">
    <TD STYLE="text-align: left; padding-right: 6pt">9.8</td>
    <TD>Entire Agreement</td>
    <TD STYLE="text-align: right">87</td></tr>
<tr style="vertical-align: middle">
    <TD STYLE="text-align: left; padding-right: 6pt">9.9</td>
    <TD>Governing Law; Jurisdiction</td>
    <TD STYLE="text-align: right">87</td></tr>
<tr style="vertical-align: middle">
    <TD STYLE="text-align: left; padding-right: 6pt">9.10</td>
    <TD>Waiver of Jury Trial</td>
    <TD STYLE="text-align: right">87</td></tr>
<tr style="vertical-align: middle">
    <TD STYLE="text-align: left; padding-right: 6pt"></TD></TR></TABLE>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-top: 6pt; padding-bottom: 6pt; border-bottom: Black 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 24pt 70%; text-align: left"><U>STRICTLY&nbsp;CONFIDENTIAL</U><BR>EXECUTION&nbsp;</P>


<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; border-collapse: collapse; font: 12pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: middle">
    <TD STYLE="text-align: left; padding-right: 6pt; width: 5%">9.11</td>
    <TD>Assignment; Third Party Beneficiaries</td>
    <TD STYLE="text-align: right; width: 5%">88</td></tr>
<tr style="vertical-align: middle">
    <TD STYLE="text-align: left; padding-right: 6pt">9.12</td>
    <TD>Specific Performance</td>
    <TD STYLE="text-align: right">88</td></tr>
<tr style="vertical-align: middle">
    <TD STYLE="text-align: left; padding-right: 6pt">9.13</td>
    <TD>Delivery by Facsimile or Electronic Transmission</td>
    <TD STYLE="text-align: right">88</td></tr>
<tr style="vertical-align: middle">
    <TD STYLE="text-align: left; padding-right: 6pt">9.14</td>
    <TD>Valuation Dispute.</td>
    <TD STYLE="text-align: right">88</td></tr>
</table>


<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center; color: blue"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center; color: blue">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center; color: blue"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-top: 6pt; padding-bottom: 6pt; border-bottom: Black 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 24pt 70%; text-align: left"><U>STRICTLY&nbsp;CONFIDENTIAL</U><BR>EXECUTION&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-transform: uppercase; text-align: center">AGREEMENT
AND PLAN OF MERGER</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in"><A NAME="Preamble"></A>AGREEMENT AND
PLAN OF MERGER, dated as of July 21, 2014 (this &ldquo;<U>Agreement</U>&rdquo;), by and among IMB HoldCo LLC, a Delaware limited
liability company (&ldquo;<U>Oxygen</U>&rdquo;), CIT Group Inc., a Delaware corporation (&ldquo;<U>Carbon</U>&rdquo;), Carbon Merger
Sub LLC, a Delaware limited liability company and wholly owned subsidiary of Carbon (&ldquo;<U>Merger Sub</U>&rdquo;) and JCF III
HoldCo I L.P., a Cayman entity, solely in its capacity as the Holders&rsquo; Representative.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-transform: uppercase; text-align: center">W I T N E
S S E T H:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">WHEREAS, the Boards of Directors of Carbon,
Oxygen and Merger Sub have determined that it is in the best interests of their respective companies and their shareholders and
members, as applicable, to consummate the stra<A NAME="Recitals"></A>tegic business combination transaction provided for herein,
pursuant to which Oxygen will, subject to the terms and conditions set forth herein, merge with and into Merger Sub (the &ldquo;<U>Merger</U>&rdquo;),
with Merger Sub as the Surviving Company (hereinafter sometimes referred to in such capacity as the &ldquo;<U>Surviving Company</U>&rdquo;)
in the Merger;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">WHEREAS, concurrently with the execution
of this Agreement, holders of greater than 90% of the aggregate Oxygen Common Interests have executed, and delivered to Oxygen,
written consents irrevocably approving the Merger and the transactions contemplated hereby and Oxygen has Made Available such written
consents to Carbon;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">WHEREAS, for federal income tax purposes,
it is intended that the Merger shall qualify as a &ldquo;reorganization&rdquo; within the meaning of Section&nbsp;368(a) of the
Internal Revenue Code of 1986, as amended (the &ldquo;<U>Code</U>&rdquo;), and this Agreement is intended to be and is adopted
as a plan of reorganization for purposes of Sections&nbsp;354 and 361 of the Code;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">WHEREAS, concurrently with the execution
of this Agreement and as a condition and inducement to Carbon&rsquo;s willingness to enter into this Agreement, Carbon has entered
into retention arrangements with Steven Mnuchin and Joseph Otting (the &ldquo;<U>Retention Agreements</U>&rdquo;);</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">WHEREAS, concurrently with the execution
of this Agreement and as a condition and inducement to Carbon&rsquo;s willingness to enter into this Agreement, Carbon has entered
into Selling Interestholder Restrictive Covenant Agreements with each of Joseph Otting and Steven Mnuchin (the &ldquo;<U>Selling
Interestholder Restrictive Covenant Agreements</U>&rdquo;);</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">WHEREAS, concurrently with the execution
of this Agreement and as a condition and inducement to Carbon&rsquo;s willingness to enter into this Agreement, Carbon has entered
into a Stockholders Agreement with certain of the holders of Oxygen Common Interests (the &ldquo;<U>Stockholders Agreement</U>&rdquo;);
and</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">WHEREAS, the parties desire to make certain
representations, warranties and agreements in connection with the Merger and also to prescribe certain conditions to the Merger.</P>



<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-top: 6pt; padding-bottom: 6pt; border-bottom: Black 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 24pt 70%; text-align: left"><U>STRICTLY&nbsp;CONFIDENTIAL</U><BR>EXECUTION&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0.25in; text-indent: 0.5in">NOW, THEREFORE, in consideration of
the mutual covenants, representations, warranties and agreements contained herein, and intending to be legally bound hereby, the
parties agree as follows:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center; text-indent: 0in"><FONT STYLE="text-transform: uppercase"><A NAME="a_Toc393714706"></A>Article
I</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center">
<A NAME="a_Ref347357571"></A>THE MERGER</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><U><A NAME="a_Toc393714707"></A></U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">1.1</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>The Merger</U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">. </FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><A NAME="a_Ref388718282"></A><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(a)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Subject to the terms and conditions of this Agreement, in accordance with the Delaware Limited Liability Company Act (the
&ldquo;<U>DLLCA</U>&rdquo;), at the Effective Time, Oxygen shall merge with and into Merger Sub. Merger Sub shall be the Surviving
Company in the Merger, and shall continue its limited liability company existence under the Laws of the State of Delaware. Upon
consummation of the Merger, the separate limited liability company existence of Oxygen shall terminate.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><A NAME="a_Ref347360099"></A><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(b)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Subject to the consent of Oxygen, authorized by its Board of Directors, which consent shall not be unreasonably withheld
or delayed, Carbon may at any time change the method of effecting the combination of Oxygen and Carbon if and to the extent that
Carbon deems such change to be desirable; <U>provided</U> that no such change shall (i) alter or change the amount, kind or allocation
of the Net Merger Consideration provided for in this Agreement, (ii) adversely affect the Tax treatment of the holders of Oxygen
Common Interests, Oxygen Converted Common Interests, Oxygen Profits Interests or Oxygen Options (each an &ldquo;<U>Oxygen Holder</U>&rdquo;
and collectively, the &ldquo;<U>Oxygen Holders</U>&rdquo;) as a result of receiving their portion of the Net Merger Consideration
or the Tax treatment of either party pursuant to this Agreement, (iii) materially impede or delay the receipt of any consents or
approvals of or complete any filings or registrations with any Governmental Entity in connection with the transactions contemplated
by this Agreement (including the receipt of FDIC Consents, FDIC Non-Objections, GSE Consents and GSE Non-Objections) or (iv) materially
impede or delay consummation of the transactions contemplated by this Agreement.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><U><A NAME="a_Toc393714708"></A><A NAME="a_Ref388718303"></A></U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">1.2</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Effective Time</U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">. The Merger shall become effective as set forth
in the certificate of merger to be filed with the Secretary of State of the State of Delaware on the Closing Date (the &ldquo;<U>Certificate
of Merger</U>&rdquo;). The term &ldquo;<U>Effective Time</U>&rdquo; shall be the date and time when the Merger becomes effective,
as set forth in the Certificate of Merger.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><U><A NAME="a_Toc393714709"></A></U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">1.3</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Effects of the Merger</U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">. At and after the Effective Time, the
Merger shall have the effects set forth in the applicable provisions of the DLLCA.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><U><A NAME="a_Toc393714710"></A><A NAME="a_Ref347358367"></A><A NAME="a_Ref347358234"></A><A NAME="a_Ref347358210"></A><A NAME="a_Ref347358146"></A></U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">1.4</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Conversion of Interests</U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">. At the Effective Time, by virtue
of the Merger and without any action on the part of Carbon, Oxygen, Merger Sub or the holder of any of the following securities:
</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><A NAME="a_Ref349723720"></A><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(a)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Subject to Section&nbsp;2.2(f), each Oxygen Common Interest that is issued and outstanding immediately prior to the Effective
Time (other than Cancelled Interests or any Oxygen Interest Award) shall be converted into the right to receive (i) a number of
shares of Carbon Common Stock equal to the Per Interest Stock Consideration and (ii) an amount of cash equal to the Per Interest
Cash Consideration, in each case as determined pursuant to Section 1.7 (the consideration referred to in clauses (i) and (ii) being
collectively referred to as the &ldquo;<U>Per Common Interest Merger Consideration</U>&rdquo;; <U>provided</U> that each Oxygen
Common Interest (other</P>


<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-top: 6pt; padding-bottom: 6pt; border-bottom: Black 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 24pt 70%; text-align: left"><U>STRICTLY&nbsp;CONFIDENTIAL</U><BR>EXECUTION&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt">than any Oxygen Interest Award) that is owned by a Non-Accredited
Investor immediately prior to the Effective Time shall instead be converted into the right to receive an amount of cash, without
interest, equal to the Merger Consideration Per Fully Diluted Interest (the &ldquo;<U>Non-Accredited Investor Common Interest Consideration</U>&rdquo;)
and the right to receive a contingent payment from the Holdback Amount and the Holder Expense Fund pursuant to and subject to the
terms and conditions of Section 6.17 and Section 6.18, respectively.<FONT STYLE="background-color: yellow"> </FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><A NAME="a_Ref390947859"></A><A NAME="a_Ref392107697"></A><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(b)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>At the Effective Time, each award of Oxygen Common Interests that is issued and outstanding but unvested as of immediately
prior to the Effective Time (an &ldquo;<U>Oxygen Interest Award</U>&rdquo;), subject to receipt of a duly executed Holder Acknowledgement
and Investor Questionnaire, shall be converted into an award (a &ldquo;<U>Carbon Stock Award</U>&rdquo;) with respect to a number
of unvested restricted shares of Carbon Common Stock (rounded to the nearest whole share) that is equal to the product of (i)&nbsp;the
number of Oxygen Common Interests subject to such Oxygen Interest Award, multiplied by (ii)&nbsp;the quotient of (A)&nbsp;the Merger
Consideration Per Fully Diluted Interest, <U>divided by</U> (B)&nbsp;the Carbon Signing Price; <U>provided</U> that each Oxygen
Interest Award that is held by a Non-Accredited Investor and is issued and outstanding but unvested as of immediately prior to
the Effective Time shall be converted into an award (a &ldquo;<U>Carbon Cash Award</U>&rdquo;) with respect to an amount of cash,
without interest, equal to the Merger Consideration Per Fully Diluted Interest. The vesting schedule and all other material terms
of each Carbon Stock Award and Carbon Cash Award shall otherwise remain substantially the same as those that were applicable to
the corresponding Oxygen Interest Award (to the extent relevant following the Effective Time) and shall have such other terms applicable
to awards in respect of Carbon Common Stock as are consistent with the terms of the Carbon Long-Term Incentive Plan, as in effect
from time to time.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(c)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>At the Effective Time, all Oxygen Common Interests that are owned, directly or indirectly, by Oxygen or any of its wholly
owned Subsidiaries (the &ldquo;<U>Cancelled Interests</U>&rdquo;) shall be cancelled and shall cease to exist and no Carbon Common
Stock or other consideration shall be delivered in exchange therefor.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><A NAME="a_Ref388718321"></A><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(d)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>All of the Oxygen Common Interests converted into the right to receive the Per Common Interest Merger Consideration or the
Non-Accredited Investor Common Interest Consideration pursuant to this Article I shall no longer be outstanding and shall automatically
be cancelled and shall cease to exist as of the Effective Time, and shall thereafter represent only the right to receive (x) the
Per Common Interest Merger Consideration and cash in lieu of fractional shares or the Non-Accredited Investor Common Interest Consideration,
as applicable, which the Oxygen Common Interests have been converted into the right to receive pursuant to this Section&nbsp;1.4
and Section&nbsp;2.2(f), without any interest thereon, and (y) a contingent payment from the Holdback Amount and the Holder Expense
Fund pursuant to and subject to the terms and conditions of Section 6.17 and Section 6.18, respectively. All of the awards of Oxygen
Common Interests converted into Carbon Stock Awards or Carbon Cash Awards, as applicable, pursuant to this Article I shall no longer
be outstanding and shall automatically be cancelled and shall cease to exist as of the Effective Time, and shall thereafter represent
only the right to receive a Carbon Stock Award or Carbon Cash Award, as applicable, and the right to receive a contingent payment
from the Holdback Amount and the Holder Expense Fund pursuant to and subject to the terms and conditions of Section 6.17 and Section
6.18, respectively; <U>provided</U> that any such amounts that are attributable to Oxygen Interest Awards shall only be</P>


<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-top: 6pt; padding-bottom: 6pt; border-bottom: Black 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 24pt 70%; text-align: left"><U>STRICTLY&nbsp;CONFIDENTIAL</U><BR>EXECUTION&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt">paid when (and if) the corresponding Carbon Stock Award vests,
and shall be forfeited if the corresponding Carbon Stock Award is forfeited. In the event any amounts attributable to Oxygen Interests
Awards are forfeited, such amounts shall be distributed reasonably promptly thereafter to the former holders of vested Oxygen Common
Interests, Oxygen Interest Awards and In-the-Money Oxygen Options, based upon such holder&rsquo;s then-applicable Holdback Percentage.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(e)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Each limited liability company interest of Merger Sub issued and outstanding immediately prior to the Effective Time shall
be converted into and become one limited liability company interest of the Surviving Company.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(f)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>At or prior to the Effective Time, Oxygen, the Board of Directors of Oxygen and its compensation committee, as applicable,
shall adopt any resolutions and take any actions that are reasonably necessary to effectuate the provisions of Section 1.4(b) and
to ensure that, notwithstanding anything to the contrary, following the Effective Time, no service provider of Oxygen and its Subsidiaries
shall have any right to acquire any securities of Oxygen, Carbon or any Subsidiary thereof or to receive any payment, right or
benefit with respect to any award previously granted in respect of securities of Oxygen, except the right to receive the consideration
as provided in Sections 1.4(b) or Section 1.6 in their capacity as Oxygen Holders.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(g)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Notwithstanding anything to the contrary set forth in Section 1.6 of the Merger Agreement or any other provision of the
Merger Agreement, nothing in this Merger Agreement is intended to, or shall, terminate or otherwise affect the rights of any holder
of options to purchase Common Interests listed on Section 3.2(a)(i) of the Oxygen Disclosure Schedules to receive (i) any Dividend
Equivalent Payments as set forth on Section 3.11(a) of the Oxygen Disclosure Schedules or (ii) any payments or benefits under Section
5.07 of the Oxygen LLC Agreement, in each case, with respect to such holder&rsquo;s options to purchase Common Interests listed
on Section 3.2(a)(i) of the Oxygen Disclosure Schedules, <U>provided</U> that, for the avoidance of doubt, in no event will there
be any payments or benefits due under Section 5.07 of the Oxygen LLC Agreement in respect of the contingent payment from the Holdback
Amount or the Holder Expense Fund.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><U><A NAME="a_Toc393714711"></A></U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">1.5</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Carbon Common Stock</U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">. At and after the Effective Time, each
share of Carbon Common Stock issued and outstanding immediately prior to the Effective Time shall remain an issued and outstanding
share of Carbon Common Stock and shall not be affected by the Merger.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><U><A NAME="a_Toc393714712"></A><A NAME="a_Ref393713221"></A><A NAME="a_Ref393712938"></A><A NAME="a_Ref393305793"></A><A NAME="a_Ref392109478"></A><A NAME="a_Ref388539144"></A><A NAME="a_Ref388538688"></A><A NAME="a_Ref347656746"></A><A NAME="a_Ref347358220"></A><A NAME="a_Toc157323164"></A><A NAME="a_Toc349309194"></A></U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">1.6</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Oxygen Options</U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">. </FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><A NAME="a_Ref354686435"></A><A NAME="a_Ref347512787"></A><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(a)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>At the Effective Time, each Oxygen Option other than an Out-of-the-Money Oxygen Option, whether or not vested, shall be
cancelled and shall entitle the holder thereof to the right to receive, (i) a number of shares of Carbon Common Stock equal to
the Per Option Stock Consideration and (ii) an amount of cash equal to the Per Option Cash Consideration, in each case as determined
pursuant to Section 1.7 (the consideration referred to in clause (i) and (ii) being collectively referred to as the &ldquo;<U>Per
Option Merger Consideration</U>&rdquo;); <U>provided</U> that in lieu of receiving the Per Option Merger Consideration, any holder
of an Oxygen Option who is a Non-Accredited Investor shall instead receive an amount of cash, without</P>


<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-top: 6pt; padding-bottom: 6pt; border-bottom: Black 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 24pt 70%; text-align: left"><U>STRICTLY&nbsp;CONFIDENTIAL</U><BR>EXECUTION&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt">interest, equal to the Option Consideration in respect of
each such Oxygen Option (the &ldquo;<U>Non-Accredited Investor Option Consideration</U>&rdquo;); <U>provided</U>, <U>further</U>
that if a holder of an Oxygen Option who is not a Non-Accredited Investor (an &ldquo;<U>Option Holder</U>&rdquo;) timely makes
a Gross Settlement Election in respect of some or all of such Option Holder&rsquo;s Oxygen Options (such Oxygen Options as are
covered by the Gross Settlement Election, the &ldquo;<U>Electing Options</U>&rdquo;), then such Option Holder shall, immediately
prior to the Effective Time, pay to Oxygen the full exercise price required to be paid to exercise such Electing Options and at
the Effective Time, such Option Holder shall not be entitled to receive the Per Option Merger Consideration in respect of such
Electing Options but shall instead be entitled to receive, in respect of such Electing Options, (i) a number of shares of Carbon
Common Stock equal to the product of (A) the Per Interest Stock Consideration multiplied by (B) the number of Common Interests
issuable upon exercise in full of such Electing Options, and (ii) an amount of cash equal to the product of (A) the Per Interest
Cash Consideration multiplied by (B) the number of Common Interests issuable upon exercise in full of such Electing Options, in
each case as determined pursuant to Section 1.7. <A NAME="a_Ref390948446"></A>At the Effective Time, each Oxygen Option with an
exercise price equal to or greater than the Merger Consideration Per Fully Diluted Interest (each, an &ldquo;<U>Out-of-the-Money
Oxygen Option</U>&rdquo;), whether or not vested, shall be cancelled for no consideration.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(b)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>At least twenty (20) Business Days prior to the Effective Time, Oxygen shall provide each Option Holder with notice of the
proposed Closing of the transactions contemplated by this Agreement and the opportunity for such Option Holder to elect, in writing
as of no later than ten (10) Business Days prior to the Effective Time, to pay to Oxygen in cash in immediately available funds
the full exercise price in respect of some or all of such Option Holder&rsquo;s Oxygen Option, which amount shall be paid in immediately
available funds, and evidence of payment of which shall be provided to Carbon, no later than three (3) Business Days prior to the
Effective Time (such election, a &ldquo;<U>Gross Settlement Election</U>&rdquo;). To extent such funds are not timely paid in accordance
with the foregoing, the Gross Settlement Election shall be null and void.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(c)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Immediately prior to the Effective Time, Oxygen, the Board of Directors of Oxygen and its compensation committee, as applicable,
shall adopt any resolutions and take any actions that are reasonably necessary to effectuate the provisions of this Section&nbsp;1.6
(including without limitation amending the terms of any outstanding Oxygen Options) and to ensure that, notwithstanding anything
to the contrary, following the Effective Time, no service provider of Oxygen and its Subsidiaries shall have any right to acquire
any securities of Oxygen, Carbon or any Subsidiary thereof or to receive any payment, right or benefit with respect to any award
previously granted in respect of securities of Oxygen except the right to receive the consideration as provided in this Section
<FONT STYLE="font-size: 10pt">&#8206;1.6 or in Section &#8206;1.4(a) or 1.4(b) in their capacity as Oxygen Holders.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><U><A NAME="a_Toc393714713"></A><A NAME="a_Ref388581132"></A></U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">1.7</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Allocation of Merger Consideration</U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">. </FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(a)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Net Merger Consideration shall be allocated among the holders of the Oxygen Common Interests and Oxygen Options as set
forth in Section 1.4, Section 1.6 and Section 1.7(b). An illustrative calculation of the allocation is set forth on <U>Annex B</U>.</P>



<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-top: 6pt; padding-bottom: 6pt; border-bottom: Black 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 24pt 70%; text-align: left"><U>STRICTLY&nbsp;CONFIDENTIAL</U><BR>EXECUTION&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><A NAME="a_Ref388774168"></A><A NAME="a_Ref390948725"></A><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(b)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>For purposes of this Agreement:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-indent: 0.5in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(i)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT> &ldquo;<U>Aggregate Cash Percentage</U>&rdquo; means fifty-nine percent (59%).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-indent: 0.5in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(ii)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>&ldquo;<U>Aggregate Fully Diluted Common Interests</U>&rdquo; means (A) the number of Oxygen Common Interests outstanding
immediately prior to the Effective Time (whether vested or unvested) <U>plus</U> (B) the number of Oxygen Common Interests that
would be issuable upon the exercise in full of all In-the-Money Oxygen Options immediately prior to the Effective Time.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-indent: 0.5in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(iii)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>&ldquo;<U>Aggregate In-The-Money Exercise Price</U>&rdquo; means the sum of the exercise prices that would be payable upon
exercise in full immediately prior to the Effective Time of all In-the-Money Oxygen Options, including the exercise prices paid
by Option Holders in connection with a Gross Settlement Election.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-indent: 0.5in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(iv)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>&ldquo;<U>Aggregate Stock Percentage</U>&rdquo; means forty-one percent (41%).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-indent: 0.5in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(v)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>&ldquo;<U>Carbon Signing Price</U>&rdquo; means $44.33; <U>provided</U> that if, prior to the Effective Time, the outstanding
shares of Carbon Common Stock shall have been increased or decreased as a result of a stock dividend, stock split, reverse stock
split or other similar change in capitalization (which, for the avoidance of doubt, shall not include a share repurchase), or if
there has been any extraordinary dividend or distribution (other than regular quarterly cash dividends), an appropriate and proportionate
adjustment shall be made to the Carbon Signing Price.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-indent: 0.5in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(vi)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>&ldquo;<U>Cash Consideration Amount</U>&rdquo; means (A) the product of (x) the Aggregate Cash Percentage <U>multiplied</U>
<U>by</U> (y) the Net Merger Consideration <U>minus</U> (B) the Holdback Amount <U>minus</U> (C) the Holder Expense Fund <U>minus</U>
(D) the aggregate Non-Accredited Investor Common Interest Consideration; <U>minus</U> (E) the aggregate Non-Accredited Investor
Option Consideration <U>minus</U> (F) the aggregate Carbon Cash Award.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-indent: 0.5in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(vii)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>&ldquo;<U>Holdback Amount</U>&rdquo; shall mean $116,000,000.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-indent: 0.5in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(viii)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>&ldquo;<U>In-the-Money Oxygen Options</U>&rdquo; means the Oxygen Options that, immediately prior to the Effective Time,
have an exercise price that is less than the Merger Consideration Per Fully Diluted Interest.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-indent: 0.5in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(ix)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>&ldquo;<U>Merger Consideration Per Fully Diluted Interest</U>&rdquo; means the quotient of (A) the sum of (w) the Net Merger
Consideration <U>minus</U> (x) the Holdback Amount <U>minus</U> (y) the Holder Expense Fund <U>plus</U> (z) the Aggregate In-The-Money
Exercise Price <U>divided</U> <U>by</U> (B) the Aggregate Fully Diluted Common Interests.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-indent: 0.5in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(x)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>&ldquo;<U>Net Merger Consideration</U>&rdquo; means (A) the Final Gross Merger Consideration <U>minus</U> (B) Tax Effected
Transaction Expenses <U>minus</U> (C) the Retention Amount.</P>


<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-top: 6pt; padding-bottom: 6pt; border-bottom: Black 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 24pt 70%; text-align: left"><U>STRICTLY&nbsp;CONFIDENTIAL</U><BR>EXECUTION&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-indent: 0.5in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(xi)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT> &ldquo;<U>Option Consideration</U>&rdquo; means for each Oxygen Option, the excess, if any, of (A) the product of (x) the
Merger Consideration Per Fully Diluted Interest, <U>multiplied</U> <U>by</U> (y) the aggregate number of Common Interests issuable
upon exercise in full of such Oxygen Option <U>minus</U> (B) the exercise price payable upon exercise in full of such Oxygen Option.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-indent: 0.5in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(xii)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>&ldquo;<U>Per Interest Cash Consideration</U>&rdquo; means (A) the Merger Consideration Per Fully Diluted Interest <U>multiplied</U>
<U>by</U> (B) a fraction, the numerator of which is the Cash Consideration Amount and the denominator of which is the sum of (x)
the Cash Consideration Amount <U>plus</U> (y) the Stock Consideration Amount.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-indent: 0.5in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(xiii)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>&ldquo;<U>Per Interest Stock Consideration</U>&rdquo; means a number of shares of Carbon Common Stock equal to (A) the Merger
Consideration Per Fully Diluted Interest <U>multiplied</U> <U>by</U> (B) a fraction, the numerator of which is the Stock Consideration
Amount and the denominator of which is the sum of (x) the Cash Consideration Amount <U>plus</U> (y) the Stock Consideration Amount
<U>divided</U> <U>by</U> (C) the Carbon Signing Price.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-indent: 0.5in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(xiv)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>&ldquo;<U>Per Option Cash Consideration</U>&rdquo; means (A) the Option Consideration <U>multiplied</U> <U>by</U> (B) a
fraction, the numerator of which is the Cash Consideration Amount and the denominator of which is the sum of (x) the Cash Consideration
Amount <U>plus</U> (y) the Stock Consideration Amount.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-indent: 0.5in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(xv)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>&ldquo;<U>Per Option Stock Consideration</U>&rdquo; means a number of shares of Carbon Common Stock equal to (A) the Option
Consideration <U>multiplied</U> <U>by</U> (B) a fraction, the numerator of which is the Stock Consideration Amount and the denominator
of which is the sum of (x) the Cash Consideration Amount <U>plus</U> (y) the Stock Consideration Amount <U>divided</U> <U>by</U>
(C) the Carbon Signing Price.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-indent: 0.5in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(xvi)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>&ldquo;<U>Rolled Equity Award Amount</U>&rdquo; means (A) the number of Oxygen Interest Awards outstanding immediately prior
to the Effective Time that are not held by Non-Accredited Investors multiplied by (B) the Merger Consideration Per Fully Diluted
Interest.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-indent: 0.5in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(xvii)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT>&ldquo;<U>Stock
Consideration Amount</U>&rdquo; means (A) the product of (x) the Aggregate Stock Percentage <U>multiplied</U> <U>by</U> (y)
the Net Merger Consideration <U>minus</U> (B) the Rolled Equity Award Amount.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><A NAME="a_Ref390331417"></A><A NAME="a_Ref392108381"></A><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(c)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Oxygen Audited Financial Statements</U></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-indent: 0.5in"><A NAME="a_Ref390948454"></A><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(i)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>As promptly as practicable following the date hereof (and in any event by December 31, 2014, Oxygen shall deliver to Carbon
(i) an audited consolidated balance sheet of Oxygen as of June 30, 2014 (the &ldquo;<U>Oxygen Audited Interim Balance Sheet</U>&rdquo;)
and (ii) the related audited consolidated statements of income of Oxygen for the six (6) months ended June 30, 2014, including
accompanying notes thereto ((i) and (ii), the &ldquo;<U>Oxygen Audited Interim Financial Statements</U>&rdquo;) which financial
statements shall be accompanied by (A) an</P>


<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-top: 6pt; padding-bottom: 6pt; border-bottom: Black 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 24pt 70%; text-align: left"><U>STRICTLY&nbsp;CONFIDENTIAL</U><BR>EXECUTION&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in">unqualified opinion of PricewaterhouseCoopers LLP regarding
such consolidated financial statements, (B) a certificate from an executive officer of Oxygen (x) affirming the compliance of such
financial statements with the covenant set forth in Section 1.7(c)(ii), (y) setting forth the calculation of the Gross Merger Consideration
derived from the Oxygen Audited Interim Financial Statements (including the calculation of Tangible Common Equity, Tangible Assets,
Required Capital, Excess Capital and the Excluded Amount) and (z) certifying that the Gross Merger Consideration is derived from
the Oxygen Audited Interim Financial Statements and was calculated in a manner consistent with this Agreement and the derivation
of the Preliminary Gross Merger Consideration from the Oxygen Unaudited Financial Statements and (C) such documents and information
used by Oxygen in its calculation of Gross Merger Consideration (including the calculation of Tangible Common Equity, Tangible
Assets, Required Capital, Excess Capital and the Excluded Amount) as are reasonably necessary for Carbon to review and verify such
calculations.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-indent: 0.5in"><A NAME="a_Ref390947747"></A><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(ii)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Oxygen Audited Interim Financial Statements (including the related notes, where applicable) (A)&nbsp;will be prepared
from, and will be in accordance with, the books and records of Oxygen and its Subsidiaries, (B)&nbsp;will fairly present in all
material respects the consolidated results of operations and consolidated financial position of Oxygen and its Subsidiaries for
the six (6) months ended June 30, 2014 or as of June 30, 2014, as applicable, (C)&nbsp;will be prepared in accordance with GAAP
consistently applied during the periods involved and (D) will be prepared on a basis consistent with the audited consolidated balance
sheet and related audited consolidated statements of income included in the Oxygen Audited Financial Statements.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-indent: 0.5in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(iii)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>In the event that Carbon disputes the correctness of the calculation of Gross Merger Consideration derived from the Oxygen
Audited Interim Financial Statements (including, to the extent permitted by the last sentence of this clause (iii), any amounts
set forth on the Oxygen Audited Interim Financial Statements), Carbon shall notify Oxygen in writing of its objections as soon
as practicable but in no event more than the earlier of (x) seventy-five (75) Business Days after receipt of the calculation from
Oxygen (a &ldquo;<U>Notice of Disagreement</U>&rdquo;) and (y) 40 Business Days prior to the anticipated Closing Date and during
such period Carbon and Oxygen will consult on a periodic basis with respect to Carbon&rsquo;s possible bases for such objections
and any errors discovered by Oxygen with respect to the calculation of Gross Merger Consideration or any amounts set forth on the
Oxygen Audited Interim Financial Statements. If Carbon does not deliver a Notice of Disagreement prior to the deadline set forth
in the preceding sentence, Oxygen&rsquo;s calculation of Gross Merger Consideration shall be final and binding on the parties.
During the ten (10) Business Days immediately following the delivery of any Notice of Disagreement from Carbon, Carbon and Oxygen
shall seek in good faith to resolve any differences that they may have with respect to any matters raised in the Notice of Disagreement.
The matters set forth in any written resolution executed by Carbon and Oxygen shall be final and binding on the parties on the
date of such written resolution. <A NAME="a_Ref385257649"></A>If, at the end of such ten (10)</P>


<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-top: 6pt; padding-bottom: 6pt; border-bottom: Black 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 24pt 70%; text-align: left"><U>STRICTLY&nbsp;CONFIDENTIAL</U><BR>EXECUTION&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in">Business Day period, Carbon and Oxygen have not been
able to resolve in writing all differences that they have with respect to the matters raised in the Notice of Disagreement, Carbon
and Oxygen shall submit to Deloitte &amp; Touche (the &ldquo;<U>Accounting Firm</U>&rdquo;) for review and resolution of any and
all matters in the Notice of Disagreement that remain in dispute, and the Accounting Firm shall reach a final, binding resolution
of all such matters that remain in dispute and a final determination of Gross Merger Consideration, which final resolution shall
not be subject to collateral attack for any reason (other than fraud) and shall be (i) in writing and signed by the Accounting
Firm, (ii) within the range of the amounts contested by Carbon and Oxygen, (iii) furnished to Carbon and Oxygen as soon as practicable
after the items in dispute have been referred to the Accounting Firm, which shall not be more than thirty (30) Business Days after
such referral, (iv) made in accordance with the terms of this Agreement and (v) conclusive and binding upon Carbon and Oxygen on
the date of delivery of such written resolution (other than in the case of fraud). Carbon and Oxygen agree to cooperate with the
Accounting Firm and to promptly provide all documents and information reasonably requested by the Accounting Firm so as to enable
it to make its determination as quickly and as accurately as possible. The fees and expenses of the Accounting Firm shall be borne
by Oxygen and Carbon in the same proportion that Oxygen&rsquo;s position, on the one hand, and Carbon&rsquo;s position, on the
other hand, initially presented to the Accounting Firm (based on the aggregate of all differences taken as a whole) bear to the
final resolution as determined by the Accounting Firm; <U>provided</U> that any fees and expenses borne by Oxygen shall be Transaction
Expenses. Carbon shall only be entitled to dispute (i) the calculation of the Gross Merger Consideration (including the calculation
of Tangible Common Equity, Tangible Assets, Required Capital, Excess Capital and the Excluded Amount) and (ii) with respect to
amounts set forth on the Oxygen Audited Interim Financial Statements, (a) mathematical errors, (b) errors discovered by Oxygen
(including if such error would be addressed by including an adjustment in its financial statements for a subsequent period) and
(c) that the Oxygen Audited Interim Financial Statements (including the related notes, where applicable), (1) were not prepared
from, and are not in accordance with, the books and records of Oxygen and its Subsidiaries, (2) were not prepared in accordance
with GAAP consistently applied during the periods involved and (3) were not prepared on a basis consistent with the audited consolidated
balance sheet and related audited consolidated statements of income included in the Oxygen Audited Financial Statements as of,
and for the period ended December 31, 2013. Notwithstanding the foregoing, changes in underlying assumptions or models (including
with respect to valuation of assets) shall not be a basis for dispute under the foregoing clause (3) so long as such changes were
not inconsistent with the standards set forth in clauses (iii) and (iv) of Section 3.8(b).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-indent: 0.5in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(iv)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Gross Merger Consideration as finally determined pursuant to Section 1.7(c)(iii) shall be the &ldquo;<U>Final Gross Merger
Consideration</U>.&rdquo;</P>


<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-top: 6pt; padding-bottom: 6pt; border-bottom: Black 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 24pt 70%; text-align: left"><U>STRICTLY&nbsp;CONFIDENTIAL</U><BR>EXECUTION&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><U><A NAME="a_Toc393714714"></A><A NAME="a_Toc391290174"></A><A NAME="a_Toc391290333"></A><A NAME="a_Toc391290446"></A><A NAME="a_Toc389500850"></A></U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">1.8</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U> Organizational Documents of the Surviving Company</U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">. At the
Effective Time, the certificate of formation of Merger Sub as in effect immediately prior to the Effective Time, shall be the certificate
of formation of the Surviving Company until thereafter amended in accordance with applicable Law. The limited liability company
agreement of Merger Sub, as in effect immediately prior to the Effective Time, shall be the limited liability company agreement
of the Surviving Company until thereafter amended in accordance with applicable Law.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><U><A NAME="a_Toc393714715"></A></U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">1.9</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Directors and Officers of the Surviving Company</U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">. The directors
of Merger Sub shall, from and after the Effective Time, become the initial directors of the Surviving Company until their successors
shall have been duly elected or appointed and qualified, or their earlier death, resignation or removal. The officers of Merger
Sub shall from and after the Effective Time, become the initial officers of the Surviving Company until their successors shall
have been duly elected or appointed and qualified, or their earlier death, resignation or removal.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><U><A NAME="a_Toc393714716"></A></U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">1.10</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Certificate of Incorporation and Bylaws of Carbon</U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">. The certificate
of incorporation of Carbon as in effect immediately prior to the Effective Time shall be the certificate of incorporation of Carbon
until amended in accordance with applicable Law. At the Effective Time, the bylaws of Carbon, as in effect immediately prior to
the Effective Time, shall be the bylaws of Carbon until thereafter amended in accordance with applicable Law. </FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><U><A NAME="a_Toc393714717"></A><A NAME="a_Ref349648166"></A></U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">1.11</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Directors and Officers of Carbon</U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">. </FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(a)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Except as set forth in this Section&nbsp;1.11, at and immediately after the Effective Time, the officers of Carbon shall
consist of the officers of Carbon in office immediately prior to the Effective Time, in each case until their respective successors
are duly elected or appointed and qualified, or their earlier death, resignation or removal.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(b)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Carbon&rsquo;s Board of Directors shall take all appropriate action so that at and after the Effective Time Steven Mnuchin
shall hold the office of Vice Chairman of Carbon and Joseph Otting shall hold the office of Co-President of Carbon. Each of the
foregoing officers shall serve until their successors have been duly elected or appointed and qualified, or their earlier death,
resignation or removal.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(c)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>At or prior to the Effective Time, Carbon&rsquo;s Board of Directors shall take all appropriate action to increase the number
of directors by two (2). The two (2) vacancies shall be filled by (i) Steven Mnuchin and (ii) Alan Frank. Each of the foregoing
directors shall serve until his or her successor has been duly elected or appointed and qualified, or his or her earlier death,
resignation or removal. If prior to the Effective Time, any Person designated to fill any such vacancy is unable or unwilling to
serve in such position, the Board of Directors of Oxygen and the Board of Directors of Carbon shall mutually agree on a replacement.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><U><A NAME="a_Toc393714718"></A><A NAME="a_Ref388718340"></A></U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">1.12</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Bank Merger</U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">. </FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(a)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>On the Closing Date and simultaneously with the Merger, CIT Bank, a Utah state-chartered bank and a wholly owned Subsidiary
of Carbon (&ldquo;<U>Carbon Bank</U>&rdquo;), will merge (the &ldquo;<U>Bank Merger</U>&rdquo;) with and into OneWest Bank N.A.,
a national bank and a wholly owned Subsidiary of Oxygen (&ldquo;<U>Oxygen Bank</U>&rdquo;); <U>provided</U> that without limiting
any of the</P>


<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-top: 6pt; padding-bottom: 6pt; border-bottom: Black 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 24pt 70%; text-align: left"><U>STRICTLY&nbsp;CONFIDENTIAL</U><BR>EXECUTION&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt">obligations of Carbon or Oxygen set forth herein with respect
to the Bank Merger or any of the conditions set forth in Section 7.1, 7.2 or 7.3 relating to the Bank Merger, if the parties agree
that operational issues relating to the Bank Merger would preclude the ability of the parties to consummate the Bank Merger simultaneously
with the Merger, Carbon and Oxygen shall act reasonably and in good faith to mutually determine whether to proceed with the Merger
prior to the Bank Merger. Oxygen Bank shall be the surviving entity in the Bank Merger (the &ldquo;<U>Surviving Bank</U>&rdquo;)
and, following the Bank Merger, the separate corporate existence of Carbon Bank shall cease.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(b)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Bank Merger shall be implemented pursuant to an agreement and plan of merger, in a form to be specified by Carbon and
reasonably acceptable to Oxygen (the &ldquo;<U>Bank Merger Agreement</U>&rdquo;). In order to obtain the necessary regulatory approvals
for the Bank Merger, the parties hereto shall cause the following to be accomplished prior to the filing of applications with any
Governmental Entity for regulatory approval of the Bank Merger: (i)&nbsp;Oxygen shall cause Oxygen Bank to adopt the Bank Merger
Agreement, Oxygen, as the sole shareholder of Oxygen Bank, shall approve the Bank Merger Agreement, and Oxygen shall cause the
Bank Merger Agreement to be duly executed by Oxygen Bank and delivered to Carbon Bank and (ii)&nbsp;Carbon shall cause Carbon Bank
to adopt the Bank Merger Agreement, Carbon, as the sole shareholder of Carbon Bank, shall approve the Bank Merger Agreement and
Carbon shall cause the Bank Merger Agreement to be duly executed by Carbon&nbsp;Bank and delivered to Oxygen Bank. Oxygen shall
cause Oxygen Bank, and Carbon shall cause Carbon Bank, to execute such certificates of merger and articles of combination and such
other documents and certificates as are necessary to make the Bank Merger effective (&ldquo;<U>Bank Merger Certificates</U>&rdquo;)
at the appropriate time as determined pursuant to the first sentence of Section 1.12. The time that the Bank Merger occurs becomes
effective pursuant to the foregoing sentence shall be the &ldquo;<U>Bank Merger Effective Time</U>&rdquo;).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(c)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The directors of the Surviving Bank shall, from and after the Bank Merger Effective Time consist of (i) the members of the
Carbon Board of Directors at the Effective Time (or if the Bank Merger Effective Time occurs following the Effective Time, the
members of the Carbon Board of Directors at such time), (ii) Nelson Chai and (iii) Joseph Otting, in each case, until their successors
shall have been duly elected or appointed and qualified, or their earlier death, resignation or removal. Oxygen Bank&rsquo;s Board
of Directors shall take all appropriate action so that at and after the Bank Merger Effective Time, Steven Mnuchin shall hold the
office of Chairman of the Surviving Bank (which, for the avoidance of doubt, is not the Chairman of the Surviving Bank Board of
Directors) and Joseph Otting shall hold the office of Chief Executive Officer and President of the Surviving Bank.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><U><A NAME="a_Toc393714719"></A><A NAME="a_Toc366690655"></A><A NAME="a_Toc366061774"></A><A NAME="a_Toc365737991"></A><A NAME="a_Toc351991686"></A><A NAME="a_Toc392890225"></A><A NAME="a_Toc392897160"></A><A NAME="a_Toc347943866"></A><A NAME="a_Toc347947688"></A><A NAME="a_Toc347947809"></A><A NAME="a_Toc347947929"></A><A NAME="a_Toc392897161"></A><A NAME="a_Toc392897162"></A></U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">1.13</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Tax Consequences</U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">. It is intended that the Merger shall qualify
as a &ldquo;reorganization&rdquo; within the meaning of Section 368(a) of the Code, and that this Agreement is intended to be and
is adopted as a &ldquo;plan of reorganization&rdquo; for the purposes of Sections 354 and 361 of the Code.</FONT></P>



<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-top: 6pt; padding-bottom: 6pt; border-bottom: Black 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 24pt 70%; text-align: left"><U>STRICTLY&nbsp;CONFIDENTIAL</U><BR>EXECUTION&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center; text-indent: 0in"><FONT STYLE="text-transform: uppercase"><A NAME="a_Toc393714720"></A><A NAME="a_Toc349846174"></A><A NAME="a_Toc349846294"></A><A NAME="a_Toc349846416"></A><A NAME="a_Toc349846536"></A><A NAME="a_Toc349846777"></A>Article
II</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><A NAME="a_Ref347357598"></A>EXCHANGE OF EQUITY INTERESTS</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><U><A NAME="a_Toc393714721"></A><A NAME="a_Ref388719022"></A></U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">2.1</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Carbon to Make Shares and Cash Available</U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">. At or prior to the
Effective Time, Carbon shall deposit, or shall cause to be deposited, with a bank or trust company designated by Carbon (the &ldquo;<U>Exchange
Agent</U>&rdquo;), (i) for the benefit of the holders of vested Oxygen Common Interests, (A) Certificates representing the aggregate
Per Interest Stock Consideration and (B) cash representing the sum of (1) the aggregate Per Interest Cash Consideration, (2) the
aggregate Non-Accredited Investor Common Interest Consideration and (3) the aggregate amount of cash payable to such holders in
lieu of fractional shares and (ii) for the benefit of holders of In-the-Money Oxygen Options, (A) Certificates representing the
aggregate Per Option Stock Consideration and (B) cash representing the sum of (1) the aggregate Per Option Cash Consideration,
(2) the aggregate Non-Accredited Investor Option Consideration and (3) the aggregate amount of cash payable to such holders in
lieu of fractional shares (such cash and Certificates for shares of Carbon Common Stock, together with any dividends or distributions
with respect thereto, being hereinafter referred to as the &ldquo;<U>Exchange Fund</U>&rdquo;), in each case for exchange in accordance
with this Article II; <U>provided</U> that Carbon may deliver the cash portion of any consideration payable to a holder of Oxygen
Options through its ordinary payroll systems in lieu of depositing such funds to the Exchange Agent as part of the Exchange Fund;
<U>provided</U>, further that to effectuate the payment provisions set forth in Section </FONT><FONT STYLE="font-size: 10pt">&#8206;1.6,
Electing Options will be treated as vested Common Interests for purposes of this Section &#8206;2.1, except that Carbon may pay
the cash portion of any consideration payable to an Electing Option through its ordinary payroll systems in lieu of depositing
such funds to the Exchange Agent as part of the Exchange Fund. </FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><U><A NAME="a_Toc393714722"></A><A NAME="a_Ref347358262"></A><A NAME="a_Ref347358168"></A></U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">2.2</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Exchange of Equity Interests</U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">. </FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><A NAME="a_Ref347358246"></A><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(a)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Between thirty (30) and sixty (60) days prior to the anticipated Closing Date, Carbon shall (A) mail or deliver to each
holder of record of one or more Oxygen Common Interests as of the Business Day immediately prior to the date of such mailing or
delivery that will be vested as of the anticipated Closing Date, (1) a letter of transmittal in a form reasonably satisfactory
to Oxygen (which, among other things, shall specify that delivery shall be effected, and risk of loss and title to the Oxygen Common
Interests shall pass, only upon proper delivery of the letter of transmittal to the Exchange Agent and include an agreement by
such holder to the treatment of the Oxygen Common Interests pursuant to this Agreement and a release of claims against Oxygen and
Carbon relating thereto, but shall not provide for any representations or warranties on the part of a Holder of Common Interests
other than with respect to title to the Common Interests delivered and due authorization, execution and delivery of the Letter
of Transmittal) (the &ldquo;<U>Letter of Transmittal</U>&rdquo;), (2) instructions for use in effecting the surrender of the Oxygen
Common Interests in exchange for the Per Common Interest Merger Consideration or the Non-Accredited Common Interest Consideration,
as applicable, and (3) an Investor Questionnaire and (B) mail or deliver to each holder of an Oxygen Option and each holder of
an Oxygen Interest Award as of the Business Day immediately prior to the date of such mailing or delivery, (1) a Holder Acknowledgement
(which, among other things, shall include an agreement by such holder to agree to the treatment of the Oxygen Options and Oxygen
Interest Awards pursuant to this Agreement and a release of claims against Oxygen and Carbon relating thereto)</P>


<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-top: 6pt; padding-bottom: 6pt; border-bottom: Black 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 24pt 70%; text-align: left"><U>STRICTLY&nbsp;CONFIDENTIAL</U><BR>EXECUTION&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt">and (2) an Investor Questionnaire. As soon as reasonably
practicable after the Effective Time, the Exchange Agent or Carbon shall mail or deliver the appropriate documents referred to
in the preceding sentence to any Holder who has not previously returned such materials to the Exchange Agent.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(b)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Upon the later of (i) the Effective Time and (ii) delivery of a properly completed, duly executed Letter of Transmittal
and a properly completed, duly executed Investor Questionnaire, or in the case of the holder of an In-the-Money Oxygen Option,
a properly completed, duly executed Holder Acknowledgement and a properly completed, duly executed Investor Questionnaire, (A)
the holder of vested Oxygen Common Interests shall be entitled to receive in exchange therefor, as applicable, promptly following
the Effective Time (1)&nbsp;a Certificate representing that number of whole shares of Carbon Common Stock to which such holder
of vested Oxygen Common Interests shall have become entitled pursuant to the provisions of Article I, if any, and (2) an amount
of cash, including any cash in lieu of fractional shares which such holder has the right to receive pursuant to the provisions
of Article I and this Article II and (B) the holder of such In-the-Money Oxygen Option shall be entitled to receive, promptly following
the Effective Time (1) a Certificate representing that number of whole shares of Carbon Common Stock to which such holder of such
In-the-Money Oxygen Option shall have become entitled pursuant to the provisions of Article I, if any, and (2) an amount of cash,
including any cash in lieu of fractional shares which such holder has the right to receive in respect of such In-the-Money Oxygen
Option pursuant to the provisions of Article I and this Article II, if any; <U>provided</U> that any cash due to a holder of Oxygen
Common Interests or In-the-Money Oxygen Options shall be paid (x) if such amount is greater than or equal to $100,000, at the holder&rsquo;s
election, by check or wire transfer and (y) if such amount is less than $100,000, by check; <U>provided further</U> that Carbon
may deliver the cash portion of any consideration payable to a holder of an In-the-Money Oxygen Option through its ordinary payroll
systems in lieu of delivery of a check or wire transfer. No interest will be paid or accrued on any cash to be paid to holders
of Oxygen Common Interests or Oxygen Options, or cash in lieu of fractional shares.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(c)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>No dividends or other distributions declared with respect to Carbon Common Stock shall be paid to any holder who has not
delivered in accordance with this Article II a properly completed, duly executed Letter of Transmittal and a properly completed,
duly executed Investor Questionnaire, or in the case of the holder of an In-the-Money Oxygen Option, a properly completed, duly
executed Holder Acknowledgement and a properly completed, duly executed Investor Questionnaire. After the delivery of such materials
in accordance with this Article II, the record holder thereof shall be entitled to receive any such dividends or other distributions,
without any interest thereon, which theretofore had become payable with respect to the whole shares of Carbon Common Stock which
the Oxygen Common Interests or Oxygen Options, as applicable, have been converted into the right to receive.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(d)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>If any Certificate representing shares of Carbon Common Stock is to be issued in, or cash is to be paid to, a name other
than that in which the Oxygen Common Interests surrendered in exchange therefor is or are recorded, it shall be a condition of
the issuance thereof that the Letter of Transmittal delivered with respect to such Oxygen Common Interests shall be accompanied
by an appropriate instrument of transfer, and that the Person requesting such exchange shall pay to the Exchange Agent in advance
any transfer or other similar Taxes required by reason of the issuance of a Certificate representing shares of Carbon Common Stock</P>


<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-top: 6pt; padding-bottom: 6pt; border-bottom: Black 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 24pt 70%; text-align: left"><U>STRICTLY&nbsp;CONFIDENTIAL</U><BR>EXECUTION&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt">in any name other than that of the record holder of the Oxygen
Common Interests surrendered, or required for any other reason, or shall establish to the satisfaction of the Exchange Agent that
such Tax has been paid or is not payable.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(e)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>After the Effective Time, there shall be no transfers on the books of Oxygen of Oxygen Common Interests that were issued
and outstanding immediately prior to the Effective Time.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><A NAME="a_Ref347358058"></A><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(f)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Notwithstanding anything to the contrary contained herein, no Certificates representing fractional shares of Carbon Common
Stock shall be issued in exchange for Oxygen Common Interests or in exchange for Oxygen Options, no dividend or distribution with
respect to Carbon Common Stock shall be payable on or with respect to any fractional share, and such fractional share interests
shall not entitle the owner thereof to vote or to any other rights of a shareholder of Carbon. In lieu of the issuance of any such
fractional share, Carbon shall pay to each former holder of vested Oxygen Common Interests or In-the-Money Oxygen Options who otherwise
would be entitled to receive such fractional share an amount in cash (rounded to the nearest cent) determined by multiplying (i)
the Carbon Closing Price by (ii) the fraction of a share (rounded to the nearest thousandth when expressed in decimal form) of
Carbon Common Stock which such holder would otherwise be entitled to receive pursuant to Section&nbsp;1.4.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(g)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Any portion of the Exchange Fund that remains unclaimed by the former holders of vested Oxygen Common Interest and In-the-Money
Oxygen Options for twelve (12) months after the Effective Time shall be paid to Carbon; <U>provided</U> that if at any time prior
to such date, any portion of the Exchange Fund that remains unclaimed would have to be delivered to a public official pursuant
to applicable abandoned property, escheat or similar Laws, the Exchange Agent shall first notify Carbon and, at Carbon&rsquo;s
option, such portion shall instead be paid to Carbon. Any former holder of vested Oxygen Common Interests or In-the-Money Oxygen
Options who has not theretofore complied with this Article II shall thereafter look only to Carbon for payment of the Per Common
Interest Merger Consideration, Per Option Merger Consideration, Non-Accredited Investor Common Interest Consideration, or Non-Accredited
Investor Option Consideration, as applicable, and any unpaid dividends and distributions on the Carbon Common Stock deliverable
in respect of each former Oxygen Common Interest or Oxygen Option such holder holds as determined pursuant to this Agreement, in
each case, without any interest thereon. Notwithstanding the foregoing, none of Carbon, Oxygen, the Exchange Agent or any other
Person shall be liable to any former holder of Oxygen Common Interests or Oxygen Options for any amount delivered in good faith
to a public official pursuant to applicable abandoned property, escheat or similar Laws.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(h)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Carbon shall be entitled to deduct and withhold, or cause the Exchange Agent to deduct and withhold, from the consideration
otherwise payable pursuant to this Agreement to any holder of vested Oxygen Common Interests or In-the-Money Oxygen Options such
amounts as it is required to deduct and withhold with respect to the making of such payment under the Code or any provision of
state, local or foreign Tax Law. To the extent that amounts are so withheld by Carbon or the Exchange Agent, as the case may be,
and paid over to the appropriate Governmental Entity, the withheld amounts shall be treated for all purposes of this Agreement
as having been paid to the holder of Oxygen Common Interests or Oxygen Options in respect of which the deduction and withholding
was made by Carbon or the Exchange</P>


<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-top: 6pt; padding-bottom: 6pt; border-bottom: Black 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 24pt 70%; text-align: left"><U>STRICTLY&nbsp;CONFIDENTIAL</U><BR>EXECUTION&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt">Agent, as the case may be. For purposes of this provision,
all Taxes required to be withheld or deducted under the Code or any provision of state, local or foreign Tax Law in respect of
a holder&rsquo;s In-the-Money Oxygen Options (including the Electing Options) (the &ldquo;<U>Option Withholding Amount</U>&rdquo;)
shall first be reduced from the aggregate Per Option Cash Consideration payable in respect of such In-the-Money Oxygen Options
(the &ldquo;<U>Option Cash Amount</U>&rdquo;) (or the Per Interest Cash Consideration in respect of an Electing Option if the holder
of such Electing Option does not separately pay the Withholding Amount in cash). If the Option Withholding Amount exceeds the Option
Cash Amount or Per Interest Cash Consideration, as applicable, the amount of the shortfall shall then reduce the Per Option Stock
Consideration or Per Interest Stock Consideration, as applicable, to be received in respect of such Oxygen Options, with the value
of such Per Option Stock Consideration or Per Interest Stock Consideration, as applicable, based on the closing-sale price of Carbon
Common Stock on the NYSE as reported by The Wall Street Journal on the Closing Date.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><A NAME="a_Ref389400159"></A><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(i)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>All shares of Carbon Common Stock received in the Merger shall bear a legend or legends (and appropriate comparable notations
or other arrangements will be made with respect to any uncertificated shares) referencing restrictions on transfer of such shares
of Carbon Common Stock under the Securities Act which legend shall state in substance:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-indent: 0in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">&ldquo;The
securities evidenced by this certificate have been issued and sold without registration under the United States Securities Act
of 1933, as amended (the &ldquo;<U>Securities Act</U>&rdquo;), or the securities laws of any state of the United States (a &ldquo;<U>State
Act</U>&rdquo;) in reliance upon certain exemptions from registration under said acts. The securities evidenced by this certificate
cannot be sold, assigned or otherwise transferred within the United States unless such sale, assignment or other transfer is (i)
made pursuant to an effective registration statement under the Securities Act and in accordance with each applicable State Act
or (ii) exempt from, or not subject to, the Securities Act and each applicable State Act.&rdquo;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(j)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Notwithstanding Section 2.2(i), the holder of any Certificate(s) for such shares of Carbon Common Stock shall be entitled
to receive from Carbon new Certificates for a like number of shares not bearing such legend (or the elimination or termination
of such notations or arrangements) upon the request of such holder at (i) such time as such restrictions are no longer applicable,
and (ii) if required by Carbon, delivery of an opinion of counsel to such holder, which opinion is reasonably satisfactory in form
and substance to Carbon, that the restriction referenced in such legend (or such notations or arrangements) is no longer required
in order to ensure compliance with the Securities Act.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><U><A NAME="a_Toc393714723"></A></U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">2.3</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Holder Expense Fund</U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">. On the Closing Date, Carbon shall pay
to the Holders&rsquo; Representative or to such other persons (and in such amounts) as may be designated by the Holders&rsquo;
Representative, by wire transfer to an account or accounts designated by the Holders&rsquo; Representative in writing prior to
the Closing Date, immediately available funds in the amount of the Holder Expense Fund.</FONT></P>



<!-- Field: Page; Sequence: 20 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-top: 6pt; padding-bottom: 6pt; border-bottom: Black 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 24pt 70%; text-align: left"><U>STRICTLY&nbsp;CONFIDENTIAL</U><BR>EXECUTION&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center; text-indent: 0in"><FONT STYLE="text-transform: uppercase"><A NAME="a_Toc393714724"></A>Article
III</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center">
<A NAME="a_Ref354687430"></A><A NAME="a_Ref347357756"></A>REPRESENTATIONS AND WARRANTIES OF OXYGEN</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Except as Previously Disclosed by Oxygen,
Oxygen hereby represents and warrants to Carbon and Merger Sub as follows:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><U><A NAME="a_Toc393714725"></A><A NAME="a_Ref347359497"></A></U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">3.1</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Corporate Organization</U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">. </FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><A NAME="a_Ref388720121"></A><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(a)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Oxygen is a limited liability company duly organized, validly existing and in good standing under the Laws of the State
of Delaware, and is a bank holding company duly registered under the BHC Act. Oxygen has the corporate power and authority to own
or lease all of its properties and assets and to carry on its business as it is now being conducted. Oxygen is duly licensed or
qualified to do business in each jurisdiction in which the nature of the business conducted by it or the character or location
of the properties and assets owned or leased by it makes such licensing or qualification necessary, except where the failure to
be so licensed or qualified would not, either individually or in the aggregate, reasonably be expected to have a Material Adverse
Effect on Oxygen. True and complete copies of the Organizational Documents of Oxygen, as amended through the date hereof have previously
been Made Available by Oxygen to Carbon. The Oxygen Organizational Documents are in full force and effect and Oxygen is not in
violation of any of their provisions.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><A NAME="a_Ref388720145"></A><A NAME="a_Ref347943479"></A><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(b)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Each Oxygen Subsidiary (i) is duly organized and validly existing under the Laws of its jurisdiction of organization, (ii)
is duly qualified to do business and, where such concept is recognized under applicable Law, in good standing in all jurisdictions
(whether federal, state, local or foreign) where its ownership or leasing of property or the conduct of its business requires it
to be so qualified and in which the failure to be so qualified would reasonably be expected to have a Material Adverse Effect on
Oxygen and (iii) has all requisite corporate power and authority to own or lease its properties and assets and to carry on its
business as now conducted. There are no restrictions on the ability of any Oxygen Subsidiary to pay dividends or distributions
except, in the case of a Subsidiary that is a regulated entity, for restrictions on dividends or distributions generally applicable
to all such regulated entities. The deposit accounts of each Subsidiary of Oxygen that is an insured depository institution are
insured by the FDIC through the Deposit Insurance Fund to the fullest extent permitted by applicable Law, all premiums and assessments
required to be paid in connection therewith have been paid when due, and no proceedings for the termination of such insurance are
pending or threatened. Section&nbsp;3.1(b) of the Oxygen Disclosure Schedule sets forth a true and complete list of all Subsidiaries
of Oxygen and any joint ventures, partnerships or similar arrangements in which Oxygen or its Subsidiaries has a limited liability,
partnership or other equity interest (and the amount and percentage of any such interest). True and complete copies of the Organizational
Documents of each Oxygen Subsidiary, as amended through the date hereof, have previously been Made Available by Oxygen to Carbon.
All such Organizational Documents are in full force and effect and Oxygen and its Subsidiaries are not in violation of any of their
provisions.</P>


<!-- Field: Page; Sequence: 21 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-top: 6pt; padding-bottom: 6pt; border-bottom: Black 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 24pt 70%; text-align: left"><U>STRICTLY&nbsp;CONFIDENTIAL</U><BR>EXECUTION&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><U><A NAME="a_Toc393714726"></A><A NAME="a_Ref347359485"></A></U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">3.2</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U> Capitalization</U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">. </FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><A NAME="a_Ref347943250"></A><A NAME="a_Ref354687027"></A><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(a)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>As of the date of this Agreement, the authorized limited liability company interests of Oxygen consist of Oxygen Common
Interests, Oxygen Converted Common Interests and Oxygen Profits Interests. As of immediately prior to the Effective Time and subject
to the adoption of the amendment to the Oxygen LLC Agreement as contemplated by Section 6.5 (the &ldquo;<U>Amended Oxygen LLC Agreement</U>&rdquo;),
the authorized limited liability company interests of Oxygen issued and outstanding will only consist of Oxygen Common Interests.
As of the date of this Agreement, Oxygen has no limited liability company interests issued and outstanding, other than 16,160,812.78
Oxygen Common Interests issued and outstanding, 492,532.01 Oxygen Converted Common Interests and 4.7286% Oxygen Profits Interests.
As of the date hereof, there are outstanding 325,405.68 options to purchase Common Interests, which if exercised in full would
result in the issuance of 325,405.68 Oxygen Common Interests. Section&nbsp;3.2(a)(i) of the Oxygen Disclosure Schedule sets forth
a true, correct and complete list, as of the date hereof, of each Oxygen Holder, and the corresponding amount, of Oxygen Common
Interests, options to purchase Common Interests, Oxygen Converted Common Interests and Oxygen Profits Interests held by such Oxygen
Holder and if applicable, the exercise price, the number of Oxygen Common Interests issuable upon exercise thereof, the Profits
Interest Percentage, the Threshold Value (as such terms are defined in the Oxygen LLC Agreement) and the vesting dates (and the
amount subject to such vesting dates). Section 3.2(a)(ii) of the Oxygen Disclosure Schedule sets forth a pro forma version of the
list referred to in the immediately preceding sentence that gives effect to Section 6.5(b) of this Agreement as if the conversions
described therein were completed on the date hereof. All of the issued and outstanding Oxygen Common Interests, Oxygen Converted
Common Interests, options to purchase Common Interests and Oxygen Profits Interests have been duly authorized and validly issued
and are fully paid (to the extent required under the Oxygen LLC Agreement), nonassessable (except as such nonassessability may
be affected by Sections 18-607 and 18-804 of the DLLCA and the Oxygen LLC Agreement) and free of preemptive rights. Other than
options to purchase Common Interests set forth on Section 3.2(a)(i) of the Oxygen Disclosure Schedule, there are no outstanding
subscriptions, options, warrants, puts, calls, rights, exchangeable or convertible securities or other commitments or agreements
of any character relating to the issued or unissued limited liability company interests or other securities of Oxygen, or otherwise
obligating Oxygen to issue, transfer, sell, purchase, redeem or otherwise acquire, any such limited liability company interests
or other securities. There are no bonds, debentures, notes or other indebtedness that have the right to vote on any matters on
which holders of limited liability company interests of Oxygen may vote and there are no contractual obligations of Oxygen or its
Subsidiaries pursuant to which Oxygen or its Subsidiaries is or could be required to register any of the limited liability company
interests or other equity ownership interests of Oxygen or its Subsidiaries or any other securities under the Securities Act.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><A NAME="a_Ref354684488"></A><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(b)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Oxygen owns, directly or indirectly, all of the issued and outstanding shares of capital stock or other equity ownership
interests of each of its Subsidiaries, free and clear of any Liens, and all of such shares or equity ownership interests are duly
authorized and validly issued and are fully paid, nonassessable and free of preemptive rights, with no personal Liability attaching
to the ownership thereof. No Oxygen Subsidiary has or is bound by any outstanding subscriptions, options, warrants, calls, rights,
commitments or agreements of any character calling for the purchase or issuance of any shares of capital stock or any other equity</P>


<!-- Field: Page; Sequence: 22 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-top: 6pt; padding-bottom: 6pt; border-bottom: Black 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 24pt 70%; text-align: left"><U>STRICTLY&nbsp;CONFIDENTIAL</U><BR>EXECUTION&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt">security of such Subsidiary or any securities representing
the right to purchase or otherwise receive any shares of capital stock or any other equity security of such Subsidiary.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(c)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Oxygen has received accredited investor questionnaires in the form set forth on Section 3.2(c)(i) of the Oxygen Disclosure
Schedules from each Oxygen Holder set forth on Section 3.2(c)(ii) of the Oxygen Disclosure Schedule.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><U><A NAME="a_Toc393714727"></A></U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">3.3</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Authority; No Violation</U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">. </FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><A NAME="a_Ref347359511"></A><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(a)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Oxygen has full limited liability company power and authority to execute and deliver this Agreement and to consummate the
transactions contemplated hereby, subject to the authorization of the Amended Oxygen LLC Agreement and the approval of the Bank
Merger Agreement by the board of directors of Oxygen Bank. The execution and delivery of this Agreement and the consummation of
the transactions contemplated hereby, including the Merger, have been duly and validly approved by the Board of Directors of Oxygen
and the requisite Oxygen Holders as required under Oxygen&rsquo;s Organizational Documents and the DLLCA, subject to the authorization
of the Amended Oxygen LLC Agreement, and no other limited liability company proceedings on the part of Oxygen are necessary to
approve this Agreement or to consummate the transactions contemplated hereby. This Agreement has been duly and validly executed
and delivered by Oxygen and (assuming due authorization, execution and delivery by Carbon and Merger Sub) constitutes a valid and
binding obligation of Oxygen, enforceable against Oxygen in accordance with its terms, except as may be limited by the Enforceability
Exceptions.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><A NAME="a_Ref388584085"></A><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(b)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Neither the execution and delivery of this Agreement by Oxygen nor the consummation by Oxygen of the transactions contemplated
hereby, nor compliance by Oxygen with any of the terms or provisions hereof, will (i) violate any provision of Oxygen&rsquo;s Organizational
Documents or (ii) assuming that the consents and approvals referred to in Section&nbsp;3.4 are duly obtained, (x) violate any Law
applicable to Oxygen or any of its Subsidiaries or any of their respective properties or assets or (y) violate, conflict with,
result in a breach of any provision of or the loss of any benefit under, constitute a default (or an event which, with notice or
lapse of time, or both, would constitute a default) under, result in the termination of or a right of termination or cancellation
under, accelerate the performance required by, or result in the creation of any Lien upon any of the respective properties or assets
of Oxygen or any of its Subsidiaries under, any of the terms, conditions or provisions of any Contract or other instrument or obligation
to which Oxygen or any of its Subsidiaries is a party, or by which they or any of their respective properties or assets may be
bound or affected, except (in the case of clause (ii)(y) above) for such violations, conflicts, breaches or defaults which, either
individually or in the aggregate, would not reasonably be expected to have a Material Adverse Effect on Oxygen. Without limitation
of the foregoing, the allocation of the Net Merger Consideration set forth in Article I as well as the treatment of each of the
Oxygen Common Interests (including Oxygen Interest Awards), Oxygen Converted Common Interests, Oxygen Profits Interests and options
to purchase Common Interests set forth in this Agreement (including as a result of the Merger) complies in all respects with applicable
Law, Oxygen&rsquo;s Organizational Documents, the applicable terms of any such securities and any Contracts with the Holders of
any such securities.</P>


<!-- Field: Page; Sequence: 23 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-top: 6pt; padding-bottom: 6pt; border-bottom: Black 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 24pt 70%; text-align: left"><U>STRICTLY&nbsp;CONFIDENTIAL</U><BR>EXECUTION&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><U><A NAME="a_Toc393714728"></A><A NAME="a_Ref347359443"></A><A NAME="a_Ref347358455"></A></U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">3.4</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U> Consents and Approvals</U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">. Except for (i) the filing of applications
and notices, as applicable, with the NYSE, (ii) the filing of any required applications, filings and notices, as applicable, with
(1) the Federal Reserve Board under the BHC Act, (2) the OCC, and approval of the foregoing applications, filings and notices,
(iii) the filing of the Certificate of Merger with the Secretary of State of the State of Delaware pursuant to the DLLCA, (iv)
the filing of the Bank Merger Certificates, and (v) such filings and approvals as are required to be made or obtained under the
securities or &ldquo;Blue Sky&rdquo; Laws of various states in connection with the issuance of the shares of Carbon Common Stock
pursuant to this Agreement, no consents or approvals of or filings or registrations with any Governmental Entity are necessary
in connection with (A) the execution and delivery by Oxygen of this Agreement or (B) the consummation by Oxygen of the Merger,
the Bank Merger and the other transactions contemplated hereby.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><U><A NAME="a_Toc393714729"></A><A NAME="a_Ref388720154"></A></U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">3.5</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Reports</U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">. Oxygen and each of its Subsidiaries have timely filed
all reports, registrations and statements, together with any amendments required to be made with respect thereto, that they were
required to file since January 1, 2011 with (i) any state regulatory authority, (ii) the SEC, (iii) the Federal Reserve Board,
(iv) the FDIC, (v) the OCC, (vi) the Office of Thrift Supervision, (vii) the CFPB, (viii) any foreign regulatory authority and
(ix) any SRO ((i) &ndash; (ix), collectively &ldquo;<U>Regulatory Agencies</U>&rdquo;), including, without limitation, any report,
registration or statement required to be filed pursuant to the Laws of the United States, any state, any foreign entity, or any
Regulatory Agency, and have paid all fees and assessments due and payable in connection therewith. Except for normal examinations
conducted by a Regulatory Agency in the ordinary course of the business of Oxygen and its Subsidiaries, no Regulatory Agency has
initiated or has pending any Proceeding or, to the Knowledge of Oxygen, investigation into the business or operations of Oxygen
or any of its Subsidiaries since January 1, 2011. There (x) is no unresolved violation, criticism, or exception by any Regulatory
Agency with respect to any report or statement relating to any examinations or inspections of Oxygen or any of its Subsidiaries
and (y) has been no formal or informal inquiries by, or disagreements or disputes with, any Regulatory Agency with respect to the
business, operations, policies or procedures of Oxygen or any of its Subsidiaries since January 1, 2011.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><U><A NAME="a_Toc393714730"></A><A NAME="a_Ref390331339"></A></U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">3.6</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Financial Statements</U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">. </FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><A NAME="a_Ref388720166"></A><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(a)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Oxygen has previously Made Available to Carbon accurate and complete copies of (a) (i) Oxygen&rsquo;s audited consolidated
balance sheet as of December 31, 2013, 2012, and 2011 and (ii) the related audited consolidated statements of income, equity and
cash flows for the fiscal years ended December 31, 2013, 2012 and 2011 ((i) and (ii), the &ldquo;<U>Oxygen Audited Financial Statements</U>&rdquo;)
and (b) (i) Oxygen&rsquo;s unaudited consolidated balance sheet as of June 30, 2014 and the related (ii) unaudited consolidated
statements of income, equity for the six (6) months ended June 30, 2014 ((i) and (ii), the &ldquo;<U>Oxygen Unaudited Financial
Statements</U>&rdquo; and collectively with the Oxygen Audited Financial Statements, the &ldquo;<U>Oxygen Financial Statements</U>&rdquo;).
The Oxygen Financial Statements (including the related notes, where applicable) (i)&nbsp;have been prepared from, and are in accordance
with, the books and records of Oxygen and its Subsidiaries, (ii)&nbsp;fairly present in all material respects the consolidated
results of operations, cash flows, changes in shareholders&rsquo; equity and consolidated financial position of Oxygen and its
Subsidiaries for the respective fiscal periods or as of the respective dates therein set forth (subject in the case of unaudited
statements to recurring year-end audit adjustments normal in nature and amount) and (iii)&nbsp;have been prepared in accordance
with GAAP consistently applied</P>


<!-- Field: Page; Sequence: 24 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-top: 6pt; padding-bottom: 6pt; border-bottom: Black 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 24pt 70%; text-align: left"><U>STRICTLY&nbsp;CONFIDENTIAL</U><BR>EXECUTION&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt">during the periods involved, except, in each case, as indicated
in such statements or in the notes thereto. The books and records of Oxygen and its Subsidiaries have been, and are being, maintained
in all material respects in accordance with GAAP and any other applicable legal and accounting requirements and reflect only actual
transactions. As of the date hereof, PricewaterhouseCoopers LLP has not resigned (or informed Oxygen that it intends to resign)
or been dismissed as independent public accountants of Oxygen as a result of or in connection with any disagreements with Oxygen
on a matter of accounting principles or practices, financial statement disclosure or auditing scope or procedure.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(b)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Neither Oxygen nor any of its Subsidiaries have any material Liability except for Liabilities (i) to the extent reflected
or reserved against on the consolidated balance sheet of Oxygen as of June 30, 2014 (including any notes thereto) included in the
Oxygen Financial Statements, (ii) incurred in the ordinary course of business consistent with past practice since June 30, 2014,
(iii) incurred in connection with this Agreement and the transactions contemplated hereby or (iv) incurred pursuant to obligations
arising under Oxygen Contracts, other than arising out of or resulting from a breach or default under such Oxygen Contracts. None
of Oxygen or any of its Subsidiaries is a party to any material &ldquo;off-balance sheet arrangements&rdquo; as defined in Item
303(a)(4) of Regulation S-K. Section 3.6(b) of the Oxygen Disclosure Schedule sets forth a true and correct list of the reserves
set forth therein as of June 30, 2014.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><A NAME="a_Ref392108003"></A><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(c)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The records, systems, controls, data and information of Oxygen and its Subsidiaries are recorded, stored, maintained and
operated under means (including any electronic, mechanical or photographic process, whether computerized or not) that are under
the exclusive ownership and direct control of Oxygen or its Subsidiaries or accountants (including all means of access thereto
and therefrom) except for any non-exclusive ownership and non-direct control that would not reasonably be expected to have, individually
or in the aggregate, a material adverse effect on Oxygen&rsquo;s system of internal controls over financial reporting. Oxygen (x)&nbsp;has
implemented and maintains disclosure controls and procedures (in accordance with the Federal Deposit Insurance Corporation Improvement
Act of 1991 (&ldquo;<U>FDICIA</U>&rdquo;)) to ensure that material information relating to Oxygen, including its Subsidiaries,
is made known to the Chief Executive Officer and the Chief Financial Officer of Oxygen by others within those entities, and (y)&nbsp;has
disclosed, based on its most recent evaluation prior to the date hereof, to Oxygen&rsquo;s outside auditors and the audit committee
of Oxygen&rsquo;s Board of Directors (i)&nbsp;any significant deficiencies and material weaknesses in the design or operation of
internal control over financial reporting (in accordance with FDICIA) which are reasonably likely to adversely affect Oxygen&rsquo;s
ability to record, process, summarize and report financial information, and (ii)&nbsp;any fraud, whether or not material, that
involves management or other employees who have a significant role in Oxygen&rsquo;s internal controls over financial reporting.
These disclosures were made in writing by management to Oxygen&rsquo;s auditors and audit committee and a copy has previously been
Made Available to Carbon.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(d)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Since January 1, 2011, (i) neither Oxygen nor any of its Subsidiaries, nor, to the Knowledge of Oxygen, any director, officer,
auditor, accountant or representative of it or any of its Subsidiaries, have received or otherwise had or obtained knowledge of
any material complaint, allegation, assertion or claim, whether written or oral, regarding the accounting or auditing practices,
procedures, methodologies or methods (including with respect to loan loss</P>


<!-- Field: Page; Sequence: 25 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-top: 6pt; padding-bottom: 6pt; border-bottom: Black 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 24pt 70%; text-align: left"><U>STRICTLY&nbsp;CONFIDENTIAL</U><BR>EXECUTION&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt">reserves, write-downs, charge-offs and accruals) of Oxygen
or any of its Subsidiaries or their respective internal accounting controls, including any material complaint, allegation, assertion
or claim that Oxygen or any of its Subsidiaries has engaged in questionable accounting or auditing practices, procedures, or methodologies
(including with respect to loan loss and other reserves, write-downs, charge-offs and accruals), and (ii) to the Knowledge of Oxygen,
no attorney representing Oxygen or any of its Subsidiaries, whether or not employed by Oxygen or any of its Subsidiaries, has reported
evidence of a material violation of applicable securities Laws, breach of fiduciary duty or similar violation by Oxygen or any
of its officers, directors, employees or agents to the Board of Directors of Oxygen or any committee thereof or to any director
or officer of Oxygen.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><U><A NAME="a_Toc393714731"></A><A NAME="a_Ref349312230"></A></U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">3.7</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Broker&rsquo;s Fees</U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">. With the exception of the engagement
of Goldman, Sachs &amp; Co. and Merrill Lynch, Pierce, Fenner &amp; Smith, Incorporated, neither Oxygen nor any Oxygen Subsidiary
nor any of their respective officers or directors have employed any broker, finder or financial advisor or incurred any Liability
for any broker&rsquo;s fees, commissions or finder&rsquo;s fees in connection with the Merger or other transactions contemplated
by this Agreement. Oxygen has Made Available to Carbon a true, correct and complete copy of any engagement letter or other Contract
between Oxygen and Goldman, Sachs &amp; Co., and between Oxygen and Merrill Lynch, Pierce, Fenner &amp; Smith, Incorporated relating
to the Merger and the other transactions contemplated by this Agreement.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><U><A NAME="a_Toc393714732"></A></U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">3.8</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Absence of Certain Changes or Events</U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">. </FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><A NAME="a_Ref347402773"></A><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(a)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Since December 31, 2013 through the date hereof, no fact, change, event, occurrence, condition or development has occurred
that has had or would reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect on Oxygen.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(b)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Since December 31, 2013 through the date hereof, (i) Oxygen and its Subsidiaries have carried on their respective businesses
in all material respects in the ordinary course consistent with past practice, (ii) neither Oxygen nor its Subsidiaries has taken
any action that would if taken after the date of this Agreement require Carbon&rsquo;s consent pursuant to Section 5.2(b), (c),
(d), (f), (g), (i), (j), (k), (l), (m), (q), (s) or (t), (iii) neither Oxygen nor its Subsidiaries has engaged in any transaction
or transactions (a &ldquo;<U>Prohibited Transaction</U>&rdquo;) that were not contemplated in the Oxygen Budget with the intent
to artificially accelerate earnings recognition, artificially increase the carrying value of an asset or artificially decrease
the carrying value of a liability and (iv) neither Oxygen nor its Subsidiaries has changed any practices, methodologies, policies
or assumptions (any such change a &ldquo;<U>Prohibited Practice</U>&rdquo;) with the intent to artificially accelerate earnings
recognition, artificially increase the carrying value of an asset or artificially decrease the carrying value of a liability.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><U><A NAME="a_Toc393714733"></A></U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">3.9</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Legal Proceedings</U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">. </FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(a)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Neither Oxygen nor any of its Subsidiaries is a party to any, and there are no pending or, to Oxygen&rsquo;s Knowledge,
threatened, material Proceedings against Oxygen or any of its Subsidiaries or any of their current or former directors or executive
officers (whether or not such Proceedings are currently being tolled).</P>


<!-- Field: Page; Sequence: 26 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-top: 6pt; padding-bottom: 6pt; border-bottom: Black 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 24pt 70%; text-align: left"><U>STRICTLY&nbsp;CONFIDENTIAL</U><BR>EXECUTION&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(b)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT> There is no material injunction, order, judgment, decree, or regulatory restriction imposed upon Oxygen, any of its Subsidiaries
or the assets of Oxygen or any of its Subsidiaries (or that, upon consummation of the Merger or the Bank Merger, would apply to
Carbon or any of its Subsidiaries).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><U><A NAME="a_Toc393714734"></A></U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">3.10</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Taxes and Tax Returns</U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(a)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Each of Oxygen and its Subsidiaries has duly and timely filed (including all applicable extensions) all material Tax Returns
in all jurisdictions in which Tax Returns are required to be filed by it, and all such Tax Returns are true, correct, and complete
in all material respects. Neither Oxygen nor any of its Subsidiaries is the beneficiary of any extension of time within which to
file any material Tax Return (other than extensions to file Tax Returns obtained in the ordinary course). All material Taxes of
Oxygen and its Subsidiaries (whether or not shown as due on any Tax Returns) have been fully and timely paid. Each of Oxygen and
its Subsidiaries has withheld and paid all material Taxes required to have been withheld and paid in connection with amounts paid
or owing to any employee, creditor, shareholder, independent contractor or other third party. The federal income Tax Returns of
Oxygen and its Subsidiaries for all years to and including 2008 have been examined by the IRS or are Tax Returns with respect to
which the applicable period for assessment under applicable Law, after giving effect to extensions or waivers, has expired. Neither
Oxygen nor any of its Subsidiaries has received written notice of assessment or proposed assessment in connection with any material
amount of Taxes, and there are no threatened in writing or pending disputes, claims, audits, examinations or other proceedings
regarding any material Tax of Oxygen and its Subsidiaries or the assets of Oxygen and its Subsidiaries. Oxygen has Made Available
to Carbon true and complete copies of any private letter ruling requests, opinions, closing agreements or gain recognition agreements
with respect to Taxes requested or executed in the last six (6) years. Neither Oxygen nor any of its Subsidiaries is a party to
or is bound by any Tax sharing, allocation or indemnification agreement or arrangement (other than such an agreement or arrangement
exclusively between or among Oxygen and its Subsidiaries, or any such agreement entered into in the ordinary course of business
and that does not relate primarily to Taxes). Neither Oxygen nor any of its Subsidiaries (A) has been a member of an affiliated
group filing a consolidated federal income Tax Return (other than a group the common parent of which was Oxygen) or (B) has any
Liability for the Taxes of any Person (other than Oxygen or any of its Subsidiaries) under Treasury Regulation Section&nbsp;1.1502-6
(or any similar provision of applicable state, local or foreign Law), as a transferee or successor, by Contract or otherwise. Neither
Oxygen nor any of its Subsidiaries has been, within the past two years or otherwise as part of a &ldquo;plan (or series of related
transactions)&rdquo; within the meaning of Section&nbsp;355(e) of the Code of which the Merger is also a part, a &ldquo;distributing
corporation&rdquo; or a &ldquo;controlled corporation&rdquo; (within the meaning of Section&nbsp;355(a)(1)(A) of the Code) in a
distribution of stock intending to qualify for tax-free treatment under Section&nbsp;355 of the Code. Neither Oxygen nor any of
its Subsidiaries has participated in a &ldquo;listed transaction&rdquo; within the meaning of Treasury Regulation Section&nbsp;1.6011-4(b)(2).
At no time during the past five years has Oxygen been a United States real property holding corporation within the meaning of Section&nbsp;897(c)(2)
of the Code. Each of OneWest Bank Group LLC and OneWest Asset Management LLC is, and since the date of its formation has been,
treated as an entity disregarded as separate from its owner pursuant to Treasury Regulation Section 301.7701-3 (and any similar
provision of state or local Law).</P>


<!-- Field: Page; Sequence: 27 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-top: 6pt; padding-bottom: 6pt; border-bottom: Black 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 24pt 70%; text-align: left"><U>STRICTLY&nbsp;CONFIDENTIAL</U><BR>EXECUTION&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><U><A NAME="a_Toc393714735"></A><A NAME="a_Toc388584447"></A></U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">3.11</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U> Employee Benefit Matters</U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">. </FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><A NAME="a_Ref347358196"></A><A NAME="a_Ref347513470"></A><A NAME="a_Toc391290197"></A><A NAME="a_Toc391290356"></A><A NAME="a_Toc391290469"></A><A NAME="a_Toc391290198"></A><A NAME="a_Toc391290357"></A><A NAME="a_Toc391290470"></A><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(a)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Section&nbsp;3.11(a) of the Oxygen Disclosure Schedule lists all material Oxygen Benefit Plans. For purposes of this Agreement,
the &ldquo;<U>Oxygen Benefit Plans</U>&rdquo; shall mean all employee benefit plans (as defined in Section&nbsp;3(3) of ERISA),
whether or not subject to ERISA, and all bonus, equity option, equity purchase, restricted equity, incentive, deferred compensation,
welfare, retiree welfare, retirement supplemental retirement, termination, severance, retention, change-in-control, employment
or other benefit plans, programs, contracts, agreements or arrangements to or with respect to which Oxygen or any Subsidiary or
any trade or business of Oxygen or any of its Subsidiaries, whether or not incorporated, all of which together with Oxygen would
be deemed a &ldquo;single employer&rdquo; within the meaning of Section&nbsp;4001 of ERISA (a &ldquo;<U>Oxygen ERISA Affiliate</U>&rdquo;),
is a party or has any current or future obligation or that are maintained, contributed to or sponsored by Oxygen or any of its
Subsidiaries or any of their respective Oxygen ERISA Affiliates, in each case for the benefit of any current or former employee,
officer, director or independent contractor of Oxygen or any of its Subsidiaries or any of their respective Oxygen ERISA Affiliates,
but excluding any &ldquo;multiemployer plan&rdquo; within the meaning of Section 4001(a)(3) of ERISA.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(b)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Oxygen has heretofore Made Available to Carbon true and complete copies, as applicable, of (i) each material Oxygen Benefit
Plan or, in the case of any material unwritten Oxygen Benefit Plan, a description of the material terms thereof, (ii)&nbsp;any
trust agreements, insurance contracts or documents of any other funding arrangements related to any material Oxygen Benefit Plan,
and such copies are true, correct and complete as of the date hereof, (iii)&nbsp;the Annual Reports (Form 5500 Series) and accompanying
schedules for the each of the last two plan years, (iv)&nbsp;the current summary plan description and any modifications thereto
for each material Oxygen Benefit Plan, (v)&nbsp;the annual financial and/or actuarial reports for each of the last two years, (vi)&nbsp;the
most recent determination letter from the IRS, and (vii)&nbsp;all material correspondences with a Governmental Entity.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(c)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Each Oxygen Benefit Plan has been established, operated and administered in all material respects in accordance with its
terms and the requirements of all applicable Laws, including ERISA and the Code. No Proceedings with respect to any Oxygen Benefit
Plan is pending or, to the Knowledge of Oxygen, threatened, other than routine claims for benefits incurred in the ordinary course
of business, and, to the Knowledge of Oxygen, no set of circumstances exists that may give rise to any such Proceedings against
the Oxygen Benefit Plans, any fiduciaries thereof with respect to their duties to the Oxygen Benefit Plans or the assets of any
of the trusts under any of the Oxygen Benefit Plans. Neither Oxygen nor any of its Subsidiaries has taken any corrective action
or made any filings under any voluntary correction program of the IRS, Department of Labor, the Pension Benefit Guaranty Corporation
or any other Governmental Entity with respect to any Oxygen Benefit Plan, and, to the Knowledge of Oxygen, no circumstances exist
that would qualify for such corrective action. None of the Oxygen Benefit Plans is under audit or investigation by the IRS, the
Department of Labor, the Pension Benefit Guaranty Corporation or any other Governmental Entity.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><A NAME="a_Ref347513830"></A><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(d)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Section&nbsp;3.11(d) of the Oxygen Disclosure Schedule identifies each Oxygen Benefit Plan that is intended to be qualified
under Section&nbsp;401(a) of the Code (the &ldquo;<U>Oxygen Qualified Plans</U>&rdquo;). The IRS has issued a favorable determination
letter with respect to</P>


<!-- Field: Page; Sequence: 28 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-top: 6pt; padding-bottom: 6pt; border-bottom: Black 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 24pt 70%; text-align: left"><U>STRICTLY&nbsp;CONFIDENTIAL</U><BR>EXECUTION&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt">each Oxygen Qualified Plan and the related trust, which letter
has not been revoked (nor has revocation been threatened), and, to the Knowledge of Oxygen, there are no existing circumstances
and, no events have occurred that could adversely affect the qualified status of any Oxygen Qualified Plan or the related trust
or increase the costs relating thereto. No trust funding any Oxygen Benefit Plan is intended to meet the requirements of Section&nbsp;501(c)(9)
of the Code.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><A NAME="a_Ref390889837"></A><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(e)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Each Oxygen Benefit Plan that is a &ldquo;nonqualified deferred compensation plan&rdquo; (as defined in Section 409A(d)(1)
of the Code) and any award thereunder, in each case that is subject to Section 409A of the Code, has (i) since March 19, 2009,
been maintained and operated, in all material respects, in good faith compliance with Section 409A of the Code and IRS Notice 2005-1
and (ii) since March 19, 2009, been, in all material respects, in documentary and operational compliance with Section 409A of the
Code. All options to purchase Common Interests have been granted with a per share exercise or reference price at least equal to
the fair market value of the underlying equity on the date of grant, within the meaning of Section 409A of the Code.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(f)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>None of Oxygen and its Subsidiaries nor any of their respective Oxygen ERISA Affiliates has ever maintained, sponsored,
contributed to or been obligated to contribute to (i) any plan that is subject to Title IV or Section&nbsp;302 of ERISA or Section&nbsp;412,
430 or 4971 of the Code , (ii) any &ldquo;multiemployer plan&rdquo; within the meaning of Section&nbsp;4001(a)(3) of ERISA (a &ldquo;<U>Multiemployer
Plan</U>&rdquo;), (iii) any plan that has two or more contributing sponsors at least two of whom are not under common control,
within the meaning of Section&nbsp;4063 of ERISA (a &ldquo;<U>Multiple Employer Plan</U>&rdquo;) or (iv)&nbsp;any plan that provides
for post-retirement medical, life insurance or other welfare-type benefits (other than as required by Section 4980B of the Code).
None of Oxygen and its Subsidiaries nor any of their respective Oxygen ERISA Affiliates has incurred, nor do any circumstances
exist that could result in, any liability (i)&nbsp;under Title IV or Section&nbsp;302 of ERISA, (ii)&nbsp;under Sections 412, 430
or 4971 of the Code, (iii)&nbsp;as a result of a complete or partial withdrawal (as those terms are defined in Part I of Subtitle
E of Title IV of ERISA) from a Multiemployer Plan or Multiple Employer Plan, (iv)&nbsp;as a result of a failure to comply with
the continuation coverage requirements of Section 601 <I>et seq</I>. of ERISA and Section 4980B of the Code, or (v)&nbsp;under
corresponding or similar provisions of foreign laws.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(g)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>All contributions required to be made to any Oxygen Benefit Plan under applicable Law or by any plan document or other contractual
undertaking, and all premiums due or payable with respect to insurance policies funding any Oxygen Benefit Plan, for any period
through the date hereof, have been timely made or paid in full or, to the extent not required to be made or paid on or before the
date hereof, have been fully reflected on the books and records of Oxygen in accordance with GAAP.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(h)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>None of Oxygen and its Subsidiaries nor any of their respective ERISA Affiliates nor any other person, including any fiduciary,
has engaged in any &ldquo;prohibited transaction&rdquo; (as defined in Section&nbsp;4975 of the Code or Section&nbsp;406 of ERISA)
that could subject any of the Oxygen Benefit Plans or their related trusts, Oxygen, any of its Subsidiaries, any of their respective
ERISA Affiliates or any person that Oxygen or any of its Subsidiaries has an obligation to indemnify, to any material tax or penalty
imposed under Section&nbsp;4975 of the Code or Section&nbsp;502 of ERISA.</P>


<!-- Field: Page; Sequence: 29 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-top: 6pt; padding-bottom: 6pt; border-bottom: Black 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 24pt 70%; text-align: left"><U>STRICTLY&nbsp;CONFIDENTIAL</U><BR>EXECUTION&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(i)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT> Neither the execution and delivery of this Agreement nor the consummation of the transactions contemplated hereby will
(either alone or in conjunction with any other event) result in, cause the vesting, exercisability or delivery of, or increase
in the amount or value of, any payment, right or other benefit to any current or former employee, officer, director or other service
provider of Oxygen or any of its Subsidiaries, or result in any limitation on the right of Oxygen or any of its Subsidiaries to
amend, merge, terminate or receive a reversion of assets from any Oxygen Benefit Plan or related trust. Without limiting the generality
of the foregoing, no amount paid or payable (whether in cash, in property, or in the form of benefits) by Oxygen or any of its
Subsidiaries in connection with the transactions contemplated hereby (either solely as a result thereof or as a result of such
transactions in conjunction with any other event) will be an &ldquo;excess parachute payment&rdquo; within the meaning of Section&nbsp;280G
of the Code. Neither Oxygen nor any of its Subsidiaries maintains or contributes to a rabbi trust or similar funding vehicle, and
the transactions contemplated by this Agreement will not cause or require Oxygen or any of its affiliates to establish or make
any contribution to a rabbi trust or similar funding vehicle. No Oxygen Benefit Plan provides for the gross-up or reimbursement
of Taxes under Section&nbsp;4999 or 409A of the Code, or otherwise.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(j)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Since January 1, 2011, there has been no pending or, to Oxygen&rsquo;s Knowledge, threatened material labor grievances or
material unfair labor practice claims or charges against Oxygen or any of its Subsidiaries, or any strikes or other material labor
disputes against Oxygen or any of its Subsidiaries. As of the date hereof, neither Oxygen nor any of its Subsidiaries are party
to or bound by any collective bargaining or similar agreement with any labor organization, or work rules or practices agreed to
with any labor organization or employee association applicable to employees of Oxygen or any of its Subsidiaries and, to the Knowledge
of Oxygen, there are no organizing efforts by any union or other group seeking to represent any employees of Oxygen or any of its
Subsidiaries.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(k)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Oxygen and its Subsidiaries have complied in all material respects with all applicable Laws regarding (i) employment, including
employment practices, employee classification, labor relations, health and safety, wages, hours and terms and conditions of employment
and fair labor standards and (ii) the payment and withholding of Taxes and other amounts in respect of their employment of current
and former employees, officers, directors or other service providers of Oxygen and its Subsidiaries, and none of Oxygen or any
of its Subsidiaries is liable for arrears of wages, taxes, penalties or other sums for failure to comply with such applicable Laws.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><U><A NAME="a_Toc393714736"></A></U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">3.12</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Compliance with Applicable Law</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><A NAME="a_Ref390947395"></A><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(a)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Oxygen and each of its Subsidiaries hold, and have at all times since January&nbsp;1, 2011, held, all material licenses,
franchises, permits and authorizations (&ldquo;<U>Permits</U>&rdquo;) necessary for the lawful conduct of their respective businesses
and ownership of their respective properties, rights and assets under and pursuant to each (and have paid all fees and assessments
due and payable in connection therewith), and, to the Knowledge of Oxygen, no suspension or cancellation of any such Permit is
threatened. Since January 1, 2011 Oxygen and each of its Subsidiaries have complied in all material respects with and are not in
material default or violation under any applicable Law relating to Oxygen or any of its Subsidiaries, including without limitation
all Laws related to data protection or privacy, the USA PATRIOT Act, the</P>


<!-- Field: Page; Sequence: 30 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-top: 6pt; padding-bottom: 6pt; border-bottom: Black 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 24pt 70%; text-align: left"><U>STRICTLY&nbsp;CONFIDENTIAL</U><BR>EXECUTION&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt">Bank Secrecy Act, the Equal Credit Opportunity Act and Regulation
B, the Fair Housing Act, the Community Reinvestment Act, the Fair Credit Reporting Act, the Truth in Lending Act and Regulation
Z, the Home Mortgage Disclosure Act, the Fair Debt Collection Practices Act, the Electronic Fund Transfer Act, the Dodd-Frank Wall
Street Reform and Consumer Protection Act, any regulations promulgated by the Consumer Financial Protection Bureau, the Interagency
Policy Statement on Retail Sales of Nondeposit Investment Products, the SAFE Mortgage Licensing Act of 2008, the Real Estate Settlement
Procedures Act and Regulation X, and any other Law relating to bank secrecy, discriminatory lending, financing or leasing practices,
money laundering prevention, Sections&nbsp;23A and 23B of the Federal Reserve Act, the Sarbanes-Oxley Act.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(b)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Without limitation, since January 1, 2011, none of Oxygen, or its Subsidiaries, or any director, officer, employee, agent
or other Person acting on behalf of Oxygen or any of its Subsidiaries has, directly or indirectly, (i) used any funds of Oxygen
or any of its Subsidiaries for unlawful contributions, unlawful gifts, unlawful entertainment or other expenses relating to political
activity; (ii) made any unlawful payment to foreign or domestic governmental officials or employees or to foreign or domestic political
parties or campaigns from funds of Oxygen or any of its Subsidiaries; (iii) violated any provision that would result in the violation
of the Foreign Corrupt Practices Act of 1977, as amended, or any similar Law; (iv) established or maintained any unlawful fund
of monies or other assets of Oxygen or any of its Subsidiaries; (v) made any fraudulent entry on the books or records of Oxygen
or any of its Subsidiaries; (vi) made any unlawful bribe, unlawful rebate, unlawful payoff, unlawful influence payment, unlawful
kickback or other unlawful payment to any Person, private or public, regardless of form, whether in money, property or services,
to obtain favorable treatment in securing business to obtain special concessions for Oxygen or any of its Subsidiaries, to pay
for favorable treatment for business secured or to pay for special concessions already obtained for Oxygen or any of its Subsidiaries
or (vii) to the Knowledge of Oxygen, is currently subject to any United States sanctions administered by the Office of Foreign
Assets Control of the United States Treasury Department.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(c)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Since January 1, 2011, Oxygen and each of its Subsidiaries has properly administered all accounts for which Oxygen or any
of its Subsidiaries acts as a fiduciary, including accounts for which Oxygen or any of its Subsidiaries serves as a trustee, agent,
custodian, personal representative, guardian, conservator or investment adviser, in accordance with the terms of the governing
documents and applicable Law in all material respects, and none of Oxygen or any of its Subsidiaries has received written notice
of any failure to properly administer any accounts for which it acts as a fiduciary. Since January 1, 2011, none of Oxygen or any
of its Subsidiaries, or any director, officer, or employee of Oxygen or its Subsidiaries, has committed any breach of trust with
respect to any such fiduciary account, and the accountings for each such fiduciary account are true and correct and accurately
reflect the assets of such fiduciary account.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(d)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>As of December 31, 2013, Oxygen and each insured depositary Subsidiary of Oxygen is &ldquo;well-capitalized&rdquo; (as that
term is defined in the relevant regulation of the institution&rsquo;s primary federal bank regulator), and the institution&rsquo;s
rating under the Community Reinvestment Act of 1997 is no less than &ldquo;satisfactory.&rdquo;</P>


<!-- Field: Page; Sequence: 31 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-top: 6pt; padding-bottom: 6pt; border-bottom: Black 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 24pt 70%; text-align: left"><U>STRICTLY&nbsp;CONFIDENTIAL</U><BR>EXECUTION&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><U><A NAME="a_Toc393714737"></A><A NAME="a_Ref388725640"></A></U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">3.13</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U> Certain Contracts</U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">. </FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><A NAME="a_Ref347358500"></A><A NAME="a_Ref388740756"></A><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(a)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Except as set forth in Section&nbsp;3.13(a) of the Oxygen Disclosure Schedule, as of the date hereof, neither Oxygen nor
any of its Subsidiaries is a party to or bound by any Contract:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-indent: 0.5in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(i)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>with respect to the employment of any directors, officers or employees, other than in the ordinary course of business consistent
with past practice;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-indent: 0.5in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(ii)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>which, upon the execution or delivery of this Agreement or the consummation of the transactions contemplated by this Agreement
will result in any payment (whether of severance pay or otherwise) becoming due from Carbon, Oxygen, or any of their respective
Subsidiaries to any officer or employee thereof;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-indent: 0.5in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(iii)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>that is a &ldquo;material contract&rdquo; (as such term is defined in Item 601(b)(10) of Regulation S-K of the SEC);</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-indent: 0.5in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(iv)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>that contains a non-compete or client or customer non-solicit requirement that restricts the conduct of Oxygen or any of
its Subsidiaries or following the Closing will restrict the conduct of Carbon or any of its Subsidiaries;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-indent: 0.5in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(v)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>that obligates Oxygen or its Subsidiaries, or following the Closing, Carbon or any of its Subsidiaries, to conduct business
with any third party on a preferential or exclusive basis or which contains &ldquo;most favored nation&rdquo; or similar covenants
(other than any such Contracts that will not obligate Carbon or any of its Subsidiaries following the Closing (other than Oxygen
and its Subsidiaries) or which are terminable by Oxygen or any of its Subsidiaries on sixty (60) days or less notice without any
material required payment or other material conditions, other than the condition of notice);</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-indent: 0.5in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(vi)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>with or to a labor union or guild (including any collective bargaining agreement);</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-indent: 0.5in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(vii)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>that relates to the incurrence of indebtedness by Oxygen or any of its Subsidiaries in the principal amount of $1,000,000
or more, including any sale and leaseback transactions, capitalized leases and other similar financing transactions;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-indent: 0.5in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(viii)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>that grants any right of first refusal, right of first offer or similar right with respect to any material assets, rights
or properties of Oxygen or its Subsidiaries;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-indent: 0.5in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(ix)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>that relates to the acquisition or disposition of any assets or business with a book value or purchase price in excess of
$10,000,000 (whether by merger, sale of stock, sale of assets or otherwise), excluding the acquisition or</P>


<!-- Field: Page; Sequence: 32 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-top: 6pt; padding-bottom: 6pt; border-bottom: Black 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 24pt 70%; text-align: left"><U>STRICTLY&nbsp;CONFIDENTIAL</U><BR>EXECUTION&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in">disposition of loans (which, for the avoidance of doubt,
are addressed solely in Section 3.13(a)(x));</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-indent: 0.5in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(x)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>that relates to the acquisition or disposition of any loan with a book value or purchase price in excess of $10,000,000,
which acquisition or disposition is pending or is otherwise not reflected on the Oxygen Interim Unaudited Financial Statements;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-indent: 0.5in"><A NAME="a_Ref388725164"></A><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(xi)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>that is a loss share agreement with the FDIC (a &ldquo;<U>Loss Share Agreement</U>&rdquo;) or any other Contract with the
FDIC with rights or Liabilities that are material in respect of the transactions between Oxygen and its Subsidiaries, on the one
hand, and the FDIC, on the other hand, in respect of (1)&nbsp;IndyMac Bank F.S.B., (2) La Jolla Bank, FSB or (3) First Federal
Bank of California, F.S.B. (collectively with the Loss Share Agreements, the &ldquo;<U>FDIC Agreements</U>&rdquo;);</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-indent: 0.5in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(xii)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>that is a Contract with Fannie Mae or Freddie Mac that is material in respect of the relationship between Oxygen and its
Subsidiaries, on the one hand, and Fannie Mae or Freddie Mac, on the other hand (collectively, the &ldquo;<U>GSE Agreements</U>&rdquo;);</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-indent: 0.5in"><A NAME="a_Ref388725237"></A><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(xiii)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>that is a Contract with Ginnie Mae, HUD, the USDA, the VA or any other federal or state Governmental Entity that insures
or guarantees residential mortgage Loans and/or residential mortgage backed securities (each a &ldquo;<U>Governmental Insurer</U>&rdquo;);</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-indent: 0.5in"><A NAME="a_Ref388725534"></A><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(xiv)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>with respect to the performance by Oxygen or its Subsidiaries of Loan servicing with any outstanding obligations that are
material to Oxygen and its Subsidiaries (the &ldquo;<U>Servicing Agreements</U>&rdquo;);</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-indent: 0.5in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(xv)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>that obligates Oxygen or any of its Subsidiaries to indemnify or hold harmless any director or executive officer of Oxygen
or any of its Subsidiaries (other than the organizational documents of Oxygen or its Subsidiaries);</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-indent: 0.5in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(xvi)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>that involved the payment of more than $1,000,000 by Oxygen and its Subsidiaries in the twelve month period ending July
30, 2014 or that is expected to in the twelve month period ending December 31, 2014 (other than any such Contracts which are terminable
by Oxygen or any of its Subsidiaries on sixty (60) days or less notice without any required payment or other material conditions,
other than the condition of notice);</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-indent: 0.5in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(xvii)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>that is a settlement agreement other than (A) releases immaterial in nature or amount entered into in the ordinary course
of business with the former employees of Oxygen or its Subsidiaries or independent contractors in connection with the routine cessation
of such employee&rsquo;s or independent contractor&rsquo;s employment or (B) agreements the performance of which does not involve
any payment after June 30, 2014 and does not impose any injunctive or other similar restrictions on Oxygen or its Subsidiaries;</P>


<!-- Field: Page; Sequence: 33 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-top: 6pt; padding-bottom: 6pt; border-bottom: Black 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 24pt 70%; text-align: left"><U>STRICTLY&nbsp;CONFIDENTIAL</U><BR>EXECUTION&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-indent: 0.5in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(xviii)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;
</FONT> that (A) grants Oxygen or one of its Subsidiaries any right to use any material Intellectual Property (other than &ldquo;shrink-wrap,&rdquo;
&ldquo;click-wrap&rdquo; or &ldquo;web-wrap&rdquo; licenses in respect of commercially available software), (B) permits any third
person to use, enforce or register any material Intellectual Property owned by Oxygen or its Subsidiaries (other than non-exclusive
licenses to end-users or customers in the ordinary course of business) or (C) restricts the right of Oxygen or one of its Subsidiaries
to use or register any material Intellectual Property owned by Oxygen or its Subsidiaries; or</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-indent: 0.5in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(xix)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>that relates to a material joint venture, partnership, limited liability company agreement or other similar agreement or
arrangement with any third party, or the formation, creation or operation, management or control of any material partnership or
joint venture with any third party.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0in">Each Contract of the type described
in this Section&nbsp;3.13(a), whether or not set forth in the Oxygen Disclosure Schedule, is referred to herein as an &ldquo;<U>Oxygen
Contract.</U>&rdquo; Oxygen has Made Available to Carbon prior to the date of this Agreement a complete and correct copy of each
Oxygen Contract, including all amendments, modifications and supplements thereto as in effect on the date of this Agreement.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(b)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Each Oxygen Contract is in full force and effect and is valid and binding on Oxygen or one of its Subsidiaries, as applicable,
and to Oxygen&rsquo;s Knowledge the other parties thereto, enforceable against Oxygen and its subsidiaries and, to Oxygen&rsquo;s
Knowledge, the other parties thereto in accordance with its terms, except as may be limited by the Enforceability Exceptions. Neither
Oxygen nor any of its Subsidiaries is, nor, to Oxygen&rsquo;s Knowledge, is any other party, in breach, default or violation (and
no event has occurred or not occurred through Oxygen&rsquo;s or any of its Subsidiaries&rsquo; action or inaction or, to Oxygen&rsquo;s
Knowledge, through the action or inaction of any third party, that with notice or the lapse of time or both would constitute a
breach, default or violation) of any term, condition or provision of any Oxygen Contract. There are no disputes pending or, to
Oxygen&rsquo;s Knowledge, threatened with respect to any Oxygen Contract and neither Oxygen nor any of its Subsidiaries has received
any written notice of the intention of any other party to an Oxygen Contract to terminate for default, convenience or otherwise
any Oxygen Contract, nor to Oxygen&rsquo;s Knowledge, is any such party threatening to do so.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><U><A NAME="a_Toc393714738"></A><A NAME="a_Ref383627444"></A></U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">3.14</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Agreements with Regulatory Agencies</U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">. </FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><A NAME="a_Ref388583392"></A><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(a)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Except for (a) the Consent Order for Oxygen, dated March 21, 2014, (b) the Consent Order for Oxygen Bank, dated March 6,
2014 and (c) the related Consent Orders for Oxygen and Oxygen Bank dated April 13, 2011 (the &ldquo;<U>Consent Orders</U>&rdquo;),
neither Oxygen nor any of its Subsidiaries is subject to any cease-and-desist or other order or enforcement action issued by, or
is a party to any written agreement, consent agreement or memorandum of understanding with, or is a party to any commitment letter
or similar undertaking to, or is subject to any order or directive by, or has been since January 1, 2011, a recipient of any supervisory
letter from, or since January 1, 2011, has adopted any policies, procedures or board resolutions at the request or suggestion of
any Regulatory Agency or other Governmental Entity that currently restricts in any material respect the conduct of its business
or that in any material manner relates to its capital</P>


<!-- Field: Page; Sequence: 34 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-top: 6pt; padding-bottom: 6pt; border-bottom: Black 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 24pt 70%; text-align: left"><U>STRICTLY&nbsp;CONFIDENTIAL</U><BR>EXECUTION&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt">adequacy, its ability to pay dividends, its credit or risk
management policies, its management or its business (each, whether or not set forth in the Oxygen Disclosure Schedule, an &ldquo;<U>Oxygen
Regulatory Agreement</U>&rdquo;), nor has Oxygen or any of its Subsidiaries been advised since January 1, 2011, by any Regulatory
Agency or other Governmental Entity that it is considering issuing, initiating, ordering, or requesting any such Oxygen Regulatory
Agreement. Except as set forth on Section 3.14 of the Oxygen Disclosure Schedule, as of the date of this Agreement, Oxygen and
its Subsidiaries have completed all actions (other than the completion of internal audits) required under the Consent Orders.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><A NAME="a_Ref388583404"></A><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(b)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Except as set forth in Section 3.14(b) of the Oxygen Disclosure Schedule, neither Oxygen nor any of its Subsidiaries has
been ordered to pay any civil monetary penalty by any Regulatory Agency or other Governmental Entity, nor have Oxygen or any of
its Subsidiaries been advised by any Regulatory Agency or other Governmental Entity that it is considering ordering any civil monetary
penalty.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><U><A NAME="a_Toc393714739"></A></U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">3.15</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Risk Management Instruments</U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">. All interest rate swaps, caps,
floors, option agreements, futures and forward contracts and other similar derivative transactions, whether entered into for the
account of Oxygen, any of its Subsidiaries or for the account of a customer of Oxygen or one of its Subsidiaries, were entered
into in the ordinary course of business and, in all material respects, in accordance with applicable rules, regulations and policies
of any Regulatory Agency with competent jurisdiction and with counterparties believed to be financially responsible at the time
and are legal, valid and binding obligations of Oxygen or one of its Subsidiaries enforceable in accordance with their terms except
as may be limited by the Enforceability Exceptions, and are in full force and effect. Oxygen and each of its Subsidiaries have
duly performed in all material respects all of their material obligations thereunder to the extent that such obligations to perform
have accrued, and, to Oxygen&rsquo;s Knowledge, there are no material breaches, violations or defaults or allegations or assertions
of such by any party thereunder.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><U><A NAME="a_Toc393714740"></A></U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">3.16</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Environmental Liability</U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">. </FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><A NAME="a_Ref388725140"></A><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(a)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Except as has not had and would not, individually or in the aggregate, reasonably be expected to be material to Oxygen and
its Subsidiaries, taken as a whole, (i) Oxygen and its Subsidiaries are in compliance with, and since January 1, 2011 have complied
with, all applicable Environmental Laws; (ii) there are no Proceedings seeking to impose, or that could reasonably result in the
imposition, on Oxygen or any of its Subsidiaries of any Liability or obligation arising under any Environmental Law, or to the
Knowledge of Oxygen, pending or threatened against Oxygen; (iii) Oxygen is not subject to any agreement, order, judgment, decree,
by or with any court, governmental authority, regulatory agency or third party imposing any Liability or obligation with respect
to Environmental Laws; (iv) to the Knowledge of Oxygen, no Hazardous Substance is present at, on, in or under any property currently
or formerly owned or leased by Oxygen or its Subsidiaries that could reasonably result in the imposition, on Oxygen or any of its
Subsidiaries of any Liability or obligation arising under any applicable Environmental Law; and (v) neither Oxygen nor any of its
Subsidiaries has assumed by contract, undertaken or provided an indemnity with respect to or otherwise become subject to any Liability
of any other Person specifically relating to any Environmental Law or concerning Hazardous Substances.</P>


<!-- Field: Page; Sequence: 35 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-top: 6pt; padding-bottom: 6pt; border-bottom: Black 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 24pt 70%; text-align: left"><U>STRICTLY&nbsp;CONFIDENTIAL</U><BR>EXECUTION&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(b)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT> Oxygen has Made Available to Carbon copies of all environmental reports, studies and assessments prepared within the past
five years that are in the possession or under the reasonable control of Oxygen or its Subsidiaries pertaining to Releases or compliance
with, or Liabilities under, Environmental Laws, in each case with respect to Owned Real Property or real property leased pursuant
to a Real Property Lease and that individually, or in the aggregate, would reasonably be expected to be material to Oxygen and
its Subsidiaries, taken as a whole.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><U><A NAME="a_Toc393714741"></A></U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">3.17</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Investment Securities and Commodities</U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">. </FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(a)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Each of Oxygen and its Subsidiaries has good title to all securities and commodities owned by it (except those sold under
repurchase agreements), free and clear of any Lien (other than Permitted Encumbrances) except to the extent such securities or
commodities are pledged in the ordinary course of business to secure obligations of Oxygen or its Subsidiaries.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(b)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Oxygen and its Subsidiaries and their respective businesses employ investment, securities, commodities, risk management
and other policies, practices and procedures that Oxygen believes are prudent and reasonable in the context of such businesses.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><U><A NAME="a_Toc393714742"></A></U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">3.18</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Property</U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">. </FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><A NAME="a_Ref388725456"></A><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(a)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Oxygen has good, valid, and marketable title to, or in the case of leased personal property assets, valid leasehold interests
in, all material tangible personal property currently used in the operation of the business of Oxygen and its Subsidiaries free
and clear of any Liens, except Permitted Encumbrances. The material tangible personal property currently used in the operation
of the business of Oxygen and its Subsidiaries is in good working order (reasonable wear and tear excepted).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><A NAME="a_Ref388541904"></A><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(b)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Section 3.18(b) of the Oxygen Disclosure Schedule sets forth a list of all real properties that are the subject of a Real
Property Lease as of the date hereof. Each of the lease agreements for real property to which Oxygen or any of its Subsidiaries
is bound or which relates to real property operated or utilized by Oxygen or any of its Subsidiaries (including all amendments,
extensions, renewals, guaranties and other agreements with respect thereto, individually, a &ldquo;<U>Real Property Lease</U>&rdquo;)
are in full force and effect and, to Oxygen&rsquo;s Knowledge, are enforceable against the landlord which is party thereto in accordance
with its terms (except as enforcement may be limited by the Enforceability Exceptions), and there are no material defaults or events
of default (or any event that with notice or lapse of time or both would become a material default or event of default) on the
part of Oxygen or any of its Subsidiaries, and to Oxygen&rsquo;s Knowledge, by any other party, under such lease agreements. Oxygen&rsquo;s
or its Subsidiaries&rsquo; possession and quiet enjoyment of the leased real property under such Real Property Lease has not been
disturbed, and to Oxygen&rsquo;s Knowledge, there are no disputes with respect to any such Real Property Lease, except for such
disturbances or disputes that, individually or in the aggregate, would not reasonably be expected to be material to Oxygen and
its Subsidiaries, taken as a whole.</P>


<!-- Field: Page; Sequence: 36 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-top: 6pt; padding-bottom: 6pt; border-bottom: Black 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 24pt 70%; text-align: left"><U>STRICTLY&nbsp;CONFIDENTIAL</U><BR>EXECUTION&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><A NAME="a_Ref389400215"></A><A NAME="a_Ref388725572"></A><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(c)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT> Section 3.18(c) of the Oxygen Disclosure Schedule sets forth a list of all real property owned by Oxygen and its Subsidiaries
(&ldquo;<U>Owned Real Property</U>&rdquo;). Oxygen or one of its Subsidiaries has valid and marketable title to the Owned Real
Property, including all appurtenances thereto and fixtures thereon, free and clear of any and all Liens except Permitted Encumbrances.
There is no purchase right, purchase option, right of first refusal or right of first offer with respect to the Owned Real Property
or any portion thereof. There are no pending or, to Oxygen&rsquo;s Knowledge, threatened condemnation proceedings against any Owned
Real Property.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><U><A NAME="a_Toc393714743"></A></U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">3.19</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Intellectual Property</U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">. </FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><A NAME="a_Ref388542035"></A><A NAME="a_Ref368501523"></A><A NAME="a_Ref368497536"></A><A NAME="a_Ref260945346"></A><A NAME="a_Toc244607726"></A><A NAME="a_Toc244603257"></A><A NAME="a_Toc244603051"></A><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(a)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Section 3.19(a) of the Oxygen Disclosure Schedule sets forth, in each case as of the date hereof, an accurate and complete
list of all: United States and foreign issued Patents, pending Patent applications, registered Marks, pending applications for
registration of Marks, registered Copyrights, and Internet domain names owned by Oxygen or any of its Subsidiaries (the foregoing
being, collectively, the &ldquo;<U>Oxygen Registered Intellectual Property</U>&rdquo;). No registrations or applications for material
Oxygen Registered Intellectual Property have expired or been canceled or abandoned except in accordance with the expiration of
the term of such rights or in the ordinary course of business.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><A NAME="a_Ref388542108"></A><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(b)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Except as set forth on Section 3.19(b) of the Oxygen Disclosure Schedule, Oxygen and its Subsidiaries own all right, title,
and interest to, or otherwise have a valid and enforceable right to use all Intellectual Property necessary for or used in the
conduct of the business of Oxygen and its Subsidiaries as currently conducted, except as would not reasonably be expected to be
material to Oxygen and its Subsidiaries, taken as a whole. All material Intellectual Property owned by Oxygen and its Subsidiaries
is owned free and clear of all Liens (except for Permitted Encumbrances).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><A NAME="a_Toc244603259"></A><A NAME="a_Toc244603053"></A><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(c)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The conduct of the business of Oxygen and its Subsidiaries as currently conducted does not infringe, violate or constitute
misappropriation of any Intellectual Property of any third Person except for such infringements, violations and misappropriations
that, individually or in the aggregate, would not reasonably be expected to be material to Oxygen and its Subsidiaries, taken as
a whole.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><A NAME="a_Toc244607729"></A><A NAME="a_Toc244603260"></A><A NAME="a_Toc244603054"></A><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(d)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>To the Knowledge of Oxygen, no third Person is infringing, violating, or misappropriating any material Intellectual Property
owned by Oxygen or its Subsidiaries. There is no (i) pending claim or (ii) asserted claim in writing (including any &ldquo;cease
and desist&rdquo; letters and invitations to license) that Oxygen or any Subsidiary has infringed, violated or misappropriated,
or is infringing or violating any Intellectual Property rights of any third Person, except for such claims that, if adversely determined,
would not reasonably be expected to be material to Oxygen and its Subsidiaries, taken as a whole.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(e)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Oxygen and its Subsidiaries have taken commercially reasonable measures to protect the confidentiality of the material Trade
Secrets of Oxygen and its Subsidiaries and third party confidential information provided to Oxygen or any Subsidiary that Oxygen
or such Subsidiary is obligated to maintain in confidence.</P>


<!-- Field: Page; Sequence: 37 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-top: 6pt; padding-bottom: 6pt; border-bottom: Black 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 24pt 70%; text-align: left"><U>STRICTLY&nbsp;CONFIDENTIAL</U><BR>EXECUTION&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><U><A NAME="a_Toc393714744"></A><A NAME="a_Ref347358741"></A></U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">3.20</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U> Related Party Transactions</U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">. </FONT>Except as set forth in
Section&nbsp;3.20 of the Oxygen Disclosure Schedule, there are no transactions or series of related transactions, Contracts, arrangements
or understandings, nor are there any currently proposed transactions or series of related transactions, between Oxygen or any of
its Subsidiaries, on the one hand, and any current or former director or &ldquo;executive officer&rdquo; (as defined in Rule 3b-7
under the Exchange Act) of Oxygen or any of its Subsidiaries or any Oxygen Holder (or any of such Person&rsquo;s immediate family
members or Affiliates) on the other hand, except those of a type available to employees of Oxygen or its Subsidiaries generally.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><U><A NAME="a_Toc393714745"></A><A NAME="a_Ref349312259"></A></U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">3.21</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>State Takeover Laws</U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">. The Board of Directors of Oxygen has
taken all actions that may be required to render inapplicable to this Agreement and the transactions contemplated hereby any &ldquo;moratorium,&rdquo;
&ldquo;control share,&rdquo; &ldquo;fair price,&rdquo; &ldquo;takeover&rdquo; or &ldquo;interested shareholder&rdquo; Law (any
such Laws, &ldquo;<U>Takeover Statutes</U>&rdquo;). No Takeover Statutes will prohibit, restrict or impair the performance of Oxygen&rsquo;s
obligations under this Agreement.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><U><A NAME="a_Toc393714746"></A></U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">3.22</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Oxygen Information</U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">. The information relating to Oxygen and
its Subsidiaries which is provided by Oxygen or its representatives for inclusion in any document filed with any Governmental Entity
in connection with the transactions contemplated by this Agreement, will not contain any untrue statement of a material fact or
omit to state a material fact necessary to make the statements therein, in light of the circumstances in which they are made, not
misleading. </FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><U><A NAME="a_Ref147755441"></A><A NAME="a_Ref264345935"></A><A NAME="a_Ref335174739"></A><A NAME="a_Ref347358769"></A><A NAME="a_Toc393714747"></A></U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">3.23</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Loan Matters</U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">. </FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><A NAME="a_Ref388542334"></A><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(a)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Each Oxygen Loan originated by Oxygen and its Subsidiaries and, to the Knowledge of Oxygen, each other Oxygen Loan has been
solicited and originated and, during the period of time such Oxygen Loan was originated, held or serviced by Oxygen or its Subsidiaries,
was administered and serviced, and the relevant loan files were maintained, in all material respects in accordance with the relevant
Loan documents, the underwriting standards of the originating bank and, in the case of such Oxygen Loans held for resale to investors,
the underwriting standards, if any, of the applicable investors and with all applicable requirements of Law, applicable GSE Requirements,
Governmental Insurer Requirements and Investor/Insurer Requirements.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><A NAME="a_Ref383683132"></A><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(b)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Except as set forth in Section 3.23(a)(i) of the Oxygen Disclosure Schedule, Oxygen is not bound by an agreement pursuant
to which Loans or pools of Loans or participations in Loans have been sold that contains any obligation of Oxygen or any of its
Subsidiaries to repurchase such Loans or interests therein solely on account of a payment default by the obligor on any such Loan.
<A NAME="a_Ref388542299"></A>Section 3.23(b) of the Oxygen Disclosure Schedule sets forth a true and correct report as regarding
the current status of (A) repurchase requests received by Oxygen or any of its Subsidiaries to repurchase any Loan or interests
therein serviced by Financial Freedom, and (B) Oxygen&rsquo;s and its Subsidiaries&rsquo; reserves in respect of potential repurchase
requests to repurchase any Loan or interests therein, in each case by any GSE, Governmental Insurer, private mortgage insurer or
investor.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(c)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Each of Oxygen and its Subsidiaries, as applicable, is approved by and is in good standing: (i) as a supervised mortgagee
by HUD to originate and service Title I FHA</P>


<!-- Field: Page; Sequence: 38 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-top: 6pt; padding-bottom: 6pt; border-bottom: Black 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 24pt 70%; text-align: left"><U>STRICTLY&nbsp;CONFIDENTIAL</U><BR>EXECUTION&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt">mortgage Loans; (ii) by the VA to originate and service VA
Loans; (iii) as a seller/servicer by Fannie Mae and Freddie Mac and (iv) by Ginnie Mae to issue mortgage backed securities.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(d)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>None of Oxygen or any of its Subsidiaries is now nor has been since January 1, 2011 subject to any material fine, suspension,
settlement or other agreement or other administrative agreement or sanction by, or any reduction in any Loan purchase commitment
from, any GSE or Governmental Insurer relating to the origination, sale or servicing of mortgage or consumer Loans. Oxygen has
not received any written notice, nor does it have any reason to believe, that any GSE proposes to limit or terminate the underwriting
authority of Oxygen and its Subsidiaries or to increase the guarantee fees payable to any GSE or Governmental Insurer.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(e)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Since March 19, 2009, except as would not reasonably be expected to be, individually or in the aggregate, material to Oxygen
or its Subsidiaries, taken as a whole, each of Oxygen and its Subsidiaries has been in compliance with all applicable federal,
state and local Laws, rules and regulations and related regulatory guidance, including the Truth-In-Lending Act and Regulation
Z, the Equal Credit Opportunity Act and Regulation B, the Real Estate Settlement Procedures Act and Regulation X, the Fair Credit
Reporting Act, the Fair Debt Collection Practices Act and all GSE Requirements, Governmental Insurer Requirements and Investor/Insurer
Requirements.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><A NAME="a_Ref388725477"></A><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(f)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Each Loan included in a pool of Loans originated, securitized or, to the Knowledge of Oxygen, acquired by Oxygen or any
of its Subsidiaries (a &ldquo;<U>Pool</U>&rdquo;) meets all eligibility requirements (including all applicable requirements for
obtaining mortgage insurance certificates and Loan guaranty certificates) for inclusion in such Pool. All such Pools have been
finally certified or, if required, recertified in accordance with all applicable Laws, rules and regulations, except where the
time for certification or recertification has not yet expired. No Pools have been improperly certified, and no Loan has been bought
out of a Pool without all required approvals of the applicable investors.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(g)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Each Oxygen Loan that is a mortgage Loan or reverse mortgage Loan is evidenced by a mortgage note or other valid and enforceable
documentation and is duly secured by a valid first lien or subordinate lien on the related mortgaged property, in each case, on
such forms and with terms that comply with applicable Law. Each such mortgage note and the related mortgage is genuine and each
is the legal, valid and binding obligation of the maker thereof, enforceable in accordance with its terms, except as may be limited
by the Enforceability Exceptions.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(h)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Advances, net of reserves, are valid and subsisting amounts owing to Oxygen and its applicable Subsidiary and are carried
on the books of Oxygen or the applicable Subsidiary at values determined in accordance with GAAP, and are not subject to setoffs
or claims arising from acts or omissions of Oxygen or any of its Subsidiaries. No GSE, Governmental Insurer, private mortgage insurer
or investor has claimed any defense, offset or counterclaim to repayment of any Advance that is pending.</P>


<!-- Field: Page; Sequence: 39 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-top: 6pt; padding-bottom: 6pt; border-bottom: Black 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 24pt 70%; text-align: left"><U>STRICTLY&nbsp;CONFIDENTIAL</U><BR>EXECUTION&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><U><A NAME="a_Toc393714748"></A></U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">3.24</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U> Loan Portfolio</U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">. </FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><A NAME="a_Ref388542523"></A><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(a)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>As of December 31, 2013, none of Oxygen or its Subsidiaries is a party to a Loan, including any Loan guaranty, with any
director, executive officer or 5% Oxygen Holder or any Affiliate of any of the foregoing other than as disclosed on 3.24(a) of
the Oxygen Disclosure Schedule. All Loans that have been made by Oxygen or its Subsidiaries that are subject to Section&nbsp;22(h)
of the Federal Reserve Act, as amended, or to Regulation O of the Federal Reserve Board (12 C.F.R. Part 215) comply therewith.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(b)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Section&nbsp;3.24(b) of the Oxygen Disclosure Schedule sets forth a listing, as of December 31, 2013, by account (and specifying
for any such Loan the Loss Share Agreement, if any, to which it is subject) of: (A) all Oxygen Loans (including participations)
with an unpaid principal balance of $10 million or more that have been accelerated by Oxygen or its Subsidiaries during the past
twelve months; (B) all Loan commitments or lines of credit of Oxygen and its Subsidiaries in an amount of $10 million or more that
have been terminated by Oxygen or its Subsidiaries during the past twelve months by reason of a default or adverse developments
in the condition of the borrower or other events or circumstances affecting the credit of the borrower; (C) each borrower, customer
or other party which has notified Oxygen or its Subsidiaries during the past twelve months of, or has asserted against Oxygen,
in each case in writing, any &ldquo;lender liability&rdquo; or similar claim, and, to the Knowledge of Oxygen, each borrower, customer
or other party which has given Oxygen or its Subsidiaries any oral notification of, or orally asserted to or against Oxygen or
any of its Subsidiaries, any such claim; (D) all Oxygen Loans, (1) that are contractually past due ninety (90) days or more in
the payment of principal and/or interest, (2) that are on non-accrual status, (3) that are classified as &ldquo;Other Loans Specially
Mentioned,&rdquo; &ldquo;Special Mention,&rdquo; &ldquo;Substandard,&rdquo; &ldquo;Doubtful,&rdquo; &ldquo;Loss,&rdquo; &ldquo;Classified,&rdquo;
&ldquo;Criticized,&rdquo; &ldquo;Watch list&rdquo; or words of similar import, together with the principal amount of and accrued
and unpaid interest on each such Loan and the identity of the obligor thereunder or (4) where a specific reserve allocation exists
in connection therewith; and (E) all assets classified by Oxygen and its Subsidiaries as real estate acquired through foreclosure
or in lieu of foreclosure, including in-substance foreclosures, and all other assets currently held that were acquired through
foreclosure or in lieu of foreclosure.<A NAME="a_Ref388542532"></A></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><A NAME="a_Ref388725556"></A><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(c)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Section&nbsp;3.24(c) of the Oxygen Disclosure Schedule sets forth a listing, as of the dates set forth therein, by account
(and specifying for any such Loan the Loss Share Agreement, if any, to which it is subject) of all Oxygen Loans where the interest
rate terms have been reduced and/or the maturity dates have been extended subsequent to the agreement under which the Loan was
originally created due to concerns regarding the borrower&rsquo;s ability to pay in accordance with such initial terms.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(d)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Oxygen has previously Made Available to Carbon, certain files on which information regarding the Oxygen Loans is recorded
(the &ldquo;<U>Tapes</U>&rdquo;). The information contained in the Tapes is true and accurate in all material respects as of the
date specified therein.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><A NAME="a_Ref388725319"></A><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(e)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Oxygen has previously Made Available to Carbon a copy of the Oxygen Bank N.A. SFR Asset Management March 2013 Loss Share
Review Report dated June 27, 2014 (the &ldquo;<U>Loss Share Review</U>&rdquo;). The information contained in the Loss Share Review
is true and accurate in all material respects as of June 27, 2014. To the Knowledge of Oxygen, neither</P>


<!-- Field: Page; Sequence: 40 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-top: 6pt; padding-bottom: 6pt; border-bottom: Black 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 24pt 70%; text-align: left"><U>STRICTLY&nbsp;CONFIDENTIAL</U><BR>EXECUTION&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt">Oxygen nor any of its Subsidiaries has been underpaid or
overpaid any amounts under the Loss Share Agreements that have not otherwise been corrected. Section 3.24(e) of the Oxygen Disclosure
Schedule set forth a true and correct report regarding the status as of June 30, 2014 of all claims for indemnification or, in
the case of the FDIC Agreements, reimbursement that have been submitted by Oxygen or its Subsidiaries pursuant to any of the FDIC
Agreements (other than the Loss Share Agreements) or GSE Agreements that have not been paid in full in the ordinary course, including
the corresponding dollar amount of each such claim.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><U><A NAME="a_Toc393714749"></A><A NAME="a_Ref388542581"></A><A NAME="a_Toc391290212"></A><A NAME="a_Toc391290371"></A><A NAME="a_Toc391290484"></A></U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">3.25</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Insurance</U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">. Section 3.25 of the Oxygen Disclosure Schedule
lists each material insurance policy maintained by or on behalf of Oxygen and its Subsidiaries as of the date hereof and a true
and complete copy of each such policy has been Made Available to Carbon prior to the date hereof. All premiums due in respect of
such insurance policies have been paid in full. All of such insurance policies are in full force and effect, and neither Oxygen
nor any Subsidiary is in material default with respect to any of its obligations under any of such insurance policies. To the Knowledge
of Oxygen, as of the date of this Agreement, (i) there is no threatened termination of, or threatened material premium increase
with respect to, any of such policies other than increases in connection with Oxygen&rsquo;s annual renewal process and (ii) there
is no material claim pending regarding Oxygen or any of its Subsidiaries under any of such policies as to which coverage has been
questioned, denied or disputed by the underwriters of such policies.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><U><A NAME="a_Toc393714750"></A><A NAME="a_Toc366690716"></A><A NAME="a_Toc366061835"></A><A NAME="a_Toc365738052"></A></U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">3.26</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Reorganization</U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">. Oxygen has not taken any action and is not
aware of any fact or circumstance that could reasonably be expected to prevent the Merger from qualifying as a &ldquo;reorganization&rdquo;
within the meaning of Section 368(a) of the Code.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center; text-indent: 0in"><A NAME="a_Toc393714751"></A><FONT STYLE="font: 12pt Times New Roman, Times, Serif; text-transform: uppercase">Article
IV</FONT><BR>
<BR>
<A NAME="a_Ref354687442"></A><A NAME="a_Ref347357807"></A>REPRESENTATIONS AND WARRANTIES OF CARBON AND MERGER SUB</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt">Except (i) as Previously Disclosed by Carbon or (ii) as disclosed
in any Carbon Reports publicly filed under Sections&nbsp;13(a), 14(a) or 15(d) of the Exchange Act by Carbon with the SEC since
December 31, 2013, and prior to the date hereof (but disregarding risk factor disclosures contained under the heading &ldquo;Risk
Factors,&rdquo; or disclosures of risks set forth in any &ldquo;forward-looking statements&rdquo; disclaimer or any other statements
that are similarly non-specific or cautionary, predictive or forward-looking in nature), Carbon and Merger Sub hereby represent
and warrant to Oxygen as follows:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><U><A NAME="a_Toc393714752"></A><A NAME="a_Ref347359564"></A></U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">4.1</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Corporate Organization</U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">. </FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(a)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Carbon is a corporation duly organized, validly existing and in good standing under the Laws of the State of Delaware and
is a bank holding company and financial holding company duly registered under the BHC Act and meets applicable requirements for
qualification as such. Carbon has the corporate power and authority to own or lease all of its properties and assets and to carry
on its business as it is now being conducted. Carbon is duly licensed or qualified to do business in each jurisdiction in which
the nature of the business conducted by it or the character or location of the properties and assets owned or leased by it makes
such licensing or qualification necessary, except where the failure to be so licensed or</P>


<!-- Field: Page; Sequence: 41 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-top: 6pt; padding-bottom: 6pt; border-bottom: Black 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 24pt 70%; text-align: left"><U>STRICTLY&nbsp;CONFIDENTIAL</U><BR>EXECUTION&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt">qualified would not, either individually or in the aggregate,
reasonably be expected to have a Material Adverse Effect on Carbon.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><A NAME="a_Ref347943538"></A><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(b)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Merger Sub is a limited liability company duly organized, validly existing and in good standing under the Laws of the State
of Delaware. Merger Sub has not conducted any business prior to the date of this Agreement and has no, and prior to the Effective
Time will have no, assets, liabilities or obligations of any nature other than those incident to its formation and pursuant to
this Agreement and the Merger and the other transactions contemplated by this Agreement.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><U><A NAME="a_Toc393714753"></A><A NAME="a_Ref347359534"></A></U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">4.2</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Capitalization</U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">. </FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><A NAME="a_Ref347945132"></A><A NAME="a_Ref354687071"></A><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(a)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The authorized capital stock of Carbon consists of 600,000,000 shares of Carbon Common Stock (par value $0.01 per share)
and 100,000,000 shares of preferred stock (par value $0.01 per share). As of June 30, 2014 there are (a) no shares of preferred
stock issued or outstanding, (b) 203,092,918 shares of Carbon Common Stock issued and outstanding, which number includes 2,965,280
restricted shares of Carbon Common Stock granted under a Carbon Stock Plan (a &ldquo;<U>Carbon Restricted Stock Award</U>&rdquo;),
(c) 17,447,692 shares of Carbon Common Stock held in treasury, (d) 59,095 shares of Carbon Common Stock reserved for issuance upon
the exercise of options granted by Carbon to purchase shares of Carbon Common Stock under a Carbon Stock Plan (as defined below)
(&ldquo;<U>Carbon Stock Options</U>&rdquo;), (e) 2,338,561 shares of Carbon Common Stock reserved for issuance upon the vesting
of restricted stock units or performance share units granted under a Carbon Stock Plan (&ldquo;<U>Carbon Restricted Stock Units</U>&rdquo;),
assuming in the case of performance share units that performance goals are satisfied at target levels and (f) no other shares of
capital stock or other voting securities of Carbon issued, reserved for issuance or outstanding. For purposes of this Agreement,
the &ldquo;<U>Carbon Stock Plans</U>&rdquo; means the Carbon Amended and Restated Long-Term Incentive Plan. All of the issued and
outstanding shares of Carbon Common Stock have been duly authorized and validly issued and are fully paid, nonassessable and free
of preemptive rights, with no personal Liability attaching to the ownership thereof.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><A NAME="a_Ref349649657"></A><A NAME="a_Ref392455792"></A><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(b)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Stock Consideration Amount has been duly authorized. At the Effective Time, the Stock Consideration Amount will be validly
issued, fully paid, nonassessable and free of preemptive rights, with no personal Liability attaching to the ownership thereof.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><U><A NAME="a_Toc393714754"></A></U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">4.3</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Authority; No Violation</U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">. </FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><A NAME="a_Ref347359580"></A><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(a)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Each of Carbon and Merger Sub has full corporate power and authority to execute and deliver this Agreement and to consummate
the transactions contemplated hereby, subject to the approval of the Bank Merger Agreement by the board of directors of Carbon
Bank. The execution and delivery of this Agreement and the consummation of the transactions contemplated by this Agreement have
been duly and validly approved by the Board of Directors of Carbon and Merger Sub, as applicable. Carbon, as the sole stockholder
of Merger Sub, has approved this Agreement and the transactions contemplated by this Agreement. No other corporate proceedings
on the part of Carbon or Merger Sub are necessary to approve this Agreement or to consummate the transactions contemplated hereby.
This Agreement has been duly and validly executed and delivered by Carbon and Merger Sub and (assuming due</P>


<!-- Field: Page; Sequence: 42 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-top: 6pt; padding-bottom: 6pt; border-bottom: Black 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 24pt 70%; text-align: left"><U>STRICTLY&nbsp;CONFIDENTIAL</U><BR>EXECUTION&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt">authorization, execution and delivery by Oxygen) constitutes
a valid and binding obligation of Carbon and Merger Sub, enforceable against Carbon and Merger Sub in accordance with its terms,
except as may be limited by the Enforceability Exceptions.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><A NAME="a_Ref388537739"></A><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(b)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Neither the execution and delivery of this Agreement by Carbon or Merger Sub, nor the consummation by Carbon or Merger Sub
of the transactions contemplated hereby, nor compliance by Carbon or Merger Sub with any of the terms or provisions hereof, will
(i) violate any provision of the Certificate of Incorporation of Carbon or Bylaws or Merger Sub&rsquo;s Certificate of Formation
or Limited Liability Company Agreement or (ii) assuming that the consents and approvals referred to in Section 4.4 are duly obtained,
(x) violate any Law applicable to Carbon, any of its Subsidiaries or any of their respective properties or assets or (y) violate,
conflict with, result in a breach of any provision of or the loss of any benefit under, constitute a default (or an event which,
with notice or lapse of time, or both, would constitute a default) under, result in the termination of or a right of termination
or cancellation under, accelerate the performance required by, or result in the creation of any Lien upon any of the respective
properties or assets of Carbon or any of its Subsidiaries under, any of the terms, conditions or provisions of any Contract or
other instrument or obligation to which Carbon or any of its Subsidiaries is a party, or by which they or any of their respective
properties or assets may be bound or affected, except (in the case of clause (ii)(y) above) for such violations, conflicts, breaches
or defaults which, either individually or in the aggregate, would not reasonably be expected to have a Material Adverse Effect
on Carbon.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><U><A NAME="a_Toc393714755"></A><A NAME="a_Ref347359464"></A><A NAME="a_Ref347358838"></A></U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">4.4</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Consents and Approvals</U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">. Except for (i) the filing of applications
and notices, as applicable, with the NYSE, (ii) the filing of any required applications, filings and notices, as applicable, with
(1) the Federal Reserve Board under the BHC Act, (2) the FDIC under the Bank Merger Act, (3) the OCC, and approval of the foregoing
applications, filings and notices, (iii) the filing of the Certificate of Merger with the Secretary of State of the State of Delaware
pursuant to the DLLCA, (iv) the filing of the Bank Merger Certificates, and (v) such filings and approvals as are required to be
made or obtained under the securities or &ldquo;Blue Sky&rdquo; Laws of various states in connection with the issuance of the shares
of Carbon Common Stock pursuant to this Agreement, no consents or approvals of or filings or registrations with any Governmental
Entity are necessary in connection with (A)&nbsp;the execution and delivery by Carbon and Merger Sub of this Agreement or (B) the
consummation by Carbon and Merger Sub of the Merger, the Bank Merger and the other transactions contemplated hereby. </FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><U><A NAME="a_Toc393714756"></A></U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">4.5</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Reports</U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">. Carbon and each of its Subsidiaries have timely filed
all reports, registrations and statements, together with any amendments required to be made with respect thereto, that they were
required to file since January 1, 2011 with any Regulatory Agencies, including, without limitation, any report, registration or
statement required to be filed pursuant to the Laws of the United States, any state, any foreign entity, or any Regulatory Agency,
and have paid all fees and assessments due and payable in connection therewith. Except for normal examinations conducted by a Regulatory
Agency in the ordinary course of the business of Carbon and its Subsidiaries, no Regulatory Agency has initiated or has pending
any Proceeding or, to the Knowledge of Carbon, investigation into the business or operations of Carbon or any of its Subsidiaries
since January 1, 2011. There (i) is no unresolved violation, criticism, or exception by any Regulatory Agency with respect to any
report or statement relating to any examinations or inspections of Carbon or any of its Subsidiaries and (ii) has been no formal
or </FONT></P>

<!-- Field: Page; Sequence: 43 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-top: 6pt; padding-bottom: 6pt; border-bottom: Black 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 24pt 70%; text-align: left"><U>STRICTLY&nbsp;CONFIDENTIAL</U><BR>EXECUTION&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">informal inquiries by, or disagreements or disputes with, any Regulatory Agency with respect to the business, operations, policies
or procedures of Carbon or any of its Subsidiaries since January 1, 2011.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><U><A NAME="a_Toc393714757"></A></U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">4.6</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Financial Statements</U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">. </FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(a)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The financial statements of Carbon and its Subsidiaries included (or incorporated by reference) in the Carbon Reports (including
the related notes, where applicable) (i)&nbsp;have been prepared from, and are in accordance with, the books and records of Carbon
and its Subsidiaries, (ii)&nbsp;fairly present in all material respects the consolidated results of operations, cash flows, changes
in shareholders&rsquo; equity and consolidated financial position of Carbon and its Subsidiaries for the respective fiscal periods
or as of the respective dates therein set forth (subject in the case of unaudited statements to recurring year-end audit adjustments
normal in nature and amount) and (iii)&nbsp;have been prepared in accordance with GAAP consistently applied during the periods
involved, except, in each case, as indicated in such statements or in the notes thereto. The books and records of Carbon and its
Subsidiaries have been, and are being, maintained in all material respects in accordance with GAAP and any other applicable legal
and accounting requirements and reflect only actual transactions. As of the date hereof, PricewaterhouseCoopers LLP has not resigned
(or informed Carbon that it intends to resign) or been dismissed as independent public accountants of Carbon as a result of or
in connection with any disagreements with Carbon on a matter of accounting principles or practices, financial statement disclosure
or auditing scope or procedure.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(b)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Neither Carbon nor any of its Subsidiaries have any material Liability, except for (i) those Liabilities that are fully
reflected or reserved against on the consolidated balance sheet of Carbon included in its Quarterly Report on Form 10-Q for the
quarterly period ended March 31, 2014 (including any notes thereto), (ii) Liabilities incurred in the ordinary course of business
consistent with past practice since March 31, 2014, or (iii) Liabilities incurred in connection with this Agreement and the transactions
contemplated hereby. None of Carbon or any of its Subsidiaries is a party to any material &ldquo;off-balance sheet arrangements&rdquo;
as defined in Item 303(a)(4) of Regulation S-K.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(c)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The records, systems, controls, data and information of Carbon and its Subsidiaries are recorded, stored, maintained and
operated under means (including any electronic, mechanical or photographic process, whether computerized or not) that are under
the exclusive ownership and direct control of Carbon or its Subsidiaries or accountants (including all means of access thereto
and therefrom) except for any non-exclusive ownership and non-direct control that would not reasonably be expected to have, individually
or in the aggregate, a material adverse effect on Carbon&rsquo;s system of internal controls over financial reporting. Carbon (x)&nbsp;has
implemented and maintains disclosure controls and procedures (as defined in Rule 13a-15(e) of the Exchange Act) to ensure that
material information relating to Carbon, including its Subsidiaries, is made known to the Chief Executive Officer and the Chief
Financial Officer of Carbon by others within those entities as appropriate to allow timely decisions regarding required disclosures
and to make the certifications required by the Exchange Act and Sections&nbsp;302 and 906 of the Sarbanes-Oxley Act, and (y)&nbsp;has
disclosed, based on its most recent evaluation prior to the date hereof, to Carbon&rsquo;s outside auditors and the audit committee
of Carbon&rsquo;s Board of Directors (i)&nbsp;any significant deficiencies and material weaknesses in the</P>


<!-- Field: Page; Sequence: 44 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-top: 6pt; padding-bottom: 6pt; border-bottom: Black 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 24pt 70%; text-align: left"><U>STRICTLY&nbsp;CONFIDENTIAL</U><BR>EXECUTION&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt">design or operation of internal control over financial reporting
(as defined in Rule 13a-15(f) of the Exchange Act) which are reasonably likely to adversely affect Carbon&rsquo;s ability to record,
process, summarize and report financial information, and (ii)&nbsp;any fraud, whether or not material, that involves management
or other employees who have a significant role in Carbon&rsquo;s internal controls over financial reporting. These disclosures
were made in writing by management to Carbon&rsquo;s auditors and audit committee and a copy has previously been made available
to Oxygen.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(d)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Since January 1, 2011, (i) neither Carbon nor any of its Subsidiaries, nor, to the Knowledge of Carbon, any director, officer,
auditor, accountant or representative of it or any of its Subsidiaries, have received or otherwise had or obtained Knowledge of
any material complaint, allegation, assertion or claim, whether written or oral, regarding the accounting or auditing practices,
procedures, methodologies or methods (including with respect to loan loss reserves, write-downs, charge-offs and accruals) of Carbon
or any of its Subsidiaries or their respective internal accounting controls, including any material complaint, allegation, assertion
or claim that Carbon or any of its Subsidiaries has engaged in questionable accounting or auditing practices, procedures, or methodologies
(including with respect to loan loss and other reserves, write-downs, charge-offs and accruals), and (ii) to the Knowledge of Carbon,
no attorney representing Carbon or any of its Subsidiaries, whether or not employed by Carbon or any of its Subsidiaries, has reported
evidence of a material violation of securities Laws, breach of fiduciary duty or similar violation by Carbon or any of its officers,
directors, employees or agents to the Board of Directors of Carbon or any committee thereof or to any director or officer of Carbon.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><U><A NAME="a_Toc393714758"></A><A NAME="a_Ref349313756"></A></U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">4.7</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Broker&rsquo;s Fees</U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">. With the exception of the engagement
of J.P. Morgan Securities LLC, neither Carbon nor any of its Subsidiaries nor any of their respective officers or directors have
employed any broker, finder or financial advisor or incurred any Liability for any broker&rsquo;s fees, commissions or finder&rsquo;s
fees in connection with the transactions contemplated by this Agreement.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><U><A NAME="a_Toc393714759"></A></U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">4.8</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Absence of Certain Changes or Events</U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">. </FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><A NAME="a_Ref347402918"></A><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(a)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Since December 31, 2013 through the date hereof, no fact, change, event, occurrence, condition or development has occurred
that have had or would reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect on Carbon.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(b)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Since December 31, 2013 through the date hereof, Carbon and its Subsidiaries have carried on their respective businesses
in all material respects in the ordinary course.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><U><A NAME="a_Toc393714760"></A></U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">4.9</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Legal Proceedings</U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">. </FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(a)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Neither Carbon nor any of its Subsidiaries is a party to any, and there are no pending or, to Carbon&rsquo;s Knowledge,
threatened, material Proceedings against Carbon or any of its Subsidiaries or any of their current or former directors or executive
officers (whether or not such Proceedings are currently being tolled).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(b)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>There is no material injunction, order, judgment, decree, or regulatory restriction imposed upon Carbon, any of its Subsidiaries
or the assets of Carbon or any of its</P>


<!-- Field: Page; Sequence: 45 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-top: 6pt; padding-bottom: 6pt; border-bottom: Black 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 24pt 70%; text-align: left"><U>STRICTLY&nbsp;CONFIDENTIAL</U><BR>EXECUTION&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt">Subsidiaries (or that, upon consummation of the Merger or
the Bank Merger, would apply to Carbon or any of its Subsidiaries).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><U><A NAME="a_Toc393714761"></A></U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">4.10</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Compliance with Applicable Law</U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">. </FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(a)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Carbon and each of its Subsidiaries hold, and have at all times since January&nbsp;1, 2011, held, all material Permits necessary
for the lawful conduct of their respective businesses and ownership of their respective properties, rights and assets under and
pursuant to each (and have paid all fees and assessments due and payable in connection therewith), and, to the Knowledge of Carbon,
no suspension or cancellation of any such Permit is threatened. Since January 1, 2011, Carbon and each of its Subsidiaries have
complied in all material respects with and are not in material default or violation under any applicable Law relating to Carbon
or any of its Subsidiaries, including without limitation all Laws related to data protection or privacy, the USA PATRIOT Act, the
Bank Secrecy Act, the Equal Credit Opportunity Act and Regulation B, the Fair Housing Act, the Community Reinvestment Act, the
Fair Credit Reporting Act, the Truth in Lending Act and Regulation Z, the Home Mortgage Disclosure Act, the Fair Debt Collection
Practices Act, the Electronic Fund Transfer Act, the Dodd-Frank Wall Street Reform and Consumer Protection Act, any regulations
promulgated by the Consumer Financial Protection Bureau, the Interagency Policy Statement on Retail Sales of Nondeposit Investment
Products, the SAFE Mortgage Licensing Act of 2008, the Real Estate Settlement Procedures Act and Regulation X, and any other Law
relating to bank secrecy, discriminatory lending, financing or leasing practices, money laundering prevention, Sections&nbsp;23A
and 23B of the Federal Reserve Act, the Sarbanes-Oxley Act.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(b)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Without limitation, since January 1, 2011, none of Carbon, or its Subsidiaries, or any director, officer, employee, agent
or other Person acting on behalf of Carbon or any of its Subsidiaries has, directly or indirectly, (i) used any funds of Carbon
or any of its Subsidiaries for unlawful contributions, unlawful gifts, unlawful entertainment or other expenses relating to political
activity; (ii) made any unlawful payment to foreign or domestic governmental officials or employees or to foreign or domestic political
parties or campaigns from funds of Carbon or any of its Subsidiaries; (iii) violated any provision that would result in the violation
of the Foreign Corrupt Practices Act of 1977, as amended, or any similar Law; (iv) established or maintained any unlawful fund
of monies or other assets of Carbon or any of its Subsidiaries; (v) made any fraudulent entry on the books or records of Carbon
or any of its Subsidiaries; (vi) made any unlawful bribe, unlawful rebate, unlawful payoff, unlawful influence payment, unlawful
kickback or other unlawful payment to any Person, private or public, regardless of form, whether in money, property or services,
to obtain favorable treatment in securing business to obtain special concessions for Carbon or any of its Subsidiaries, to pay
for favorable treatment for business secured or to pay for special concessions already obtained for Carbon or any of its Subsidiaries
or (vii) to the Knowledge of Carbon, is currently subject to any United States sanctions administered by the Office of Foreign
Assets Control of the United States Treasury Department.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(c)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Since January 1, 2011, Carbon and each of its Subsidiaries has properly administered all accounts for which Carbon or any
of its Subsidiaries acts as a fiduciary, including accounts for which Carbon or any of its Subsidiaries serves as a trustee, agent,
custodian, personal representative, guardian, conservator or investment adviser, in accordance</P>


<!-- Field: Page; Sequence: 46 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-top: 6pt; padding-bottom: 6pt; border-bottom: Black 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 24pt 70%; text-align: left"><U>STRICTLY&nbsp;CONFIDENTIAL</U><BR>EXECUTION&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt">with the terms of the governing documents and applicable
Law in all material respects, and none of Carbon or any of its Subsidiaries has received notice of any failure to properly administer
any accounts for which it acts as a fiduciary. Since January 1, 2011, none of Carbon or any of its Subsidiaries, or any director,
officer, or employee of Carbon or its Subsidiaries, has committed any breach of trust with respect to any such fiduciary account,
and the accountings for each such fiduciary account are true and correct and accurately reflect the assets of such fiduciary account.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(d)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>As of December 31, 2013, Carbon and each insured depositary Subsidiary of Carbon is &ldquo;well-capitalized&rdquo; (as that
term is defined in the relevant regulation of the institution&rsquo;s primary federal bank regulator), and the institution&rsquo;s
rating under the Community Reinvestment Act of 1997 is no less than &ldquo;satisfactory.&rdquo;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><U><A NAME="a_Toc393714762"></A><A NAME="a_Ref388725016"></A></U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">4.11</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Agreements with Regulatory Agencies</U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">. </FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(a)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Neither Carbon nor any of its Subsidiaries is subject to any cease-and-desist or other order or enforcement action issued
by, or is a party to any written agreement, consent agreement or memorandum of understanding with, or is a party to any commitment
letter or similar undertaking to, or is subject to any order or directive by, or has been ordered to pay any civil monetary penalty
by, or has been since January 1, 2011, a recipient of any supervisory letter from, or since January 1, 2011, has adopted any policies,
procedures or board resolutions at the request or suggestion of any Regulatory Agency or other Governmental Entity that currently
restricts in any material respect the conduct of its business or that in any material manner relates to its capital adequacy, its
ability to pay dividends, its credit or risk management policies, its management or its business (each, whether or not set forth
in the Carbon Disclosure Schedule, a &ldquo;<U>Carbon Regulatory Agreement</U>&rdquo;), nor has Carbon or any of its Subsidiaries
been advised since January 1, 2011, by any Regulatory Agency or other Governmental Entity that it is considering issuing, initiating,
ordering or requesting any such Carbon Regulatory Agreement.<A NAME="a_Ref388537517"></A></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(b)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Except as set forth in Section 4.11(b) of the Carbon Disclosure Schedule, neither Carbon nor any of its Subsidiaries has
been ordered to pay any civil monetary penalty by any Regulatory Agency or other Governmental Entity, nor have Carbon or any of
its Subsidiaries been advised by any Regulatory Agency or other Governmental Entity that it is considering ordering any civil monetary
penalty</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><U><A NAME="a_Toc393714763"></A></U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">4.12</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Available Funds</U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">. As of the Closing, Carbon will have sufficient
funds available to it to deliver the Aggregate Cash Consideration.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><U><A NAME="a_Toc393714764"></A></U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">4.13</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Reorganization</U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">. Carbon has not taken any action and is not
aware of any fact or circumstance that could reasonably be expected to prevent the Merger from qualifying as a &ldquo;reorganization&rdquo;
within the meaning of Section 368(a) of the Code.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><U><A NAME="a_Toc393714765"></A></U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">4.14</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Carbon Information</U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">. The information relating to Carbon and
its Subsidiaries which is provided by Carbon or its representatives for inclusion in any document filed with any Governmental Entity
in connection with the transactions contemplated by this Agreement, will not contain any untrue statement of a material fact or
omit to state a material fact necessary to make the statements therein, in light of the circumstances in which they are made, not
misleading. </FONT></P>



<!-- Field: Page; Sequence: 47 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-top: 6pt; padding-bottom: 6pt; border-bottom: Black 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 24pt 70%; text-align: left"><U>STRICTLY&nbsp;CONFIDENTIAL</U><BR>EXECUTION&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center; text-indent: 0in"><FONT STYLE="text-transform: uppercase"><A NAME="a_Toc393714766"></A>Article
V</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center">
COVENANTS RELATING TO CONDUCT OF BUSINESS</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><U><A NAME="a_Toc393714767"></A></U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">5.1</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Conduct of Business Prior to the Effective Time</U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">. During the
period from the date of this Agreement to the Effective Time, except as expressly required or permitted by this Agreement, or as
required by applicable Law, or with the prior written consent of Carbon, Oxygen shall, and shall cause each of its Subsidiaries
to, (a) conduct its business in the ordinary course and (b) use reasonable best efforts to maintain and preserve intact its business
organization, assets, employees and relationships with regulators, customers, suppliers, employees, licensors and licensees and
other third parties. Subject to the terms and conditions of this Agreement, including Section 6.1, during the period from the date
of this Agreement to the Effective Time, Oxygen and Carbon shall use their respective reasonable best efforts to take or cause
to be taken all actions, and do or cause to be done all things, necessary, proper or advisable on their respective parts under
this Agreement and applicable Laws to consummate and make effective the Merger and the other transactions contemplated by this
Agreement as soon as reasonably practicable and, except as expressly required or permitted by this Agreement, or as required by
applicable Law, or with the prior written consent of the other party, Oxygen and Carbon shall, and shall cause each of its Subsidiaries
to take no action that is intended to or would reasonably be expected to result in the failure of any of the conditions set forth
in Article VII.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><U><A NAME="a_Toc393714768"></A><A NAME="a_Ref347359072"></A></U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">5.2</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Oxygen Forbearances</U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">. During the period from the date of this
Agreement to the Effective Time, except (x) as required by applicable Law, (y) as expressly required or permitted by this Agreement
or (z) as set forth in Section 5.2 of the Oxygen Disclosure Schedule, Oxygen shall not, and shall not permit any of its Subsidiaries
to, without the prior written consent of Carbon (which, other than in the case of clauses (b), (c) (solely as such clause (c) relates
to assets under the IndyMac Bank, F.S.B. Loss Share Agreement), (d), (e) (solely as such clause (e) relates to FDIC Agreements
and GSE Agreements), (f), (g), (i), (j), (k), (l), (m), (n), (p), (q), (r) (s), (t) or, solely in respect of each of the foregoing,
(u) below, shall not be unreasonably withheld or delayed):</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(a)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>other than in the ordinary course of business consistent with past practice, incur any indebtedness, for borrowed money
(other than indebtedness of Oxygen or any of its wholly owned Subsidiaries to Oxygen or any of its Subsidiaries), assume, guarantee,
endorse or otherwise as an accommodation become responsible for the obligations of any other Person (other than Oxygen or any of
its Subsidiaries);</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><A NAME="a_Ref347358407"></A><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(b)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>(i)&#9;adjust, split, combine or reclassify any limited liability company interests or other equity interests;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-indent: 0.5in"><A NAME="a_Ref354687618"></A><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(i)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>make, declare or pay any dividend, or make any other distribution on, or directly or indirectly redeem, purchase or otherwise
acquire, any of its limited liability company interests, other equity interests, or any securities or obligations convertible (whether
currently convertible or convertible only after the passage of time or the occurrence of certain events) into or exchangeable for
any of its limited liability company interests or other equity interests except any</P>


<!-- Field: Page; Sequence: 48 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-top: 6pt; padding-bottom: 6pt; border-bottom: Black 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 24pt 70%; text-align: left"><U>STRICTLY&nbsp;CONFIDENTIAL</U><BR>EXECUTION&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in">dividends paid by any of the Subsidiaries of Oxygen to
Oxygen or any of its wholly owned Subsidiaries;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-indent: 0.5in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(ii)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>(A) issue, grant, sell or otherwise permit to become outstanding, or authorize the issuance of, any additional limited liability
company interests or other equity interests or securities convertible or exchangeable into, or exercisable for, any limited liability
company interests or other equity interests or any equity-based awards or interests or other rights of any kind to acquire any
limited liability company interests or other equity interests, except pursuant to the exercise or settlement of options to purchase
Common Interests, Oxygen Converted Common Interests or Oxygen Profits Interests outstanding as of the date hereof, in each case
in accordance with their terms or Section 6.5(b), or (B) enter into any Contract, understanding or arrangement with respect to
the sale or voting of its limited liability company interests, other equity interests or other securities;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(c)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>sell, transfer, pledge, lease grant, license, mortgage, assign, encumber or otherwise dispose of (including by merger) any
of its material properties or assets (other than any assets subject to the IndyMac Bank, F.S.B. Loss Share Agreement) to any Person
other than a wholly owned Subsidiary, in each case except in the ordinary course of business consistent with past practice (including
non-exclusive licenses to end-users or customers), or for Permitted Liens, or cancel, release or assign any material indebtedness
to any such Person or any claims held by any such Person;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(d)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>acquire (whether by merger or consolidation, acquisition of stock or assets or by formation of a joint venture or otherwise,
but excluding by way of foreclosures or acquisitions of control in a fiduciary or similar capacity or in satisfaction of debts
previously contracted in good faith, in each case in the ordinary course of business consistent with past practice) any other Person,
other than a wholly owned subsidiary of Oxygen, or make any material investment in (either by purchase of stock or securities,
contributions to capital, property transfers, or purchase of any property or assets) any other Person or property or assets of
any other Person, in each case other than a wholly owned Subsidiary of Oxygen;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(e)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>terminate any Oxygen Contract or amend, waive, or fail to use reasonable best efforts to enforce any material provision
of, any Oxygen Contract, in each case except in the ordinary course of business consistent with past practice (other than a FDIC
Agreement or GSE Agreement), or enter into any Contract that would constitute an Oxygen Contract if it were in effect on the date
of this Agreement or renew any Oxygen Contract other than any Contract which is terminable by Oxygen or its Subsidiaries on sixty
(60) days or less notice without any required material payment or other conditions, other than the condition of notice; <U>provided</U>
that this Section 5.2(e) shall not restrict the entry into any Oxygen Contract (other than a FDIC Agreement or GSE Agreement) that
relates to (i) the incurrence of indebtedness permitted to be incurred pursuant to Section 5.2(a) or (ii) any settlement of a Proceeding
permitted pursuant to Section 5.2(g);</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><A NAME="a_Ref354686847"></A><A NAME="a_Ref354686748"></A><A NAME="a_Ref347657637"></A><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(f)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>except as required by an Oxygen Benefit Plan as in effect on the date hereof or as required by applicable Law or this Agreement,
(i) become a party to, enter into</P>


<!-- Field: Page; Sequence: 49 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-top: 6pt; padding-bottom: 6pt; border-bottom: Black 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 24pt 70%; text-align: left"><U>STRICTLY&nbsp;CONFIDENTIAL</U><BR>EXECUTION&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt">(other than entry into offer letters in the ordinary course
of business consistent with past practice that does not conflict with any other provision of this Section 5.2(f) (for the avoidance
of doubt, including providing rights to severance or change-in-control compensation or benefits)), adopt, materially amend or terminate
(or commit to become a party to, enter into, adopt, materially amend or terminate) any Oxygen Benefit Plan (or arrangement that
had it existed as of the date hereof, would have been an Oxygen Benefit Plan), (ii) increase in any manner the compensation or
benefits payable to any current or former director, employee or other service provider of Oxygen or any of its Subsidiaries or
pay any amounts to any such individual not otherwise due, other than increases in the ordinary course of business consistent with
past practice (A) of 2% or less in the aggregate base salaries (and corresponding increases in target bonuses occurring solely
as a result of such increases in base salaries) payable to current employees of Oxygen or its Subsidiaries whose annual target
compensation is less than $500,000 or (B) of 5% or less in annual base salary (and corresponding increases in target bonuses occurring
solely as a result of such increases in base salaries) payable to any current employee of Oxygen or its Subsidiaries whose annual
target compensation is less than $500,000 in connection with the promotion of such employee in the ordinary course of business
consistent with past practice and provided that such increase does not raise such employee&rsquo;s annual target compensation above
$500,000, (iii)&nbsp;pay or award, or commit to pay or award, any bonuses or incentive compensation, other than the determination
and payment of annual bonuses in respect of Oxygen&rsquo;s 2014 fiscal year in the ordinary course consistent with past practice
and the terms of the applicable bonus programs with the aggregate amount of such bonuses not to exceed an annualized amount calculated
at the same accrual rate for such bonuses reflected in the Oxygen Audited Interim Financial Statements, which amount is set forth
on Section 5.2(f)(iii) of the Oxygen Disclosure Schedule and which accrual is determined in the ordinary course of business consistent
with past practice, (iv) grant or accelerate the vesting of any compensation or benefits for the benefit of any current or former
employee, officer, director or other service provider of Oxygen or any of its Subsidiaries, (v)&nbsp;enter into any collective
bargaining agreement or similar labor agreement, (vi) provide any funding for any rabbi trust or similar arrangement, or take any
action to fund or in any other way secure the payment of any compensation or benefits, or (vii) hire or terminate (other than for
cause) the employment of any individual with annual target compensation in excess of $500,000;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(g)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>commence, settle or compromise any Proceeding, except for (i) any settlement (A) involving only monetary remedies with a
value not in excess of $1 million, with respect to any individual Proceeding or $5 million, in the aggregate (in excess of, in
each case, any settlement payments that are actually recovered from trusts or other third parties or reserves in respect thereof
to the extent reflected in the Oxygen Unaudited Financial Statements), subject to prior consultation with Carbon and (B) that is
not otherwise reasonably likely to be material to Oxygen and its Subsidiaries (or following the Closing, Carbon and its Subsidiaries)
and (ii) the commencement of any Proceeding in the ordinary course of business consistent with past practice;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(h)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>waive or release any rights or claims material to Oxygen and its Subsidiaries or agree or consent to the issuance of any
injunction, decree, order or judgment restricting or adversely affecting its business or operations in any material respect;</P>


<!-- Field: Page; Sequence: 50 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-top: 6pt; padding-bottom: 6pt; border-bottom: Black 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 24pt 70%; text-align: left"><U>STRICTLY&nbsp;CONFIDENTIAL</U><BR>EXECUTION&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(i)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT> amend its Organizational Documents, or enter into a plan of consolidation, merger, share exchange, reorganization or similar
business combination (other than with respect to consolidations, mergers, share exchanges, reorganizations or similar business
combinations solely involving its wholly owned Subsidiaries);<B><I> </I></B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(j)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>except as contemplated by the forecast Made Available to Carbon, restructure or make any material change to its investment
securities or derivatives portfolio or its interest rate exposure, through purchases, sales or otherwise, or the manner in which
the portfolio is classified or reported, in a manner that is not consistent with Oxygen&rsquo;s existing investment policy previously
Made Available to Carbon;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(k)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>implement or adopt any material change in its accounting principles, practices or methods, including reserving methodologies,
other than as may be required by GAAP;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(l)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>enter into any new line of business or change in any material respect its lending, investment, underwriting, risk and asset
liability management and other banking and operating, securitization and servicing policies or expand its SBA 7A program, except,
in each case, as required by applicable Law or as requested by any Governmental Entity;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(m)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>make any material changes in its policies and practices with respect to (i)&nbsp;underwriting, pricing, originating, acquiring,
selling, servicing, or buying or selling rights to service, Loans or (ii) its hedging practices and policies, except, in each case,
as required by applicable Law or as requested by any Governmental Entity;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><A NAME="a_Ref354688856"></A><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(n)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>(i) except for Loans or commitments for Loans that have been approved by Carbon prior to the date of this Agreement, without
prior consultation with Carbon, (1) make or acquire any individual Loan or issue a commitment (or renew or extend an existing commitment)
for any individual Loan if under Oxygen&rsquo;s credit policies previously Made Available to Carbon such Loan or commitment would
require the approval of the Oxygen Board of Directors or (ii) without prior consultation with Carbon, enter into agreements relating
to, or consummate purchases or sales of, whole individual Loans if under Oxygen&rsquo;s credit policies previously Made Available
to Carbon such action would require the approval of the Oxygen Board of Directors;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(o)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>make application for the opening, relocation or closing of any, or open, relocate or close any, branch office, loan production
office or other significant office or operations facility of it or its Subsidiaries or acquire or sell or agree to acquire or sell,
any branch office or any deposit liabilities;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(p)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>make any capital expenditure in excess of $2,500,000 individually or $10,000,000 in the aggregate;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(q)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>materially reduce the amount of insurance coverage or fail to renew or replace any material existing insurance policies;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(r)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>terminate or allow to lapse any Permit or amend a Permit in a manner that materially adversely impacts the ability to conduct
its business;</P>


<!-- Field: Page; Sequence: 51 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-top: 6pt; padding-bottom: 6pt; border-bottom: Black 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 24pt 70%; text-align: left"><U>STRICTLY&nbsp;CONFIDENTIAL</U><BR>EXECUTION&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(s)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT> adopt a plan of complete or partial liquidation, dissolution, restructuring, recapitalization or other reorganization;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(t)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>take any action or knowingly fail to take any action that could reasonably be expected to prevent the Merger from qualifying
as a &ldquo;reorganization&rdquo; within the meaning of Section 368(a) of the Code; or</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(u)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>agree to take, make any commitment to take, or adopt any resolutions of its board of directors or similar governing body
in support of, any of the actions prohibited by this Section&nbsp;5.2.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><U><A NAME="a_Toc393714769"></A><FONT STYLE="font: 12pt Times New Roman, Times, Serif">5.3</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Carbon Forbearances.</U><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT> During the period from the date of this Agreement to the Effective Time, except as required by applicable Law, and, except
as expressly required or permitted by this Agreement, Carbon shall not, and shall not permit any of its Subsidiaries to, without
the prior written consent of Oxygen:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(a)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>amend its Organizational Documents in a manner that would adversely affect in any material respect Oxygen, the Oxygen Holders
or the transactions contemplated by this Agreement;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(b)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>take any action or knowingly fail to take any action that could reasonably be expected to prevent the Merger from qualifying
as a &ldquo;reorganization&rdquo; within the meaning of Section 368(a) of the Code; or</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(c)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>agree to take, make any commitment to take, or adopt any resolutions of its board of directors or similar governing body
in support of, any of the actions prohibited by this Section 5.3.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center; text-indent: 0in"><A NAME="a_Toc393714771"></A><FONT STYLE="font: 12pt Times New Roman, Times, Serif; text-transform: uppercase">Article
VI</FONT><BR>
<BR>
ADDITIONAL AGREEMENTS</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><U><A NAME="a_Toc393714772"></A><A NAME="a_Ref347359406"></A><A NAME="a_Ref347359118"></A></U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">6.1</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Regulatory Matters; Third Party Consents</U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">. </FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><A NAME="a_Ref388725354"></A><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(a)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The parties hereto shall cooperate with each other and use their respective reasonable best efforts to promptly prepare
and file all necessary documentation, to effect all applications, notices, petitions and filings, to obtain as promptly as practicable
all permits, consents, approvals and authorizations of all third parties and Governmental Entities which are necessary or advisable
to consummate the transactions contemplated by this Agreement (including the Merger and the Bank Merger), and to comply with the
terms and conditions of all such permits, consents, approvals and authorizations of all such Governmental Entities, it being agreed
that, within thirty (30) days after the date hereof, the parties will file any application, notice or report required to be filed
by such party with any Governmental Entity with respect to a Requisite Regulatory Approval; <U>provided</U> that this Section 6.1(a)
shall not govern the parties&rsquo; respective obligations regarding the FDIC Consents, FDIC Non-Objections, GSE Consents and GSE
Non-Objections. Each of the parties hereto shall have the right to review in advance, and,</P>


<!-- Field: Page; Sequence: 52 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-top: 6pt; padding-bottom: 6pt; border-bottom: Black 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 24pt 70%; text-align: left"><U>STRICTLY&nbsp;CONFIDENTIAL</U><BR>EXECUTION&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt">to the extent practicable, each will consult the other on,
in each case subject to applicable Laws relating to the exchange of information, all the non-confidential information relating
to Oxygen or Carbon, as the case may be, and any of their respective Subsidiaries, which appear in any filing made with, or written
materials submitted to, any third party or any Governmental Entity in connection with the transactions contemplated by this Agreement.
In exercising the foregoing right, each of the parties hereto shall act reasonably and as promptly as practicable. The parties
hereto agree that they will consult with each other with respect to the obtaining of all permits, consents, approvals and authorizations
of all third parties and Governmental Entities necessary or advisable to consummate the transactions contemplated by this Agreement
and each party will keep the other apprised of the status of matters relating to completion of the transactions contemplated herein,
including promptly furnishing the other with copies of any material notices or other communications received by such party or,
to the Knowledge of such party, its Representatives from any third party and/or Governmental Entity with respect to the transactions
contemplated by this Agreement, in each case to the extent permitted by applicable Law. Each of the parties shall, upon request,
furnish each other with all information concerning themselves, their Subsidiaries, directors, officers, and shareholders (or members)
and such other matters as may be reasonably necessary or advisable in connection with any filing, notice, statement or application
made by or on behalf of Carbon, Oxygen or any of their respective Subsidiaries to any Governmental Entity in connection with the
Merger, the Bank Merger and the other transactions contemplated by this Agreement.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><A NAME="a_Ref389400476"></A><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(b)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Promptly following the date hereof, Oxygen shall provide a mutually agreed written notice of the proposed transactions contemplated
by this Agreement (including the Merger and the Bank Merger) to the FDIC requesting, with respect to each of the FDIC Agreements,
either (i) the written consent of the FDIC to the transactions contemplated by this Agreement (including the Merger and the Bank
Merger) (a &ldquo;<U>FDIC Consent</U>&rdquo;) or (ii) a written acknowledgement from the FDIC that its consent is not required
(a &ldquo;<U>FDIC Non-Objection</U>&rdquo;). The written notice will state with respect to certain specified FDIC Agreements that
Oxygen believes that consent from the FDIC to the transactions contemplated by this Agreement (including the Merger and the Bank
Merger) is not required. Oxygen will use reasonable best efforts to obtain, with respect to each of the FDIC Agreements, either
a FDIC Consent or a FDIC Non-Objection, in each case, without payment to the FDIC, termination or modification, waiver or amendment
adverse to, additional liability to, or loss of any benefits by, Carbon or Oxygen or their Subsidiaries with respect to any such
FDIC Agreements; <U>provided</U> that if required by the FDIC as a condition to granting such FDIC Consent or FDIC Non-Objection,
Oxygen and its Subsidiaries shall be obligated to (A) make one or more payments to the FDIC and/or (B) amend, modify, waive, or
agree to forebear from enforcing, the terms of, or terminate, any FDIC Agreements (any of the foregoing in clause (B), a &ldquo;<U>FDIC
Modification</U>&rdquo;), in each case that is conditioned on completion of the Merger; <U>provided</U> that (x) the aggregate
present value of any such payment and (y) the aggregate present value of the benefits foregone by, and additional Liabilities to,
Carbon, Oxygen and their Subsidiaries as a result of, arising out of, or relating to any such FDIC Modifications as compared to
the terms of the FDIC Agreements had they remained in effect without such FDIC Modifications net of (z) the aggregate present value
of any benefits received by Oxygen, or of any Liabilities with respect to which Oxygen is released, as a result of, arising out
of, or relating to any such FDIC Modifications as compared to the terms of the FDIC Agreements had they remained in effect without
such FDIC Modifications ((x) and (y), net of (z), a &ldquo;<U>FDIC Payment</U>&rdquo;) is, in the aggregate, a reasonable amount.</P>


<!-- Field: Page; Sequence: 53 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-top: 6pt; padding-bottom: 6pt; border-bottom: Black 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 24pt 70%; text-align: left"><U>STRICTLY&nbsp;CONFIDENTIAL</U><BR>EXECUTION&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><A NAME="a_Ref389401145"></A><A NAME="a_Ref390948341"></A><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(c)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT> Promptly following the date hereof, Oxygen shall provide a mutually agreed written notice of the proposed transactions
contemplated by this Agreement (including the Merger and the Bank Merger) to each GSE requesting, with respect to each of the GSE
Agreements, (i) the written consent of the applicable GSE to the transactions contemplated by this Agreement (including the Merger
and the Bank Merger) (a &ldquo;<U>GSE Consent</U>&rdquo;) or (ii) a written acknowledgement from the applicable GSE that its consent
is not required (a &ldquo;<U>GSE Non-Objection</U>&rdquo;). The written notice will state with respect to certain specified GSE
Agreements that Oxygen believes that consent from the applicable GSE to the transactions contemplated by this Agreement (including
the Merger and the Bank Merger) is not required. Oxygen will use reasonable best efforts to obtain, with respect to each of the
GSE Agreements, either a GSE Consent or a GSE Non-Objection, in each case, without payment to any GSE or termination or modification,
waiver or amendment adverse to, any additional Liability to, or loss of any benefit by, Carbon or Oxygen or their Subsidiaries
with respect to any such GSE Agreements; <U>provided </U>that if required by any GSE as a condition to granting such GSE Consent
or GSE Non-Objection, Oxygen and its Subsidiaries shall be obligated, to (A) make one or more payments to any GSE and/or (B) amend,
modify, waive, or agree to forebear from enforcing, the terms of, or terminate, any GSE Agreements (any of the foregoing in clause
(B), a &ldquo;<U>GSE Modification</U>&rdquo;), in each case that is conditioned on completion of the Merger; <U>provided</U> that
(x) the aggregate present value of any such payment and (y) the aggregate present value of the benefits foregone by, and additional
Liabilities to, Carbon, Oxygen and their Subsidiaries as a result of, arising out of, or relating to any such GSE Modifications
as compared to the terms of the GSE Agreements had they remained in effect without such GSE Modifications net of (z) the aggregate
present value of any benefits received by Oxygen, or of any Liabilities with respect to which Oxygen is released, as a result of,
arising out of, or relating to any such GSE Modifications as compared to the terms of the GSE Agreements had they remained in effect
without such GSE Modifications ((x) and (y), net of (z), a &ldquo;<U>GSE Payment</U>&rdquo;) is, in the aggregate, a reasonable
amount.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><A NAME="a_Ref239131643"></A><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(d)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Oxygen and Carbon shall cooperate with each other in connection with obtaining each FDIC Consent or FDIC Non-Objection and
each GSE Consent or GSE Non-Objection. Neither Oxygen nor Carbon may participate or agree to participate in any substantive in-person
meeting, telephone call or discussion with the FDIC or any GSE (other than unscheduled calls received from, or unscheduled discussions
initiated by, the FDIC or any GSE) relating to the transactions contemplated by this Agreement (including any FDIC Consent, FDIC
Non-Objection, GSE Consent or GSE Non-Objection) unless it consults with the other party in advance and provides the other with
the opportunity to participate in such meeting, call or discussion (other than unscheduled calls received from, or unscheduled
discussions initiated by, the FDIC or any GSE). Carbon and Oxygen shall have the right to review in advance, and, to the extent
practicable, each will consult the other on all correspondence or information that will be provided to the FDIC and the GSEs relating
to the FDIC Consents, the FDIC Non-Objections, the GSE Consents or GSE Non-Objections or otherwise relating to the transactions
contemplated by this Agreement.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><A NAME="a_Ref390947826"></A><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(e)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Notwithstanding the foregoing, nothing contained in this Agreement shall be deemed to require (i) Carbon or its Subsidiaries
to (and without the prior written consent of Carbon, Oxygen and its Subsidiaries shall not) (A) take any action, or commit to take
any action, or agree to any condition or restriction, in connection with obtaining the foregoing permits, consents, approvals and
authorizations of Governmental Entities that would reasonably be</P>


<!-- Field: Page; Sequence: 54 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-top: 6pt; padding-bottom: 6pt; border-bottom: Black 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->53<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 24pt 70%; text-align: left"><U>STRICTLY&nbsp;CONFIDENTIAL</U><BR>EXECUTION&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt">expected to have, individually or in the aggregate, a material
adverse effect (measured on a scale relative to Oxygen and its Subsidiaries, taken as a whole) on Carbon and its Subsidiaries after
giving effect to the transactions contemplated hereby or (B) make or incur or commit to make or incur any FDIC Payment that is,
in the aggregate, not a reasonable amount in the context of Section 6.1(b) of this Agreement or GSE Payment in an amount that is,
in the aggregate, not a reasonable amount in the context of Section 6.1(c) of this Agreement or (ii) Oxygen or its Subsidiaries
to (and without the prior written consent of Oxygen, Carbon and its Subsidiaries shall not) make or incur or commit to make or
incur any FDIC Payment or GSE Payment that is, in the aggregate, not a reasonable amount in the context of Section 6.1(b) of this
Agreement or GSE Payment in an amount that is, in the aggregate, not a reasonable amount in the context of Section 6.1(c) of this
Agreement ((i) or (ii) a &ldquo;<U>Burdensome Condition</U>&rdquo;). Fifty percent (50%) of any FDIC Payment or GSE Payment that
Oxygen, Carbon or their respective Subsidiaries make, incur or commit to make or incur that does not constitute a Burdensome Condition
shall be fully reflected as a Transaction Expense in the calculation of the Net Merger Consideration in an amount reasonably satisfactory
to Carbon and Oxygen (or finally determined pursuant Section 9.14).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><U><A NAME="a_Toc393714773"></A></U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">6.2</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Access to Information</U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">. </FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><A NAME="a_Ref347359087"></A><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(a)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Upon reasonable notice and subject to applicable Laws, each party shall, and shall cause each of its Subsidiaries to, afford
to the officers, employees, accountants, counsel, advisors and other representatives of the other party, access, during normal
business hours during the period prior to the Effective Time, to its properties, books, employees, Contracts, commitments and records,
and, during such period, shall, and shall cause its Subsidiaries to, make available to the other party (i) a copy of each report,
schedule, registration statement and other document filed or received by it during such period pursuant to the requirements of
federal securities Laws or federal or state banking Laws (other than reports or documents which Oxygen is not permitted to disclose
under applicable Law), and (ii) all other information concerning its business, properties and personnel as may reasonably be requested.
Neither party, nor any of its Subsidiaries, shall be required to provide access to or to disclose information where such access
or disclosure jeopardize the attorney-client privilege of the institution in possession or control of such information or violates
any applicable Law or Contract; <U>provided</U> that such party will use reasonable best efforts to make appropriate substitute
disclosure arrangements under circumstances in which the restrictions of the preceding sentence apply.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><A NAME="a_Ref347359800"></A><A NAME="a_Ref388546115"></A><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(b)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Each party shall hold all information furnished by or on behalf of the other party or any of its Subsidiaries or representatives
pursuant to Section&nbsp;6.2(a) in confidence to the extent required by, and in accordance with, the provisions of the Confidentiality
Agreement.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><A NAME="a_Ref389400593"></A><A NAME="a_Ref392185937"></A><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(c)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Prior to the Closing, Oxygen shall, and shall cause its Subsidiaries to, and shall use its reasonable best efforts to cause
its Representatives to, provide all cooperation that is necessary, customary or advisable and reasonably requested by Carbon to
assist Carbon in the arrangement of (i) any third party debt or equity financing for the purpose of financing the Net Merger Consideration,
any Stock Repurchase or any repayment or refinancing of debt contemplated by this Agreement or required in connection with the
transactions contemplated hereby and any other amounts required to be paid in connection with the consummation of the</P>


<!-- Field: Page; Sequence: 55 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-top: 6pt; padding-bottom: 6pt; border-bottom: Black 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->54<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 24pt 70%; text-align: left"><U>STRICTLY&nbsp;CONFIDENTIAL</U><BR>EXECUTION&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt">transactions contemplated hereby and all related fees and
expenses of Carbon and its Subsidiaries (the &ldquo;<U>Financing</U>&rdquo;) (it being understood that the receipt of such Financing
is not a condition to the Merger) or (ii) any repurchase of Carbon Common Stock by Carbon (a &ldquo;<U>Stock Repurchase</U>&rdquo;);
<U>provided</U> that nothing herein shall require such cooperation to the extent it would (A) unreasonably disrupt the conduct
of the business or operations of Oxygen or its Subsidiaries, (B) require Oxygen or any of its Subsidiaries to agree to pay any
fees, reimburse any expenses or otherwise incur any liability or give any indemnities prior to the Closing for which it is not
promptly reimbursed or simultaneously indemnified or (C) require Oxygen or any of its Subsidiaries to take any action that would
reasonably be expected to result in any violation of, or default under its Organization Documents, any applicable Laws or any Contract.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><A NAME="a_Ref392186603"></A><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(d)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Such cooperation required by Section 6.2(c) shall include, without limitation, as promptly as reasonably practical following
a request from Carbon for such information, furnishing Carbon and any of its financing sources, if applicable, with (i) the Oxygen
Financial Statements (and once available pursuant to Section 1.7(c), the Oxygen Audited Interim Financial Statements), (ii) unaudited
consolidated balance sheets and related statements of operations and comprehensive income and cash flows for Oxygen and its Subsidiaries
for each fiscal quarter following the quarter ended June 30, 2014 that ends on a date that is not a fiscal year end, (iii) audited
consolidated balance sheets and related consolidated statements of operations and comprehensive income, stockholders&rsquo; equity
and cash flows for the fiscal year ended December 31, 2014, in each case prepared in accordance with GAAP, and providing such other
financial and (iv) and such other information and data regarding Oxygen and its Subsidiaries as Carbon may reasonably request in
connection with such Financing or Stock Repurchase, in each case of (i) through (iv) which may be included in documents filed with
the SEC in connection with such Financing or Stock Repurchase. Carbon shall promptly, upon request by Oxygen, reimburse Oxygen
for all reasonable costs and expenses (including reasonable attorneys&rsquo; fees, but excluding for the avoidance of doubt, the
costs of Oxygen&rsquo;s preparation of its annual and quarterly financial statements) incurred by Oxygen or any of its Subsidiaries
or their respective Representatives in connection with the Financing or a Stock Repurchase, including the cooperation of Oxygen
and its Subsidiaries and Representatives contemplated by this Section 6.2(d), and shall indemnify and hold harmless Oxygen, its
Subsidiaries and their respective Representatives from and against any and all losses, damages, claims, costs or expenses suffered
or incurred by any of them in connection with the arrangement of the Financing, a Stock Repurchase and any information used in
connection therewith, except with respect to (a) any information expressly provided by Oxygen or its Subsidiaries in writing for
use in connection with the Financing or a Stock Repurchase or (b) any fraud or intentional misrepresentation or willful misconduct
by any such persons.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><A NAME="a_Toc388584481"></A><A NAME="a_Ref347359132"></A><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(e)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>No investigation by either of the parties or their respective representatives shall affect or be deemed to modify or waive
the representations and warranties of the other set forth herein.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><U><A NAME="a_Toc393714774"></A></U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">6.3</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Employee Benefit Plans</U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><A NAME="a_Ref347360205"></A><A NAME="a_Ref347360115"></A><A NAME="a_Ref347359226"></A><A NAME="a_Ref390948050"></A><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(a)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Following the Effective Time, Carbon shall provide each individual who is an employee of Oxygen and its Subsidiaries at
the Effective Time (any such person, a &ldquo;Continuing Employee&rdquo; and, collectively, the &ldquo;<U>Continuing Employees</U>&rdquo;),
while employed by</P>


<!-- Field: Page; Sequence: 56 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-top: 6pt; padding-bottom: 6pt; border-bottom: Black 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->55<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 24pt 70%; text-align: left"><U>STRICTLY&nbsp;CONFIDENTIAL</U><BR>EXECUTION&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt">Carbon or its Subsidiaries, with compensation opportunities
and employee benefits that are substantially comparable in the aggregate (excluding any benefits accelerated or payable as a result
of the transactions contemplated by this Agreement) to the compensation opportunities and employee benefits provided to similarly
situated employees of Carbon and its Subsidiaries; <U>provided</U>, that for purposes of the foregoing sentence the compensation
opportunities and employee benefit plans generally provided to employees of Oxygen as of immediately prior to the Effective Time
shall be deemed to be substantially comparable, on an aggregate basis, to those provided to similarly situated employees of Carbon
and its Subsidiaries for purposes of this sentence, it being understood that the Continuing Employees may commence participation
in Carbon&rsquo;s benefit plans on different dates following the Effective Time with respect to different benefit plans. Any Continuing
Employee whose employment is terminated within the one-year period following the Effective Time under circumstances that would
entitle such Continuing Employee to severance benefits under the severance plan of Carbon and its Subsidiaries that is applicable
to similarly situated employees of Carbon and its Subsidiaries, shall be entitled to severance benefits under such severance plan.
Nothing contained in this Section&nbsp;6.3(a) shall be deemed to grant any Continuing Employee any right to continued employment
after the Closing Date.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><A NAME="a_Ref390948407"></A><A NAME="a_Toc531407312"></A><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(b)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>With respect to any employee benefit plans of Carbon or its Subsidiaries providing benefits to any Continuing Employee after
the Effective Time (a &ldquo;<U>New Benefit Plan</U>&rdquo;)<A NAME="a_Toc531407313"></A>, Carbon shall: (i) waive all pre-existing
conditions, exclusions and waiting periods with respect to participation and coverage requirements applicable to such employees
and their eligible dependents under any New Benefit Plans that provide health care benefits in which such employees first become
eligible to participate after the Effective Time, except to the extent such pre-existing conditions, exclusions or waiting periods
would apply under the analogous Oxygen Benefit Plan; (ii) to the extent allowed by the provider of any New Benefit Plan that provides
health care benefits, provide each such employee and their eligible dependents with credit for any co-payments and deductibles
paid prior to the Effective Time under an Oxygen Benefit Plan that provided health care benefits (to the same extent that such
credit was given under the analogous Oxygen Benefit Plan prior to the Effective Time) in satisfying any applicable deductible or
out-of-pocket requirements under any such New Benefit Plans in the plan year in which such employees first become eligible to participate
after the Effective Time; and (iii)&nbsp;recognize all service of such Continuing Employees with Oxygen and its Subsidiaries as
well as actual service by such Continuing Employees with any predecessors to Oxygen and its Subsidiaries, including any entities
the stock or assets of were acquired by Oxygen and its Subsidiaries, for all purposes in any New Benefit Plan in which such employees
first become eligible to participate after the Effective Time to the same extent that such service was taken into account under
the analogous Oxygen Benefit Plan prior to the Effective Time and for purposes of any severance plan of Carbon or its Subsidiaries
in which such Continuing Employee participates; <U>provided</U> that the foregoing service recognition shall not apply (A) to the
extent it would result in duplication of benefits for the same period of services, (B) for purposes of any defined benefit retirement
plan or benefit plan that provides retiree welfare benefits or (C) to any benefit plan that is a frozen plan or provides grandfathered
benefits.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(c)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>If requested by Carbon in writing delivered to Oxygen not less than ten (10) Business Days before the Closing Date,&nbsp;the&nbsp;Board
of Directors of Oxygen&nbsp;(or the appropriate committee thereof) shall&nbsp;adopt resolutions and take such corporate action
as is</P>


<!-- Field: Page; Sequence: 57 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-top: 6pt; padding-bottom: 6pt; border-bottom: Black 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->56<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 24pt 70%; text-align: left"><U>STRICTLY&nbsp;CONFIDENTIAL</U><BR>EXECUTION&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt">necessary&nbsp;to terminate Oxygen&rsquo;s 401(k) plans (collectively,
the &ldquo;<U>Oxygen 401(k) Plan</U>&rdquo;), effective as of immediately prior to the Closing&nbsp;Date. Following the Effective
Time and as soon as practicable following receipt of a favorable determination letter from the IRS on the termination of the Oxygen
401(k) Plan, the assets thereof shall be distributed to the participants, and Carbon shall, to the extent permitted by applicable
Law, permit the Continuing Employees who are then actively employed to make rollover contributions of &ldquo;eligible rollover
distributions&rdquo; (within the meaning of Section 401(a)(31) of the Code, inclusive of loans to the extent permitted by Carbon&rsquo;s
applicable 401(k) plan), in the form of cash, in an amount equal to the full account balance (including loans to the extent permitted
by Carbon&rsquo;s applicable 401(k) plan) distributed to such Continuing Employee from the Oxygen 401(k) Plan to Carbon&rsquo;s
applicable 401(k) plan. The parties will cooperate in good faith to arrange for the repayment of participant loans prior to the
Effective Time or to facilitate the continuation of such loans following the Effective Time to the extent practical and commercially
reasonable.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(d)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Nothing in this Agreement shall confer upon any employee, officer, director or consultant of Carbon or Oxygen or any of
their Subsidiaries or affiliates any right to continue in the employ or service of Oxygen, Carbon or any Subsidiary or affiliate
thereof, or shall interfere with or restrict in any way the rights of Oxygen, Carbon or any Subsidiary or affiliate thereof to
discharge or terminate the services of any employee, officer, director or consultant of Carbon or Oxygen or any of their Subsidiaries
or affiliates at any time for any reason whatsoever, with or without cause. Nothing in this Agreement shall be deemed to (i)&nbsp;establish,
amend, or modify any Oxygen Benefit Plan, New Benefit Plan or any other benefit or employment plan, program, agreement or arrangement,
or (ii) alter or limit the ability of Carbon or any of its Subsidiaries or affiliates to amend, modify or terminate any particular
Oxygen Benefit Plan, New Benefit Plan or any other benefit or employment plan, program, agreement or arrangement after the Effective
Time. Without limiting the generality of the final sentence of Section&nbsp;9.11, nothing in this Agreement, express or implied,
is intended to or shall confer upon any person, including without limitation any current or former employee, officer, director
or consultant of Carbon or Oxygen or any of their Subsidiaries or affiliates, any right, benefit or remedy of any nature whatsoever
under or by reason of this Agreement.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><U><A NAME="a_Toc393714775"></A><A NAME="a_Ref392532920"></A></U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">6.4</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Indemnification; Directors&rsquo; and Officers&rsquo; Insurance</U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">.
</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(a)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>From and after the Effective Time, Carbon shall cause the Surviving Company and its Subsidiaries, to (i) indemnify and hold
harmless each of its present and former directors and officers (collectively, the &ldquo;<U>Indemnified Parties</U>&rdquo;) against
any costs or expenses (including reasonable attorneys&rsquo; fees), judgments, fines, losses, claims, damages or liabilities incurred
in connection with any Proceedings, arising out of or pertaining to matters existing or occurring at or prior to the Effective
Time, including the transactions contemplated by this Agreement and actions relating to the enforcement of this Section 6.4, whether
asserted or claimed prior to, at or after the Effective Time, to the fullest extent that Oxygen or such Subsidiary, as the case
may be, would have been permitted under its respective organizational documents in effect on the date of this Agreement or agreements
in existence as of the date hereof and set forth on Section 6.4(a) of the Oxygen Disclosure Schedule providing for indemnification
between Oxygen or any of its Subsidiaries and any Indemnified Party, subject to limitations imposed by applicable Law (including
the advancing of expenses as incurred to the fullest extent permitted under applicable Law); <U>provided</U>, the Person to whom
such expenses are</P>


<!-- Field: Page; Sequence: 58 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-top: 6pt; padding-bottom: 6pt; border-bottom: Black 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->57<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 24pt 70%; text-align: left"><U>STRICTLY&nbsp;CONFIDENTIAL</U><BR>EXECUTION&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt">advanced provides an undertaking to the Surviving Company
to repay such advances if it is ultimately determined that such Person is not entitled to indemnification).&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><A NAME="a_Ref393308717"></A><A NAME="a_Ref349728192"></A><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(b)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>For six (6) years after the Effective Time, Carbon shall cause the Surviving Company to maintain in effect, at its own expense,
directors&rsquo; and officers&rsquo; liability and fiduciary liability insurance covering those Persons who are currently covered
by Oxygen&rsquo;s directors&rsquo; and officers&rsquo; liability and fiduciary liability insurance policies (true, correct and
complete copies of which have been heretofore delivered to Carbon) either through continuation of the current policy or substitution
by Carbon of another policy therefor on terms, including with respect to coverage and insurance limits (with no retention), with
an insurer or insurers that have at the time such coverage is written the same or higher A.M. Best rating as Carbon&rsquo;s current
primary insurer for such type of insurance, not materially less favorable than the terms of such current insurance coverage with
respect to claims arising from or related to facts or events which occurred at or prior to the Effective Time (including the transactions
contemplated by this Agreement); <U>provided</U> that in complying with its obligations pursuant to the terms of this Section<FONT STYLE="font-size: 10pt">&#8206;</FONT>
6.4(b), Carbon shall not be required to expend annually in the aggregate an amount in excess of 250% of the annual premium currently
paid by Oxygen (which current amount is set forth on Section <FONT STYLE="font-size: 10pt">&#8206;6.4(b) of the Oxygen Disclosure
Schedule) (the &ldquo;<U>Premium Cap</U>&rdquo;) and if Carbon cannot obtain such insurance coverage without paying in excess of
the Premium Cap, Carbon shall purchase such insurance with the maximum aggregate coverage available for the Premium Cap. In lieu
of the foregoing insurance coverage and in satisfaction of its obligations under this Section &#8206;6.4(b), Carbon may direct
Oxygen to purchase, at Carbon&rsquo;s expense, a six (6) year prepaid &ldquo;tail policy&rdquo; that provides the coverage in this
Section &#8206;6.4(b)</FONT>; <U>provided,</U> <U>further</U> that if the premium for such &ldquo;tail coverage&rdquo; exceeds
the Premium Cap, then Carbon may, at its sole cost, direct Oxygen to obtain &ldquo;tail coverage&rdquo; with the maximum aggregate
coverage available for the Premium Cap applied over the term of such policy.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(c)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>In the event that, after the Effective Time, Carbon or the Surviving Company or any of their respective successors or assigns
(i) consolidates with or merges into any other person and is not the continuing or surviving corporation or entity of such consolidation
or merger or (ii) transfers or conveys all or a substantial portion of its properties and other assets to any person, then, and
in each case, Carbon or the Surviving Company, as applicable, shall cause proper provision to be made so that such successors and
assigns shall expressly assume the obligations set forth in this Section 6.4.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(d)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The provisions of this Section 6.4 are intended for the benefit of, and will be enforceable by, each Indemnified Party,
his or her heirs and his or her representatives and are in addition to, are not in substitution for, any other rights to indemnification
or contribution that any such person may have from Carbon, the Surviving Company, or any of their Subsidiaries or any other person
by contract or otherwise except as expressly provided herein. The obligations of Carbon under this Section 6.4 shall not be terminated
or modified in such a manner as to adversely affect the rights of any Indemnified Party to whom this Section 6.4 applies unless
(x) such termination or modification is required by applicable Law or (y) the affected Indemnified Party has consented in writing
to such termination or modification.</P>


<!-- Field: Page; Sequence: 59 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-top: 6pt; padding-bottom: 6pt; border-bottom: Black 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->58<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 24pt 70%; text-align: left"><U>STRICTLY&nbsp;CONFIDENTIAL</U><BR>EXECUTION&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><U><A NAME="a_Toc393714776"></A></U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">6.5</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U> Certain Oxygen Actions</U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">. </FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><A NAME="a_Ref388725276"></A><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(a)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Prior to the Closing, Oxygen shall take such actions and obtain such consents, approvals and waivers, in each case, as are
necessary, required or advisable to dissolve and wind-up the affairs of OneWest Bank Group LLC and OneWest Asset Management LLC
in accordance with the organizational documents of OneWest Bank Group LLC and OneWest Asset Management LLC and the DLLCA. Such
dissolution shall be effected with no cost or Liability to Carbon or its Subsidiaries or Oxygen or any of its Subsidiaries (other
than any cost that is fully reflected as a Transaction Expense).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><A NAME="a_Ref388540767"></A><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(b)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Prior to the Closing, Oxygen shall take such actions and obtain such consents, approvals and waivers, in each case as are
necessary, required or advisable to (i) convert all outstanding Oxygen Profits Interests into Oxygen Common Interests and (ii)
convert all outstanding Oxygen Converted Common Interests into Oxygen Common Interests, in each case in accordance with the terms
of the Oxygen LLC Agreement, any applicable Grant Schedules (as defined in the Oxygen LLC Agreement), the terms of the Oxygen Profits
Interests and Oxygen Converted Common Interests and the DLLCA.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(c)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Prior to Closing, Oxygen shall take reasonable steps within the meaning of Rule 506(c) of Regulation D of the Securities
Act to verify whether as of the Effective Time, each Oxygen Holder is an &ldquo;accredited investor&rdquo; as defined in Rule 501(a)
of Regulation D of the Securities Act and shall keep Carbon informed with respect to such verification process, including the results
thereof.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(d)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Between the date hereof and the Closing Date, Oxygen shall submit to a vote of the interestholders of Oxygen or any applicable
affiliate for their determination all payments or benefits that in the absence of such a vote could reasonably be viewed as &ldquo;parachute
payments&rdquo; (within the meaning of Section 280G of the Code and the regulations thereunder), including the Retention Agreements,
made to any individuals who are &ldquo;disqualified individuals&rdquo; (within the meaning of Section 280G(c) of the Code and the
regulations thereunder). Such interestholder vote shall, in the reasonable determination of Oxygen based on the advice of counsel,
meet the requirements of Section 280G(b)(5)(B) of the Code and the regulations thereunder, including using reasonable best efforts
to obtain any necessary waivers. Any materials prepared in connection with such interestholder vote (including disclosures and
waiver materials) shall be subject to the review and reasonable comment of Carbon.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><U><A NAME="a_Toc393714777"></A><A NAME="a_Toc389500909"></A></U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">6.6</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Additional Agreements</U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">. In case at any time after the Effective
Time any further action is necessary or desirable to carry out the purposes of this Agreement (including, without limitation, any
merger between a Subsidiary of Carbon, on the one hand, and a Subsidiary of Oxygen, on the other) or to vest the Surviving Company
with full title to all properties, assets, rights, approvals, immunities and franchises of any of the parties to the Merger, the
proper officers and directors of each party to this Agreement and their respective Subsidiaries shall take all such necessary action
as may be reasonably requested by Carbon.</FONT></P>



<!-- Field: Page; Sequence: 60 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-top: 6pt; padding-bottom: 6pt; border-bottom: Black 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->59<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 24pt 70%; text-align: left"><U>STRICTLY&nbsp;CONFIDENTIAL</U><BR>EXECUTION&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><U><A NAME="a_Toc393714778"></A><A NAME="a_Ref347359243"></A></U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">6.7</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Advice of Changes</U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">. </FONT></P>
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(a)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT> Carbon and Oxygen shall each promptly advise the other party of any fact, change, event or circumstance that has had or
is reasonably likely to have a Material Adverse Effect on it or which it believes would or would be reasonably likely to cause
or constitute a material breach of any of its representations, warranties or covenants contained herein; <U>provided</U> that any
failure to give notice in accordance with the foregoing with respect to any breach shall not be deemed to constitute a violation
of this Section&nbsp;6.7 or the failure of any condition set forth in Section&nbsp;7.2 or 7.3 to be satisfied, or otherwise constitute
a breach of this Agreement by the party failing to give such notice, in each case unless the underlying breach would independently
result in a failure of the conditions set forth in Section&nbsp;7.2 or 7.3 to be satisfied.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(b)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Carbon and Oxygen shall each promptly advise the other party of (i) any notice or other communication from any Person alleging
that the consent of such Person is or may be required in connection with the transactions contemplated by this Agreement or (ii)
upon receiving any communication from any Governmental Entity or third party whose consent or approval is required for consummation
of the transactions contemplated by this Agreement that causes such party to believe that there is a reasonable likelihood that
any such consent or approval will not be obtained or that the receipt of any such consent or approval will be materially delayed.
Oxygen shall notify Carbon as promptly as practicable of any notice or other communication from any party to any Oxygen Contract
to the effect that such party has terminated or intends to terminate or otherwise materially adversely modify its relationship
with Oxygen or any of its Subsidiaries as a result of the transactions contemplated by this Agreement</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><U><A NAME="a_Toc393714779"></A><A NAME="a_Ref347359424"></A><A NAME="a_Toc389500912"></A></U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">6.8</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Public Announcements</U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">. Oxygen and Carbon</FONT> agree that
the initial press release to be issued with respect to the execution and delivery of this Agreement shall be in a form agreed to
by the parties and that the parties shall consult with each other before issuing any press release or making any public announcement
with respect to this Agreement and the transactions contemplated hereby and shall not issue any such press release or make any
such public announcement without the prior consent of the other party (which shall not be unreasonably withheld, delayed or conditioned);
<U>provided </U>that a party may, without the prior consent of the other party (but after prior consultation, to the extent practicable
in the circumstances) issue such press release or make such public statement to the extent required by applicable Law or the applicable
rules of any stock exchange. Without limiting the reach of the preceding sentence, Oxygen and Carbon shall cooperate to develop
all public announcement materials and make appropriate management available at presentations related to the transactions contemplated
by this Agreement as reasonably requested by the other party.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><U><A NAME="a_Toc393714780"></A></U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">6.9</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Takeover Statutes</U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">. Oxygen and its Subsidiaries shall not take
any action that would cause the transactions contemplated by this Agreement to be subject to requirements imposed by any Takeover
Statute. If any Takeover Statute may become, or may purport to be, applicable to the transactions contemplated hereby and thereby,
each of Carbon and Oxygen and the members of their respective Boards of Directors shall grant such approvals and take such actions
as are necessary so that the transactions contemplated by this Agreement may be consummated as promptly as practicable on the terms
contemplated hereby and otherwise act to eliminate or minimize the effects of any Takeover Statute on any of the transactions contemplated
by this Agreement.</FONT></P>


<!-- Field: Page; Sequence: 61 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-top: 6pt; padding-bottom: 6pt; border-bottom: Black 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->60<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 24pt 70%; text-align: left"><U>STRICTLY&nbsp;CONFIDENTIAL</U><BR>EXECUTION&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><U><A NAME="a_Toc393714781"></A></U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">6.10</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U> No Solicitation of Alternative Transactions</U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">. </FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><A NAME="a_Ref388546375"></A><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(a)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Prior to the Closing Date, or until this Agreement is terminated in accordance with its terms, Oxygen shall not, and shall
cause its Affiliates and its and their directors, officers, employees, accountants, financial advisors, attorneys and other advisors
or representatives (&ldquo;<U>Representatives</U>&rdquo;) not to, directly or indirectly, solicit or initiate discussions or engage
in negotiations with, or provide information (other than publicly available information) to, or authorize any Representative or
other Person to solicit or initiate discussions or engage in negotiations with, or provide information to, any Person (other than
Carbon or its Representatives) concerning any potential sale of equity interests of (including through an initial public offering),
or merger, consolidation, combination, sale of assets, reorganization or other similar transaction involving Oxygen or any of its
Subsidiaries.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(b)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Oxygen shall and shall cause its Affiliates and Representatives to immediately terminate any existing discussions or negotiations
with any Person (other than Carbon) conducted heretofore with respect to any of the potential transactions described in Section
6.10(a), and promptly following the date hereof shall use reasonable best efforts to cause all persons other than Carbon, if any,
who have been furnished confidential information regarding Oxygen in connection with the solicitation of or discussions regarding
any of the transactions described in Section 6.10(a) within the twelve (12) months prior to the date hereof promptly to return
or destroy such information. Oxygen agree not to, and to cause its Affiliates and Representatives not to, release any third party
from the confidentiality, standstill, employee non-solicit or other provisions of any agreement with respect to the transactions
described in Section 6.10(a) and shall immediately take all steps necessary to terminate any approval that may have been heretofore
given under any such provisions authorizing any Person to engage in any transaction described in Section 6.10(a).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><U><A NAME="a_Toc393714782"></A></U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">6.11</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>NYSE Listing</U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">. Carbon shall cause the shares of Carbon Common
Stock to be issued in the Merger to be approved for listing on the NYSE, subject to official notice of issuance, prior to the Effective
Time. </FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><U><A NAME="a_Toc393714783"></A><A NAME="a_Ref388546421"></A></U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">6.12</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Termination of Affiliate Arrangements</U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">. </FONT>At or prior
to the Closing, (i) Oxygen shall, and shall cause each of its Subsidiaries to, terminate the Contracts between Oxygen and its Subsidiaries,
on the one hand, and the Oxygen Holders or their Affiliates, on the other hand, other than (A) the Oxygen LLC Agreement, (B) those
Contracts listed in Section 6.12 of the Oxygen Disclosure Schedule, (C) Contracts between or among Oxygen or any Subsidiary of
Oxygen, on the one hand, and one or more Subsidiaries of Oxygen, on the other hand, and (D) any Oxygen Benefit Plan or any other
employment, retention, bonus, severance, consulting, non-disclosure or similar agreement entered into between Oxygen or one of
its Subsidiaries, on one hand, and any current or former officer, director or employee of Oxygen or one of its Subsidiaries, on
the other hand, in each case, without payment or incurrence of further Liability thereunder and (ii) Oxygen will deliver to Carbon
evidence of the termination of such Contracts required to be terminated pursuant to this Section 6.12, which evidence shall be
reasonably acceptable to Carbon.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><U><A NAME="a_Toc393714784"></A></U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">6.13</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Rule 144</U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">. Following the Closing, Carbon agrees that it will
use reasonable best efforts to satisfy the information requirements in Rule 144(c) under the </FONT></P>

<!-- Field: Page; Sequence: 62 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-top: 6pt; padding-bottom: 6pt; border-bottom: Black 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->61<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 24pt 70%; text-align: left"><U>STRICTLY&nbsp;CONFIDENTIAL</U><BR>EXECUTION&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">Securities Act which are necessary
to enable former Oxygen Holders to transfer the shares of Carbon Common Stock they receive in the Merger from time to time pursuant
to the exemptions provided by Rule 144 under the Securities Act</FONT>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><U><A NAME="a_Toc393714785"></A></U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">6.14</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Transaction Expenses</U>.<FONT STYLE="font: 12pt Times New Roman, Times, Serif">&nbsp;</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(a)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>On or prior to the twentieth (20<SUP>th</SUP>) Business Day before the Closing Date, Oxygen will provide to Carbon its good
faith list of the estimated Transaction Expenses which list shall include a description of each such amount and the corresponding
estimated dollar amount for each expense. Carbon shall instruct KPMG LLP to review the schedule of estimated Transaction Expenses
and perform its good faith analysis of any Tax benefits (reduced by any Tax cost) that have been or will be actually realized by
Oxygen and its Subsidiaries in cash, credit or a reduction in Taxes otherwise payable in each case during the taxable period ending
on or prior to the Closing Date as a result of (and to the extent of) the payment and proper current deduction of such Transaction
Expenses in, and the proper allocation of such Transaction Expenses and Retention Amounts to, such period (the &ldquo;<U>Estimated
Transaction Expense Tax Benefits</U>&rdquo;) and deliver to Carbon and Oxygen, at least twenty (20) Business Days prior to the
Closing Date, a written report setting forth its good faith estimate of the amount of the Estimated Transaction Expense Tax Benefits,
including a reasonably detailed explanation of the reasons for such determination (the &ldquo;<U>Transaction Tax Analysis</U>&rdquo;),
which analysis shall (i) take into account such information (to the extent relevant) as may be supplied by Oxygen to KPMG LLP (ii)
use an assumed combined federal and state tax rate for Oxygen of forty percent (40%) (including for purposes of the estimates referenced
in clause (iv)), (iii) be computed on a &ldquo;with and without&rdquo; basis (subject to clause (iv)) and (iv) give effect to any
deduction for any potential payments to be made pursuant to Section 5.07 of the Oxygen LLC Agreement (based on an estimate of such
payments, which estimate shall be determined assuming the highest marginal federal, state and local tax rates apply to each holder
of In-the-Money Oxygen Options (the &ldquo;<U>Unitholder Assumptions</U>&rdquo;)) and any Compensation Deduction Benefit (as defined
in the Oxygen LLC Agreement and based on an estimate of such amount, which estimate shall be determined based on the Unitholder
Assumptions) (and any such deductions shall be treated as having been utilized before any deduction or tax benefit described in
this Section 6.14). Oxygen may cause PricewaterhouseCoopers LLP to review and analyze the Transaction Tax Analysis, and, if Oxygen
delivers to Carbon a good faith written objection to all or any part of the Transaction Tax Analysis based on PricewaterhouseCoopers
LLP&rsquo;s review and analysis thereof (the &ldquo;<U>Tax Analysis Objections</U>&rdquo;), Carbon and Oxygen shall meet and discuss
the Tax Analysis Objections and use reasonable good faith efforts to resolve any disagreement of the parties in respect of the
Tax Analysis Objections prior to the Closing Date. If notwithstanding their respective reasonable good faith efforts Carbon and
Oxygen are unable to resolve any disagreement of the parties in respect of the Tax Analysis Objections, the determination of the
Estimated Transaction Expense Tax Benefits set forth in the Transaction Tax Analysis delivered by KPMG LLP to Carbon and Oxygen
(as modified by agreement of Carbon and Oxygen) will be binding on the parties for the purpose of this Section 6.14 (such final
and binding analysis, the &ldquo;<U>Final Transaction Tax Analysis</U>&rdquo;).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(b)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>On or prior to the 5th Business Day before the Closing Date, Oxygen will provide to Carbon a true, correct and complete
list of the final Transaction Expenses, which list shall include a description of each amount and the corresponding dollar amount
thereof. Carbon</P>


<!-- Field: Page; Sequence: 63 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-top: 6pt; padding-bottom: 6pt; border-bottom: Black 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->62<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 24pt 70%; text-align: left"><U>STRICTLY&nbsp;CONFIDENTIAL</U><BR>EXECUTION&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt">shall apply the Final Transaction Tax Analysis to the Transaction
Expenses to determine in good faith the amount of any Tax benefits (reduced by any Tax cost) that have been or will be actually
realized by Oxygen and its Subsidiaries in cash, credit or a reduction in Taxes otherwise payable in each case during the taxable
period ending on or prior to the Closing Date as a result of (and to the extent of) the payment and proper current deduction of
such Transaction Expenses in, and the proper allocation of such Transaction Expenses to, such period. Notwithstanding the foregoing,
such benefits shall not include any Tax benefit reflected in the Oxygen Audited Interim Financial Statements or otherwise already
included in the calculation of Gross Merger Consideration.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><U><A NAME="a_Toc393714786"></A><A NAME="a_Ref390278504"></A></U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">6.15</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Oxygen Dividends</U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">. Following the date hereof, (i) Oxygen and
Carbon shall, and shall cause their Subsidiaries to, cooperate and use reasonable best efforts to obtain the necessary approvals
of the Governmental Entities that are required for the dividend in cash prior to Closing from Oxygen Bank to Oxygen of the maximum
amount of capital permitted by the Governmental Entities and (ii) Oxygen shall cause Oxygen Bank to dividend, in cash such amount
approved by the necessary Governmental Entities (the &ldquo;<U>Approved Oxygen Bank Dividend</U>&rdquo;) prior to the Closing.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><U><A NAME="a_Toc393714787"></A></U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">6.16</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Section 16 Matters</U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">. Prior to the Effective Time, Carbon shall
take all such steps as may be required to cause any dispositions of acquisitions of shares of Carbon Common Stock (including derivative
securities with respect to Carbon Common Stock) resulting from the transactions contemplated by this Agreement by each individual
who will become subject to such reporting requirements with respect to Carbon, to be exempt under Rule 16b-3 promulgated under
the Exchange Act.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><U><A NAME="a_Toc393714788"></A><A NAME="a_Ref390944650"></A><A NAME="a_Toc391290249"></A><A NAME="a_Toc391290409"></A><A NAME="a_Toc391290521"></A></U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">6.17</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Holdback Amount</U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">. The parties agree to the terms and procedures
specified on Exhibit A in respect of the Holdback Amount.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><U><A NAME="a_Toc393714789"></A><A NAME="a_Ref393452238"></A></U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">6.18</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Holders&rsquo; Representative.</U></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(a)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The parties have designated JCF III HoldCo I L.P. as the initial Holders&rsquo; Representative for certain limited purposes
set forth herein and JCF III HoldCo I L.P. hereby agrees to act in such capacity effective as of the Effective Time. By virtue
of duly executing and delivering a Letter of Transmittal or Holder Acknowledgement, as the case may be, which contains (i) the
irrevocable agreement of an Oxygen Holder to be bound by this Section 6.18 and to appoint JCF III HoldCo I L.P. as the initial
Holders&rsquo; Representative and (ii) an irrevocable power of attorney granted to the Holders&rsquo; Representative for the Holders&rsquo;
Representative to take the actions contemplated by this Section 6.18, such Oxygen Holder (an &ldquo;<U>Electing Oxygen Holder</U>&rdquo;)
shall have the benefit of the Holders&rsquo; Representative exercising the rights set forth herein with respect to such Electing
Oxygen Holder. Following the Effective Time, the Holders&rsquo; Representative may be changed at any time by approval of Electing
Oxygen Holders that collectively would be entitled to more than 60% of any subsequent Released Holdback Amount (&ldquo;<U>Requisite
Holders</U>&rdquo;); provided that such Holders&rsquo; Representative shall be reasonably acceptable to Carbon. In the event that
the Holders&rsquo; Representative has resigned or been removed, a new Holders&rsquo; Representative shall be appointed by a vote
of the Requisite Holders, such appointment to become effective upon the written acceptance thereof by the new Holders&rsquo; Representative.</P>


<!-- Field: Page; Sequence: 64 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-top: 6pt; padding-bottom: 6pt; border-bottom: Black 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->63<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 24pt 70%; text-align: left"><U>STRICTLY&nbsp;CONFIDENTIAL</U><BR>EXECUTION&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(b)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT> The Holders&rsquo; Representative shall have such powers and authority as are necessary to carry out the functions assigned
to it under this Agreement; <U>provided</U> that the Holders&rsquo; Representative shall have no power or authority to act on behalf
of any Oxygen Holder who is not an Electing Oxygen Holder. Without limiting the generality of the foregoing, from and after the
Effective Time, the Holders&rsquo; Representative shall have full power, authority and discretion to act on behalf of an Electing
Oxygen Holder&rsquo;s in connection with the transactions contemplated by Section 6.17 of this Agreement, including executing documents,
making all elections and decisions to be made by such Electing Oxygen Holder in connection with the transactions contemplated by
Section 6.17 of this Agreement, giving and receiving notices on behalf of such Electing Oxygen Holder and receiving the Holdback
Reports and disputing the matters contained therein pursuant to Section 6.17, and exercising the rights set forth in Section 9.11
with respect to the Electing Oxygen Holders. A decision, action, consent, instruction or omission of the Holders&rsquo; Representative
(acting in its capacity as the Holders&rsquo; Representative) shall constitute a decision, action, consent, instruction or omission
of each Electing Oxygen Holder and shall be final, binding and conclusive upon each Electing Oxygen Holder.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(c)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Holders&rsquo; Representative shall at all times be entitled to rely on any directions received from the Requisite Holders
and shall be entitled to engage such counsel, experts and other agents and consultants as it shall deem necessary in connection
with exercising its powers and performing its function hereunder and (in the absence of bad faith on the part of the Holders&rsquo;
Representative) shall be entitled to conclusively rely on the opinions and advice of such Persons. No bond shall be required of
the Holders&rsquo; Representative, and the Holders&rsquo; Representative shall not receive compensation for its services. The Holders&rsquo;
Representative shall be entitled to reimbursement from the Electing Oxygen Holders for all reasonable expenses, disbursements and
advances (including fees and disbursements of its counsel, experts and other agents and consultants) incurred by the Holders&rsquo;
Representative in such capacity, and shall be entitled to indemnification by the Electing Oxygen Holders against any loss, liability
or expenses arising out of actions taken or omitted to be taken in its capacity as the Holders&rsquo; Representative (except for
those arising out of the Holders&rsquo; Representatives&rsquo; gross negligence or willful misconduct), including the costs and
expenses of investigation and defense of claims; provided that the Holders&rsquo; Representative shall first recover such expenses,
disbursements, losses, liabilities and advances from the Holder Expense Fund.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><A NAME="a_Ref393713757"></A><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(d)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Carbon and its Affiliates shall be entitled to rely upon any decision, action, consent, instruction or omission of the Holders&rsquo;
Representative relating to the transactions contemplated in Section 6.17 as being the decision, action, consent, instruction or
omission of each Electing Oxygen Holder. Notwithstanding anything to the contrary, each Electing Oxygen Holder, on behalf of itself
and its Affiliates, representatives, agents, successors and assigns, voluntarily, irrevocably, unconditionally and completely waives
and releases, acquits and forever discharges Carbon and its Subsidiaries, and each of their respective present and future Affiliates
and their respective directors, officers, shareholders, partners, members, agents and representatives, and the predecessors, successors
and assigns of each of the foregoing other than the Holders&rsquo; Representative (each such persons collectively, the &ldquo;<U>Released
Parties</U>&rdquo;) from any and all claims, demands, rights, promises, causes of actions, suits, expenses, damages, Liabilities
and obligations of any nature whatsoever (whether based on any Law, known or unknown, suspected or claimed, fixed or contingent,
matured or unmatured, determined or determinable, at law or in equity) (each a &ldquo;<U>Claim</U>&rdquo;) in any way arising out
of or based on any action or omission</P>


<!-- Field: Page; Sequence: 65 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-top: 6pt; padding-bottom: 6pt; border-bottom: Black 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->64<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 24pt 70%; text-align: left"><U>STRICTLY&nbsp;CONFIDENTIAL</U><BR>EXECUTION&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt">of the Holders&rsquo; Representative, the appointment of
the Holders&rsquo; Representative, any obligations of the Holders&rsquo; Representative under this Agreement or any documents or
instruments delivered in connection herewith, or any actions or omissions of any Released Party taken in reliance upon any decision,
action, consent, instruction or omission of the Holders&rsquo; Representative, in each case pursuant to or in accordance with this
Section 6.18.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(e)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Holders&rsquo; Representative hereby represents and warrants to Carbon, Oxygen and Merger Sub as follow: (i) The Holders&rsquo;
Representative has all requisite power and authority to execute and deliver this Agreement, (ii) the execution and delivery by
the Holders&rsquo; Representative of this Agreement and the performance by the Holders&rsquo; Representative of its obligations
hereunder do not and will not conflict with, violate any provision of, any applicable Law or Contract applicable to the Holders&rsquo;
Representative, and (iii) this Agreement has been duly and validly executed and delivered by the Holders&rsquo; Representative
and constitutes a valid and binding agreement of the Holders&rsquo; Representative; enforceable against the Holders&rsquo; Representative
in accordance with its terms, except as may be limited by the Enforceability Exceptions.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(f)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>In the event that the Holders&rsquo; Representative determines, in its sole and absolute discretion, that the amount of
the Holder Expense Fund exceeds the expenses incurred by the Holders&rsquo; Representative in such capacity, prior to the final
release of any funds payable to the Oxygen Holders, the Holder Representative shall transfer such excess amount to Carbon solely
for disbursement (or otherwise cause such excess amount to be disbursed) to the Oxygen Holders as though such amounts were Released
Holdback Amounts being distributed pursuant to 6.17(f); <U>provided</U>, <U>however</U>, that notwithstanding anything to the contrary
in this Agreement, in no event shall such excess amount become part of the Holdback Amount or otherwise become payable to Carbon.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center; text-indent: 0in"><A NAME="a_Toc393714790"></A><A NAME="a_Toc392897233"></A><A NAME="a_Toc391290251"></A><A NAME="a_Toc391290411"></A><A NAME="a_Toc391290523"></A><A NAME="a_Toc391290252"></A><A NAME="a_Toc391290412"></A><A NAME="a_Toc391290524"></A><A NAME="a_Toc391290253"></A><A NAME="a_Toc391290413"></A><A NAME="a_Toc391290525"></A><A NAME="a_Toc349846253"></A><A NAME="a_Toc349846373"></A><A NAME="a_Toc349846495"></A><A NAME="a_Toc349846615"></A><A NAME="a_Toc349846735"></A><A NAME="a_Toc349846855"></A><A NAME="a_Toc349846254"></A><A NAME="a_Toc349846374"></A><A NAME="a_Toc349846496"></A><A NAME="a_Toc349846616"></A><A NAME="a_Toc349846736"></A><A NAME="a_Toc349846856"></A><FONT STYLE="font: 12pt Times New Roman, Times, Serif; text-transform: uppercase">Article
VII</FONT><BR>
<BR>
<A NAME="a_Ref347357894"></A>CONDITIONS PRECEDENT</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><U><A NAME="a_Toc393714791"></A><A NAME="a_Ref389400558"></A></U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">7.1</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Conditions to Each Party&rsquo;s Obligation to Effect the Merger</U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">.
The respective obligations of the parties to effect the Merger shall be subject to the satisfaction (or, to the extent permitted
by applicable Law, the waiver by Carbon and Oxygen) at or prior to the Effective Time of the following conditions:</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(a)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>NYSE Listing</U>. The shares of Carbon Common Stock to be issued in the Merger shall have been authorized for listing
on the NYSE, subject to official notice of issuance.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(b)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Regulatory Approvals</U>. All Requisite Regulatory Approvals shall have been obtained and shall remain in full force
and effect and all statutory waiting periods in respect thereof shall have expired.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(c)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>No Burdensome Condition</U>. The consummation of the Merger, the Bank Merger and the other transactions contemplated
by this Agreement shall not result in any Burdensome Condition.</P>


<!-- Field: Page; Sequence: 66 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-top: 6pt; padding-bottom: 6pt; border-bottom: Black 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->65<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 24pt 70%; text-align: left"><U>STRICTLY&nbsp;CONFIDENTIAL</U><BR>EXECUTION&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(d)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U> No Injunctions or Restraints; Illegality</U>. No order, injunction or decree issued by any court or agency of competent
jurisdiction or other legal restraint or prohibition preventing the consummation of the Merger, the Bank Merger or any of the other
transactions contemplated by this Agreement shall be in effect. No Law shall have been enacted, entered, promulgated or enforced
by any Governmental Entity which prohibits or makes illegal consummation of the Merger, the Bank Merger or any of the other transactions
contemplated by this Agreement.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><U><A NAME="a_Toc393714792"></A><A NAME="a_Ref390944823"></A><A NAME="a_Ref390278525"></A><A NAME="a_Ref347359605"></A><A NAME="a_Ref347359260"></A></U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">7.2</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Conditions to Obligations of Carbon and Merger Sub</U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">. The obligation
of Carbon and Merger Sub to effect the Merger is also subject to the satisfaction, or waiver by Carbon, at or prior to the Effective
Time, of the following conditions:</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(a)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Representations and Warranties</U>. The representations and warranties of Oxygen set forth in (i) Sections&nbsp;3.2(a),
3.2(b) (with respect to Oxygen Bank only) and 3.8(a) shall be true and correct in all respects (other than, in the case of Section
3.2(a) and 3.2(b) (with respect to Oxygen Bank only), such failures to be true and correct as are <I>de minimis</I> in effect in
the context of Section 3.2(a) and 3.2(b) (with respect to Oxygen Bank only)), in each case as of the date of this Agreement and
as of the Closing Date as though made on and as of the Closing Date (except to the extent such representations and warranties speak
as of an earlier date, in which case such representation and warranty shall be true and correct as of such earlier date), and (ii)
Sections 3.1 (first two sentences only),&nbsp;3.2(b) (other than with respect to Oxygen Bank), 3.3(a), 3.3(b)(i), 3.3(b) (last
sentence only), 3.7, 3.13(a) (solely with respect to the FDIC Agreements and GSE Agreements) and 3.21 (in each case, read without
giving effect to any qualification as to materiality or Material Adverse Effect set forth in such representations or warranties)
shall be true and correct in all material respects as of the date of this Agreement and as of the Closing Date as though made on
and as of the Closing Date (except to the extent such representations and warranties speak as of an earlier date, in which case
such representation and warranty shall be true and correct as of such earlier date). All other representations and warranties of
Oxygen set forth in this Agreement (read without giving effect to any qualification as to materiality or Material Adverse Effect
set forth in such representations or warranties and, in the case of the representation and warranties in Section 3.23(a) and Section
3.23(f), read without giving effect to any Knowledge qualification in such representations or warranties) shall be true and correct
in all respects as of the date of this Agreement and as of the Closing Date as though made on and as of the Closing Date (except
to the extent such representations and warranties speak as of an earlier date, in which case such representation and warranty shall
be true and correct as of such earlier date); <U>provided</U> that for purposes of this sentence, such representations and warranties
shall be deemed to be true and correct unless the failure or failures of such representations and warranties to be so true and
correct, either individually or in the aggregate, and without giving effect to any qualification as to materiality or Material
Adverse Effect set forth in such representations or warranties, has had or would reasonably be expected to have a Material Adverse
Effect on Oxygen. Carbon shall have received a certificate signed on behalf of Oxygen by an executive officer of Oxygen to the
foregoing effect.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(b)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Performance of Obligations of Oxygen</U>. Oxygen shall have performed in all material respects the obligations required
to be performed by it under this Agreement at or prior to the Closing Date, and Carbon shall have received a certificate signed
on behalf of Oxygen by an executive officer of Oxygen to such effect.</P>


<!-- Field: Page; Sequence: 67 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-top: 6pt; padding-bottom: 6pt; border-bottom: Black 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->66<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 24pt 70%; text-align: left"><U>STRICTLY&nbsp;CONFIDENTIAL</U><BR>EXECUTION&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><A NAME="a_Ref389400570"></A><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(c)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U> Material Adverse Effect</U>. Since the date of this Agreement, no fact, change, event, occurrence, condition or development
has occurred that has had or would reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect
on Oxygen.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(d)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>FDIC Agreements</U>. (1) A FDIC Consent or FDIC Non-Objection with respect to each of the FDIC Agreements shall have
been received and shall remain in full force and effect, (2) all FDIC Agreements shall remain in full force and effect without
any modification, waiver or amendment adverse to, loss of any benefit by, payment in respect of, or any additional Liability to,
Carbon or Oxygen or their Subsidiaries with respect to any such FDIC Agreements other than any FDIC Modification or FDIC Payment
that would not constitute a Burdensome Condition and is in compliance in all respects with Section 6.1(b) and (3) no event or condition
shall exist which would reasonably be expected to constitute, or with notice or lapse of time or both would reasonably be expected
to constitute, a material breach of Oxygen or any of its Subsidiaries under any FDIC Agreements.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(e)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>GSE Agreements</U>. (1) A GSE Consent or GSE Non-Objection with respect to each of the GSE Agreements shall have been
received and shall remain in full force and effect, (2) all GSE Agreements shall remain in full force and effect without any modification,
waiver or amendment adverse to, loss of any benefit by, payment in respect of, or any additional Liability to, Carbon or Oxygen
or their Subsidiaries with respect to any such GSE Agreements following the date hereof other than any GSE Modification or GSE
Payment that would not constitute a Burdensome Condition and is in compliance in all respects with Section 6.1(c) and (3) no event
or condition shall exist which would reasonably be expected to constitute, or with notice or lapse of time or both would reasonably
be expected to constitute, a material breach of Oxygen or any of its Subsidiaries under any GSE Agreements.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(f)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Retention Agreements</U>. (1) Each Retention Agreement shall remain in full force and effect other than as a result of
death or permanent disability, (2) no event or condition exists which constitutes or, after notice or lapse of time or both, will
constitute a material breach of any employee under any such Retention Agreement and (3) Joseph Otting shall remain employed by
Oxygen in good standing other than as a result of death or permanent disability.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(g)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Selling Interestholder Restrictive Covenant Agreement</U>. (1) Each Selling Interestholder Restrictive Covenant Agreement
shall remain in full force and effect and (2)&nbsp;no event or condition exists which constitutes or, after notice or lapse of
time or both, will constitute a material breach of any Oxygen Holder under a Selling Interestholder Restrictive Covenant Agreement.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(h)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Stockholders Agreement</U>. (1) The Stockholders Agreement shall remain in full force and effect and (2)&nbsp;no event
or condition exists which constitutes or, after notice or lapse of time or both, will constitute a material breach of any Oxygen
Holder under the Stockholders Agreement.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(i)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Carbon Stock Repurchase</U>. The Requisite Regulatory Approvals shall expressly contemplate Carbon having the ability
to return $500 million in capital to its</P>


<!-- Field: Page; Sequence: 68 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-top: 6pt; padding-bottom: 6pt; border-bottom: Black 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->67<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 24pt 70%; text-align: left"><U>STRICTLY&nbsp;CONFIDENTIAL</U><BR>EXECUTION&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt">shareholders through one or more Stock Repurchases following
the date of this Agreement and prior to or promptly following the Closing.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(j)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Approved Oxygen Bank Dividend</U>. Oxygen Bank shall have paid the Approved Oxygen Bank Dividend in full.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(k)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Federal Tax Opinion</U>. Carbon shall have received the opinion of Wachtell, Lipton, Rosen &amp; Katz, in form and substance
reasonably satisfactory to Carbon, dated as of the Closing Date, to the effect that, on the basis of facts, representations and
assumptions set forth or referred to in such opinion, the Merger shall qualify as a &ldquo;reorganization&rdquo; within the meaning
of Section 368(a) of the Code. In rendering such opinion, counsel may require and rely upon representations contained in certificates
of officers of Carbon, reasonably satisfactory in form and substance to such counsel.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><U><A NAME="a_Toc393714793"></A><A NAME="a_Ref390944833"></A><A NAME="a_Ref390278529"></A><A NAME="a_Ref347359633"></A><A NAME="a_Ref347359272"></A><A NAME="a_Toc389500924"></A></U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">7.3</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Conditions to Obligations of Oxygen</U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">. The obligation of Oxygen
to effect the Merger is also subject to the satisfaction or waiver by Oxygen at or prior to the Effective Time of the following
conditions:</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(a)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Representations and Warranties</U>. The representations and warranties of Carbon set forth in (i) Sections&nbsp;4.2(a)
and 4.8(a) shall be true and correct in all respects (other than, in the case of Section 4.2(a), such failures to be true and correct
as are <I>de minimis</I> in effect in the context of Section 4.2(a)), in each case as of the date of this Agreement and as of the
Closing Date as though made on and as of the Closing Date (except to the extent such representations and warranties speak as of
an earlier date, in which case such representation and warranty shall be true and correct as of such earlier date), and (ii) Sections&nbsp;4.1
(first two sentences only), 4.2(b), 4.3(a), 4.3(b)(i) and 4.7 (read without giving effect to any qualification as to materiality
or Material Adverse Effect set forth in such representations or warranties) shall be true and correct in all material respects
as of the date of this Agreement and as of the Closing Date as though made on and as of the Closing Date (except to the extent
such representations and warranties speak as of an earlier date, in which case such representation and warranty shall be true and
correct as of such earlier date). All other representations and warranties of Carbon set forth in this Agreement (read without
giving effect to any qualification as to materiality or Material Adverse Effect set forth in such representations or warranties)
shall be true and correct in all respects as of the date of this Agreement and as of the Closing Date as though made on and as
of the Closing Date (except to the extent such representations and warranties speak as of an earlier date, in which case such representation
and warranty shall be true and correct as of such earlier date); <U>provided</U> that for purposes of this sentence, such representations
and warranties shall be deemed to be true and correct unless the failure or failures of such representations and warranties to
be so true and correct, either individually or in the aggregate, and without giving effect to any qualification as to materiality
or Material Adverse Effect set forth in such representations or warranties, has had or would reasonably be expected to have a Material
Adverse Effect on Carbon. Oxygen shall have received a certificate signed on behalf of Carbon by an executive officer of Carbon
to the foregoing effect.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(b)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Performance of Obligations of Carbon</U>. Carbon and Merger Sub shall have performed in all material respects the obligations
required to be performed by it under this</P>


<!-- Field: Page; Sequence: 69 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-top: 6pt; padding-bottom: 6pt; border-bottom: Black 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->68<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 24pt 70%; text-align: left"><U>STRICTLY&nbsp;CONFIDENTIAL</U><BR>EXECUTION&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt">Agreement at or prior to the Closing Date, and Oxygen shall
have received a certificate signed on behalf of Carbon by an executive officer of Carbon to such effect.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(c)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Material Adverse Effect</U>. Since the date of this Agreement, no fact, change, event, occurrence, condition or development
has occurred that has had or would reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect
on Carbon.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(d)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Federal Tax Opinion</U>. Oxygen shall have received the opinion of Cleary Gottlieb Steen &amp; Hamilton LLP, in form
and substance reasonably satisfactory to Oxygen, dated as of the Closing Date, to the effect that, on the basis of facts, representations
and assumptions set forth or referred to in such opinion, the Merger shall qualify as a &ldquo;reorganization&rdquo; within the
meaning of Section 368(a) of the Code. In rendering such opinion, counsel may require and rely upon representations contained in
certificates of officers of Oxygen, reasonably satisfactory in form and substance to such counsel.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center; text-indent: 0in"><A NAME="a_Toc393714794"></A><A NAME="a_Toc384226025"></A><A NAME="a_Toc384226026"></A><A NAME="a_Toc384226027"></A><FONT STYLE="font: 12pt Times New Roman, Times, Serif; text-transform: uppercase">Article
VIII</FONT><BR>
<BR>
TERMINATION AND AMENDMENT</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><U><A NAME="a_Toc393714795"></A><A NAME="a_Ref347359777"></A><A NAME="a_Ref347359303"></A></U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">8.1</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Termination</U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">. This Agreement may be terminated at any time
prior to the Effective Time:</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(a)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>by mutual consent of Carbon and Oxygen in a written instrument authorized by the Board of Directors of each;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><A NAME="a_Ref354687147"></A><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(b)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>by either Carbon or Oxygen if any Governmental Entity that must grant a Requisite Regulatory Approval has denied approval
of the consummation of the transactions contemplated by this Agreement, including the Merger or Bank Merger, and such denial has
become final and nonappealable or any Governmental Entity of competent jurisdiction shall have issued a final nonappealable order,
injunction or decree permanently enjoining or otherwise prohibiting or making illegal the consummation of the transactions contemplated
by this Agreement, including the Merger or Bank Merger;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><A NAME="a_Ref390948779"></A><A NAME="a_Ref347359879"></A><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(c)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>by either Carbon or Oxygen if the Merger shall not have been consummated on or before the first anniversary of the date
of this Agreement (the &ldquo;<U>Termination Date</U>&rdquo;); or</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><A NAME="a_Ref347359866"></A><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(d)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>(i) by either Carbon or Oxygen if there shall have been a breach of any of the covenants or agreements or any of the representations
or warranties set forth in this Agreement by the other party, which breach, either individually or in the aggregate with all other
breaches by such party, would constitute, if occurring or continuing on the Closing Date, the failure of any of the conditions
set forth in Section 7.1, Section&nbsp;7.2 (in the case of a termination by Carbon) or Section 7.3 (in the case of a termination
by Oxygen), and which is not cured within the earlier of (A) the Termination Date or (B) the date that is thirty (30) days following
written notice to the party committing such breach, or by its nature or timing cannot be cured during such period<A NAME="a_Ref347359896"></A>
or (ii) by Carbon if there is a fact, change, event, occurrence, condition or development that has caused the failure of the condition
set forth in Section 7.2(c) to be satisfied</P>


<!-- Field: Page; Sequence: 70 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-top: 6pt; padding-bottom: 6pt; border-bottom: Black 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->69<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 24pt 70%; text-align: left"><U>STRICTLY&nbsp;CONFIDENTIAL</U><BR>EXECUTION&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt">and such failure is not cured within the earlier of (A) the
Termination Date or (B) the date that is sixty (60) days following written notice to Oxygen of the failure to satisfy the condition
set forth in Section 7.2(c) or (iii) by Oxygen if there is a fact, change, event, occurrence, condition or development that has
caused the failure of the condition set forth in Section 7.3(c) to be satisfied and such failure is not cured within the earlier
of (A) the Termination Date or (B) the date that is sixty (60) days following written notice to Carbon of the failure to satisfy
the condition set forth in Section7.3(c);<BR>
<BR>
<U>provided</U>, that the party desiring to terminate this Agreement pursuant to clause&nbsp;(b), (c) or (d) of this Section&nbsp;8.1,
is not then in material breach of any of its representations, warranties, covenants or agreements contained in this Agreement and
that the failure of the Closing to occur did not arise out of, or result from, a material breach by the terminating party of any
representation, warranty, covenant or agreement. The terminating party shall give written notice of such termination to the other
party in accordance with Section&nbsp;9.4, specifying the provision or provisions hereof pursuant to which such termination is
effected and confirm that the Board of Directors of such terminating party has authorized such termination.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><U><A NAME="a_Toc393714796"></A><A NAME="a_Ref347360037"></A><A NAME="a_Ref347359980"></A><A NAME="a_Ref347359817"></A><A NAME="a_Toc347943957"></A><A NAME="a_Toc347947779"></A><A NAME="a_Toc347947900"></A><A NAME="a_Toc347948019"></A></U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">8.2</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Effect of Termination</U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">. In the event of termination of this
Agreement by either Carbon or Oxygen as provided in Section&nbsp;8.1, this Agreement shall forthwith become void and have no effect,
and none of Carbon, Oxygen, any of their respective Subsidiaries or any of the officers or directors of any of them shall have
any Liability of any nature whatsoever hereunder, or in connection with the transactions contemplated hereby, except that (i) Sections
6.2(c) and 8.2 and Article IX (other than Section&nbsp;9.1) and the Confidentiality Agreement shall survive any termination of
this Agreement, and (ii) notwithstanding anything to the contrary contained in this Agreement, neither Carbon nor Oxygen shall
be relieved or released from any Liabilities arising out of its willful and material breach of any provision of this Agreement
prior to termination.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><U><A NAME="a_Toc393714797"></A></U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">8.3</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Amendment</U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">. Subject to compliance with applicable Law and Section&nbsp;1.1(b),
this Agreement may be amended (a) prior to the Effective Time, by an instrument in writing signed on behalf of Oxygen and Carbon,
by action taken or authorized by their respective Boards of Directors (provided that any such amendment that would adversely affect
the rights or obligations of the Holder&rsquo;s Representative shall also be signed on behalf of the Holder&rsquo;s Representative)
and (b) following the Effective Time, by an instrument in writing signed on behalf of Carbon and each of the parties hereto.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><U><A NAME="a_Toc393714798"></A></U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">8.4</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Extension; Waiver</U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">. At any time prior to the Effective Time,
the parties hereto, by action taken or authorized by their respective Board of Directors, may, to the extent legally allowed, (a)
extend the time for the performance of any of the obligations or other acts of the other parties hereto, (b) waive any inaccuracies
in the representations and warranties contained herein or in any document delivered pursuant hereto, and (c) waive compliance with
any of the agreements or satisfaction of any conditions contained herein. Any agreement on the part of a party hereto to any such
extension or waiver shall be valid only if set forth in a written instrument signed on behalf of such party, but such extension
or waiver or failure to insist on strict compliance with an obligation, covenant, agreement or condition shall not operate as a
waiver of, or estoppel with respect to, any subsequent or other failure.</FONT></P>



<!-- Field: Page; Sequence: 71 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-top: 6pt; padding-bottom: 6pt; border-bottom: Black 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->70<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 24pt 70%; text-align: left"><U>STRICTLY&nbsp;CONFIDENTIAL</U><BR>EXECUTION&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center; text-indent: 0in"><FONT STYLE="text-transform: uppercase"><A NAME="a_Toc393714799"></A>Article
IX</FONT></P>
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center">
<A NAME="a_Ref347357963"></A>GENERAL PROVISIONS</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><U><A NAME="a_Toc393714800"></A><A NAME="a_Ref347359832"></A></U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">9.1</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Closing</U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">. Subject to the terms and conditions of this Agreement,
the closing of the Merger (the &ldquo;<U>Closing</U>&rdquo;) will take place at 10:00 a.m. New York City time at the offices of
Wachtell, Lipton, Rosen &amp; Katz, on a date which shall be no later than three (3) Business Days after the satisfaction or waiver
(subject to applicable Law) of the latest to occur of the conditions set forth in Article VII hereof (other than those conditions
that by their nature can only be satisfied at the Closing, but subject to the satisfaction or waiver thereof), unless extended
by mutual agreement of the parties (the &ldquo;<U>Closing Date</U>&rdquo;).</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><U><A NAME="a_Toc393714801"></A></U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">9.2</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Nonsurvival of Representations, Warranties and Agreements</U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">.
None of the representations, warranties, covenants and agreements in this Agreement or in any instrument delivered pursuant to
this Agreement shall survive the Effective Time, except for Section&nbsp;6.3(a) and for those other covenants and agreements contained
herein and therein which by their terms apply or are to be performed in whole or in part after the Effective Time. </FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><U><A NAME="a_Toc393714802"></A></U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">9.3</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Expenses</U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">. Except as otherwise set forth herein, all costs
and expenses incurred in connection with this Agreement and the transactions contemplated hereby shall be paid by the party incurring
such expense.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><U><A NAME="a_Toc393714803"></A><A NAME="a_Ref347360161"></A><A NAME="a_Ref347360158"></A></U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">9.4</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Notices</U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">. All notices and other communications hereunder shall
be in writing and shall be deemed given if delivered personally, telecopied (with confirmation), mailed by registered or certified
mail (return receipt requested) or delivered by an express courier (with confirmation) to the parties at the following addresses
(or at such other address for a party as shall be specified by like notice):</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(a)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>if to Oxygen, to:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in">IMB HoldCo LLC</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in">888 East Walnut Street</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in">Pasadena, California 91101-7211</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 1.5in">Attention: Steven Mnuchin</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 1.5in"><I>With a copy (which shall not constitute notice)
to: </I></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in">Cleary Gottlieb Steen &amp; Hamilton LLP</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in">One Liberty Plaza</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in">New York, NY 10006</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 1.5in">&nbsp;</TD>
    <TD STYLE="width: 0.8in">Attention:&#9;</TD>
    <TD>Christopher E. Austin</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Benet J. O&rsquo;Reilly</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>Facsimile:</TD>
    <TD>(212) 225-3999&#9;</TD></TR>
</TABLE>
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-indent: 0.5in"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in">&#9;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">and</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(b)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>if to Carbon or Merger Sub, to:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in">CIT Group Inc.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in">1 CIT Drive</P>
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in">Livingston, NJ&nbsp; 07039&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in">Attention:&#9;General Counsel</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 1.5in">Facsimile:&#9;(973) 740-5264</P>


<!-- Field: Page; Sequence: 72 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-top: 6pt; padding-bottom: 6pt; border-bottom: Black 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->71<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 24pt 70%; text-align: left"><U>STRICTLY&nbsp;CONFIDENTIAL</U><BR>EXECUTION&nbsp;</P>


<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 1.5in"><I>With a copy (which shall not constitute notice)
to:</I></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 80%; font: 8pt Times New Roman, Times, Serif; border-collapse: collapse; margin-left: 1.5in">
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; width: 50%"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">Wachtell, Lipton, Rosen &amp; Katz</FONT></TD>
    <TD STYLE="width: 50%; padding-right: 5.4pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">51 West 52nd Street</FONT></TD>
    <TD STYLE="padding-right: 5.4pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">New York, NY&nbsp;&nbsp;10019</FONT></TD>
    <TD STYLE="padding-right: 5.4pt">&nbsp;</TD></TR>
</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 80%; font: 8pt Times New Roman, Times, Serif; border-collapse: collapse; margin-left: 1.5in">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 15%; padding-right: 5.4pt"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">Attention:</FONT></TD>
    <TD STYLE="width: 85%; padding-right: 5.4pt"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">Edward D. Herlihy</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">David C. Karp</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">Facsimile:</FONT></TD>
    <TD STYLE="padding-right: 5.4pt"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(212) 403-2000</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(c)</FONT><FONT STYLE="font: 8pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>if to the Holders&rsquo; Representative, to:</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 80%; font: 8pt Times New Roman, Times, Serif; border-collapse: collapse; margin-left: 1.5in">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; padding-right: 5.4pt"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">JCF III HoldCo I L.P.</FONT></TD>
    <TD STYLE="width: 50%; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">c/o JC Flowers &amp; Co. </FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">717 Fifth Avenue, 26<SUP>th</SUP> Floor</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">New York, NY 10022</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD></TR>
</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 80%; font: 8pt Times New Roman, Times, Serif; border-collapse: collapse; margin-left: 1.5in">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 15%"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">Attention:</FONT></TD>
    <TD STYLE="width: 85%"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">Sally Rocker</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 12pt Times New Roman, Times, Serif">John Oros </FONT></TD></TR>
</TABLE>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><U><A NAME="a_Toc393714804"></A><A NAME="a_Ref347360136"></A></U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">9.5</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Interpretation; Definitions<FONT STYLE="font: 12pt Times New Roman, Times, Serif">.</FONT></U></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(a)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The parties have participated jointly in negotiating and drafting this Agreement. In the event that an ambiguity or a question
of intent or interpretation arises, this Agreement shall be construed as if drafted jointly by the parties, and no presumption
or burden of proof shall arise favoring or disfavoring any party by virtue of the authorship of any provision of this Agreement.
When a reference is made in this Agreement to Articles, Sections, Exhibits or Schedules, such reference shall be to an Article
or Section of or Exhibit or Schedule to this Agreement unless otherwise indicated. The table of contents and headings contained
in this Agreement are for reference purposes only and shall not affect in any way the meaning or interpretation of this Agreement.
The Oxygen Disclosure Schedule and the Carbon Disclosure Schedule, as well as all other schedules and all exhibits hereto, shall
be deemed part of this Agreement and included in any reference to this Agreement.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(b)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The words &ldquo;hereof,&rdquo; &ldquo;herein&rdquo; and &ldquo;hereunder&rdquo; and words of like import used in this
Agreement shall refer to this Agreement as a whole and not to any particular provision of this Agreement. The captions herein
are included for convenience of reference only and shall be ignored in the construction or interpretation hereof. Any singular
term in this Agreement shall be deemed to include the plural, and any plural term the singular. Whenever the words &ldquo;include,&rdquo;
&ldquo;includes&rdquo; or &ldquo;including&rdquo; are used in this Agreement, they shall be deemed to be followed by the words
&ldquo;without limitation,&rdquo; whether or not they are in fact followed by those words or words of like import. &ldquo;Writing,&rdquo;
&ldquo;written&rdquo; and comparable terms refer to printing, typing and other means of reproducing words (including electronic
media) in a visible form. References to any agreement or contract are to that agreement or contract as amended, modified or supplemented
from time to time in accordance with the terms hereof and thereof; <U>provided</U></P>


<!-- Field: Page; Sequence: 73 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-top: 6pt; padding-bottom: 6pt; border-bottom: Black 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->72<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 24pt 70%; text-align: left"><U>STRICTLY&nbsp;CONFIDENTIAL</U><BR>EXECUTION&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt">that with respect to any agreement or contract listed on
any schedules hereto, all such amendments, modifications or supplements must also be listed in the appropriate schedule. References
to any Person include the successors and permitted assigns of that Person. References from or through any date mean, unless otherwise
specified, from and including or through and including, respectively. References to &ldquo;Law,&rdquo; &ldquo;Laws&rdquo; or to
a particular statute or Law shall mean such Law or statute as amended, modified or supplemented from time to time up to the Closing
and shall be deemed also to include any and all rules and regulation promulgated thereunder.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(c)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>As used in this Agreement, the following terms have the meanings ascribed thereto below.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Accounting Firm</U>&rdquo;
shall have the meaning set forth in Section 1.7(c)(iii).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Advances</U>&rdquo; means,
with respect to Oxygen, any of its Subsidiaries or any Servicing Agreements, the moneys that have been advanced by Oxygen or any
of its Subsidiaries on or before the Closing Date from its funds in connection with its servicing of any Loans.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">&ldquo;<U>Affiliate</U>&rdquo;
means, with respect to a specified Person, any Person that directly or indirectly controls, is controlled by, or is under common
control with, such specified Person; </FONT>for purposes of this definition, &ldquo;<I><U>control</U></I>&rdquo; (including, with
correlative meanings, the terms &ldquo;<I><U>controlled by</U></I>&rdquo; or &ldquo;<I><U>under</U> <U>common control with</U></I>&rdquo;),
as applied to any person, means the possession, directly or indirectly, of (i) ownership, control or power to vote 25% or more
of the outstanding shares of any class of voting securities of such person, (ii) control, in any manner, over the election of a
majority of the directors, trustees or general partners (or individuals exercising similar functions) of such person or (iii) the
power to exercise a controlling influence over the management or policies of such person as determined by the Federal Reserve;
<I>provided</I>, <I>however</I>, no portfolio company of any investment fund, vehicle or account advised, managed or sponsored
by any Oxygen Holder or its Affiliates shall be deemed an Affiliate of Oxygen, any of its Subsidiaries or any Oxygen Holder for
purposes of this Agreement other than Sections 3.20, 3.24(a) and 6.12.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Aggregate Cash Percentage</U>&rdquo;
shall have the meaning set forth in Section 1.7.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Aggregate Fully Diluted Common
Interests</U>&rdquo; shall have the meaning set forth in Section 1.7.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Aggregate In-The-Money Exercise
Price</U>&rdquo; shall have the meaning set forth in Section 1.7.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Aggregate Stock Percentage</U>&rdquo;
shall have the meaning set forth in Section 1.7.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Agreement</U>&rdquo; shall
have the meaning set forth in the Preamble.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Amended Oxygen LLC Agreement</U>&rdquo;
shall have the meaning set forth in Section 3.2(a).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Approved Oxygen Bank Dividend</U>&rdquo;
shall have the meaning set forth in Section 6.15.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Bank Merger</U>&rdquo; shall
have the meaning set forth in Section 1.12.</P>


<!-- Field: Page; Sequence: 74 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-top: 6pt; padding-bottom: 6pt; border-bottom: Black 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->73<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 24pt 70%; text-align: left"><U>STRICTLY&nbsp;CONFIDENTIAL</U><BR>EXECUTION&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Bank Merger Agreement</U>&rdquo;
shall have the meaning set forth in Section 1.12.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Bank Merger Certificates</U>&rdquo;
shall have the meaning set forth in Section 1.12.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Bank Merger Effective Time</U>&rdquo;
shall have the meaning set forth in Section 1.12.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>BHC Act</U>&rdquo; means the
Bank Holding Company Act of 1956, as amended.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Burdensome Condition</U>&rdquo;
shall have the meaning set forth in Section 6.1(e).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">&ldquo;<U>Business
Day</U>&rdquo; means any day other than a Saturday, Sunday or any other day on which commercial banks in New York, New York are
authorized or required by </FONT>Law to close.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Cancelled Interests</U>&rdquo;
shall have the meaning set forth in Section 1.4(c).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Carbon</U>&rdquo; shall have
the meaning set forth in the Preamble.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Carbon Bank</U>&rdquo; shall
have the meaning set forth in Section 1.12(a).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Carbon Cash Award</U>&rdquo;
shall have the meaning set forth in Section 1.4(b).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Carbon Closing Price</U>&rdquo;
means the average, rounded to the nearest one ten thousandth, of the closing-sale prices of Carbon Common Stock on the NYSE as
reported by The Wall Street Journal for the five full trading days ending on (and including) the day preceding the Closing Date.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Carbon Disclosure Schedule</U>&rdquo;
shall have the meaning set forth in Section 9.6(a).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Carbon Regulatory Agreement</U>&rdquo;
shall have the meaning set forth in Section 4.11(a).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Carbon Reports</U>&rdquo; means
each final registration statement, prospectus, report, schedule and definitive proxy statement filed with or furnished to the SEC
since January 1, 2014 by Carbon pursuant to the Securities Act or the Exchange Act.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Carbon Restricted Stock Award</U>&rdquo;
shall have the meaning set forth in Section 4.2(a).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Carbon Restricted Stock Units</U>&rdquo;
shall have the meaning set forth in Section 4.2(a).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Carbon Signing Price</U>&rdquo;
shall have the meaning set forth in Section 1.7.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Carbon Stock Award</U>&rdquo;
shall have the meaning set forth in Section 1.4(b).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Carbon Stock Options</U>&rdquo;
shall have the meaning set forth in Section 4.2(a).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Carbon Stock Plans</U>&rdquo;
shall have the meaning set forth in Section 4.2(a).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Cash Consideration Amount</U>&rdquo;
shall have the meaning set forth in Section 1.7.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Certificate</U>&rdquo; means
a certificate or book&#45;entry account statement, as applicable.</P>


<!-- Field: Page; Sequence: 75 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-top: 6pt; padding-bottom: 6pt; border-bottom: Black 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->74<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 24pt 70%; text-align: left"><U>STRICTLY&nbsp;CONFIDENTIAL</U><BR>EXECUTION&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Certificate of Merger</U>&rdquo;
shall have the meaning set forth in Section 1.2.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>CFPB</U>&rdquo; means the Consumer
Financial Protection Bureau.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">&ldquo;<U>Claim</U>&rdquo;
shall have the meaning set forth in Section </FONT><FONT STYLE="font-size: 10pt">&#8206;6.18(d).</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Closing</U>&rdquo; shall have
the meaning set forth in Section 9.1.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Closing Date</U>&rdquo; shall
have the meaning set forth in Section 9.1.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Code</U>&rdquo; shall have
the meaning set forth in the Recitals.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Common Equity</U>&rdquo; means
the amount set forth in the line item &ldquo;total members equity&rdquo; on the Oxygen Audited Interim Balance Sheet, which amount
as reflected in the balance sheet included in the Oxygen Unaudited Financial Statements was $2,914,268,110.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Confidentiality Agreement</U>&rdquo;
means the confidentiality agreement, dated January 2, 2013, between Carbon and Oxygen, as amended on February 6, 2014.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Consent Orders</U>&rdquo; shall
have the meaning set forth in Section 3.14(a).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Continuing Employees</U>&rdquo;
shall have the meaning set forth in Section 6.3(a).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Contract</U>&rdquo; means any
written contract, agreement, license, note, lease, mortgage, indenture, commitment, understanding or other legally binding agreement.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Copyrights</U>&rdquo; shall
have the meaning set forth in the definition of Intellectual Property.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Delaware Courts</U>&rdquo;
shall have the meaning set forth in Section 9.9(b).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>DLLCA</U>&rdquo; shall have
the meaning set forth in Section 1.1(a).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Effective Time</U>&rdquo; shall
have the meaning set forth in Section 1.2.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Electing Options</U>&rdquo;
shall have the meaning set forth in Section 1.6(a).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Electing Oxygen Holder</U>&rdquo;
shall have the meaning set forth in Section 6.18(a).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Enforceability Exceptions</U>&rdquo;
means bankruptcy, insolvency, moratorium, reorganization or similar Laws affecting the rights of creditors generally and the availability
of equitable remedies.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Environmental Laws</U>&rdquo;
means all Laws relating to: (i) the protection or restoration of the environment (including, without limitation, air, surface water,
groundwater, drinking water supply, surface land, subsurface land), health and safety as it relates to hazardous substance exposure
or natural resources; (ii) the handling, use, presence, disposal, release or threatened release of, or exposure to, any Hazardous
Substance; or (iii) noise, odor, wetlands, indoor air, pollution, contamination or any injury to persons or property from exposure
to any Hazardous Substance.</P>


<!-- Field: Page; Sequence: 76 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-top: 6pt; padding-bottom: 6pt; border-bottom: Black 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->75<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 24pt 70%; text-align: left"><U>STRICTLY&nbsp;CONFIDENTIAL</U><BR>EXECUTION&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>ERISA</U>&rdquo; means the
Employee Retirement Income Security Act of 1974, as amended.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Estimated Transaction Expense
and Retention Amounts Tax Benefits</U>&rdquo; shall have the meaning set forth in Section 6.14(a).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Excess Capital</U>&rdquo; means
the amount of Tangible Common Equity reflected on the Oxygen Audited Interim Balance Sheet <U>minus</U> the Required Capital.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Exchange Act</U>&rdquo; means
the Securities Exchange Act of 1934, as amended.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Exchange Agent</U>&rdquo; shall
have the meaning set forth in Section 2.1.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Exchange Fund</U>&rdquo; shall
have the meaning set forth in Section 2.1.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Excluded Amount</U>&rdquo;
means the aggregate increase to clauses (i) and (ii) of the definition of &ldquo;Gross Merger Consideration&rdquo; resulting, directly
or indirectly, from the Prohibited Transactions and Prohibited Practices, if any.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Fannie Mae</U>&rdquo; means
the Federal National Mortgage Association.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>FDIC</U>&rdquo; means the Federal
Deposit Insurance Corporation.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>FDIC Agreements</U>&rdquo;
shall have the meaning set forth in Section 3.13(a)(xi).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>FDIC Consent</U>&rdquo; shall
have the meaning set forth in Section 6.1(b).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>FDIC Modification</U>&rdquo;
shall have the meaning set forth in Section 6.1(b).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>FDIC Non-Objection</U>&rdquo;
shall have the meaning set forth in Section 6.1(b).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>FDIC Payment</U>&rdquo; shall
have the meaning set forth in Section 6.1(b).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>FDICIA</U>&rdquo; shall have
the meaning set forth in Section 3.6(c).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Federal Reserve Board</U>&rdquo;
means the Board of Governors of the Federal Reserve System.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Final Gross Merger Consideration</U>&rdquo;
has the meaning set forth in Section 1.7(c)(iv).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Final Offer</U>&rdquo; shall
have the meaning set forth in Section 9.14.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Final Resolution</U>&rdquo;
means with respect to a Proceeding, (i) a final and non-appealable decision, judgment or award by a Governmental Entity of competent
jurisdiction with respect to such Proceeding, (ii) a binding settlement agreement entered into by Carbon or its Subsidiaries with
a third party with respect to such Proceeding or (iii) the written agreement of Carbon and the Holders&rsquo; Representative with
respect to the final resolution of such Proceeding.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Final Transaction Tax Analysis</U>&rdquo;
shall have the meaning set forth in Section 6.14(a).</P>


<!-- Field: Page; Sequence: 77 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-top: 6pt; padding-bottom: 6pt; border-bottom: Black 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->76<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 24pt 70%; text-align: left"><U>STRICTLY&nbsp;CONFIDENTIAL</U><BR>EXECUTION&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Financial Freedom</U>&rdquo;
means the third-party reverse mortgage servicing business conducted by Oxygen and its Subsidiaries (or following Closing, by Carbon
and its Subsidiaries).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Financing</U>&rdquo; shall
have the meaning set forth in Section 6.2(c).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Freddie Mac</U>&rdquo; means
the Federal Home Loan Mortgage Corporation.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>GAAP</U>&rdquo; means generally
accepted accounting principles in the United States, consistently applied.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Ginnie Mae</U>&rdquo; means
the Government National Mortgage Association.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Goodwill and Intangibles</U>&rdquo;
means the amount set forth in the line item &ldquo;goodwill and other intangible assets&rdquo; on the Oxygen Audited Interim Balance
Sheet, which amount as reflected in the balance sheet included in the Oxygen Unaudited Financial Statements was $109,708,298.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Governmental Entity</U>&rdquo;
means any federal, state, local or foreign government, any transnational governmental organization or any court of competent jurisdiction,
arbitral, administrative agency or commission or other governmental authority or instrumentality, domestic or foreign, or any national
securities exchange or any SRO.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Governmental Insurer</U>&rdquo;
shall have the meaning set forth in Section 3.13(a)(xiii).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">&ldquo;<U>Governmental
Insurer Requirements</U>&rdquo; means the requirements of any Governmental Insurer as such requirements are available and updated
</FONT>or amended from time to time electronically or in writing in guides, bulletins, handbooks, industry letters, mortgagee letters,
circulars or other similar communications from the respective governmental insurer or in written agreements between the respective
governmental insurer and Oxygen or one of its Subsidiaries.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Gross Merger Consideration</U>&rdquo;
means an amount equal to the sum of (i) the product of (A) 1.3 <U>multiplied</U> <U>by</U> (B) Required Capital <U>plus</U> (ii)
Excess Capital <U>minus</U> (iii) any Excluded Amounts.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Gross Settlement Election</U>&rdquo;
shall have the meaning set forth in Section 1.6(b).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>GSE Agreements</U>&rdquo; shall
have the meaning set forth in Section 3.13(a)(xii).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>GSEs</U>&rdquo; means Fannie
Mae and Freddie Mac (each individually, a &ldquo;<U>GSE</U>&rdquo;).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>GSE Consent</U>&rdquo; shall
have the meaning set forth in Section 6.1(c).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>GSE Modification</U>&rdquo;
shall have the meaning set forth in Section 6.1(c).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>GSE Non-Objection</U>&rdquo;
shall have the meaning set forth in Section 6.1(c).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>GSE Payment</U>&rdquo; shall
have the meaning set forth in Section 6.1(c).</P>


<!-- Field: Page; Sequence: 78 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-top: 6pt; padding-bottom: 6pt; border-bottom: Black 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->77<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 24pt 70%; text-align: left"><U>STRICTLY&nbsp;CONFIDENTIAL</U><BR>EXECUTION&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>GSE Requirements</U>&rdquo;
means the requirements of any GSE as such requirements are available and updated or amended from time to time electronically or
in writing in handbooks, guides, guidelines, manuals, mortgagee letters, circulars, bulletins, industry letters or other similar
communications from the respective GSE (or its conservator) or in written agreements between the GSE and Oxygen or one of its Subsidiaries..</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Hazardous Substance</U>&rdquo;
means any substance listed, defined, designated or classified as hazardous, toxic, radioactive or dangerous, or otherwise regulated,
under any Environmental Law, whether by type or by quantity, including any substance containing any such substance as a component,
and including, without limitation, any hazardous waste, toxic waste, pollutant, contaminant, hazardous substance, toxic substance,
petroleum or any derivative or by-product thereof, radon, radioactive material, asbestos, asbestos-containing material, urea formaldehyde
foam insulation, lead and polychlorinated biphenyl.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Holdback Amount</U>&rdquo;
has the meaning set forth in Section 1.7.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Holdback Percentage</U>&rdquo;
means a fraction, the numerator of which is the sum of (i) the vested Oxygen Common Interests plus (ii) the Oxygen Common Interests
issuable upon exercise of In-the Money Oxygen Options plus (iii) the Oxygen Interest Awards, in each case held by such Oxygen Holder
immediately prior to the Effective Time, and the denominator of which, is the sum of (i) all vested Oxygen Common Interests <U>plus</U>
(ii) all Common Interests issuable upon exercise of In-the Money Oxygen Options <U>plus</U> (iii) all Oxygen Interest Awards, in
each case outstanding immediately prior to the Effective Time.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Holdback Reports</U>&rdquo;
shall have the meaning set forth in Exhibit A.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Holder Acknowledgment</U>&rdquo;
means a holder acknowledgement.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Holder Expense Fund</U>&rdquo;
means $2,000,000.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Holders&rsquo; Representative</U>&rdquo;
shall have the meaning set forth in the Recitals.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>HUD</U>&rdquo; means the United
States Department of Housing and Urban Development.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Indemnified Parties</U>&rdquo;
shall have the meaning set forth in Section 6.4(a).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Independent Valuation Firm</U>&rdquo;
shall have the meaning set forth in Section 9.14.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Intellectual Property</U>&rdquo;
means all intellectual property rights existing anywhere in the world associated with all: (i) patents and patent applications,
including continuations, divisionals, continuations-in-part, reissues or reexaminations and patents issuing thereon (collectively,
&ldquo;<U>Patents</U>&rdquo;), (ii) trademarks, service marks, trade dress, logos, corporate names, trade names and Internet domain
names, together with the goodwill associated with any of the foregoing, and all applications and registrations therefor (collectively,
&ldquo;<U>Marks</U>&rdquo;), (iii) copyrights and registrations and applications therefor, works of authorship and moral rights
(collectively, &ldquo;<U>Copyrights</U>&rdquo;), (iv) Software, and (v) trade secrets, discoveries, concepts, ideas, research and
development, algorithms, know-how, formulae, inventions (whether or not patentable), processes, techniques,</P>


<!-- Field: Page; Sequence: 79 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-top: 6pt; padding-bottom: 6pt; border-bottom: Black 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->78<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 24pt 70%; text-align: left"><U>STRICTLY&nbsp;CONFIDENTIAL</U><BR>EXECUTION&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt">technical data, designs, drawings, specifications, in each
case excluding any rights in respect of any of the foregoing that comprise or are protected by Patents (collectively, &ldquo;<U>Trade
Secrets</U>&rdquo;).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>In-the-Money Oxygen Options</U>&rdquo;
shall have the meaning set forth in Section 1.7.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Investor/Insurer Requirements</U>&rdquo;
means the applicable rules, regulations, announcements, notices, directives, instructions, servicing guidelines, and mortgage letters
of the investor and/or private mortgage insurer of the Loan, including the applicable provisions of any pooling and servicing agreement
or any other agreements with investors and private mortgage insurers pursuant to which Oxygen is the servicer of the Loan, all
as may be amended from time to time.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Investor Questionnaire</U>&rdquo;
means an investor questionnaire in the form attached as <U>Annex A</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>IRS</U>&rdquo; means the Internal
Revenue Service.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Knowledge</U>&rdquo; means
(i) with respect to Oxygen, the actual knowledge of any of the officers of Oxygen listed on Section&nbsp;9.5(a) of the Oxygen Disclosure
Schedule, after reasonable investigation, and (ii) with respect to Carbon, the actual knowledge of any of<A NAME="PB_85_085454_2983"></A>
the officers of Carbon listed on Section&nbsp;9.5 of the Carbon Disclosure Schedule, after reasonable investigation.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Law</U>&rdquo; means any law
(including common law), treaty, statute, ordinance, code, rule, regulation, judgment, decree, order, writ, award, injunction, decree,
directive, authorization or determination enacted, entered, promulgated, enforced or issued by any Governmental Entity.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Letter of Transmittal</U>&rdquo;
shall have the meaning set forth in Section 2.2.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Liability</U>&rdquo; means
any and all debts, liabilities and obligations, whether fixed, contingent or absolute, matured or unmatured, accrued or not accrued,
determined or determinable, secured or unsecured, disputed or undisputed, subordinated or unsubordinated, or otherwise.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Liens</U>&rdquo; means any
security interest, pledge, hypothecation, mortgage, deed of trust, lien (including environmental and Tax liens), assignment, charge,
encumbrance, restriction, reservation, declaration, easement, right of way, lease, agreement to lease, encroachment, severance
of oil, gas or mineral rights, license, or other security interest of any kind or nature whatsoever (including those created by,
arising under or evidenced by any conditional sale or other title retention agreement), the interest of a lessor under a capital
lease, conditional or installment sales contract, contract for deed, any financing lease or any agreement to provide any of the
foregoing or any other similar restriction on ownership or, with respect to any real or personal property, any defect in or cloud
on title to such asset or contractual restriction on the ownership or use of such asset, land use or zoning ordinance or regulation,
or sale of or limitation of air or development rights.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Loan</U>&rdquo; shall mean,
as applicable, any extension of credit or commitment to extend credit.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Loss</U>&rdquo; means any and
all losses, claims, damages, Liabilities, obligations, costs and expenses, whether or not reserved (including, without limitation,
as a result of any notices,</P>


<!-- Field: Page; Sequence: 80 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-top: 6pt; padding-bottom: 6pt; border-bottom: Black 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->79<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 24pt 70%; text-align: left"><U>STRICTLY&nbsp;CONFIDENTIAL</U><BR>EXECUTION&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">Proceedings,
demands, assessments, judgments, awards, costs, penalties, Taxes and reasonable expenses, including reasonable attorneys&rsquo;
and other professionals&rsquo; fees and disbursements)</FONT>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Loss Share Agreement</U>&rdquo;
shall have the meaning set forth in Section 3.13(a)(xi).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Loss Share Review</U>&rdquo;
shall have the meaning set forth in Section3.24(e).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Made Available</U>&rdquo; means
made available to Carbon at the offices of Cleary Gottlieb Steen &amp; Hamilton LLP or in the Project Driver online dataroom prior
to the date hereof.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Marks</U>&rdquo; shall have
the meaning set forth in the definition of Intellectual Property.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Material Adverse Effect</U>&rdquo;
means, with respect to Oxygen or Carbon, as the case may be, any fact, change, event, occurrence, condition or development which
(i) has, or would reasonably be expected to have, a material adverse effect on the business, properties, assets, liabilities, results
of operations or financial condition of such party and its Subsidiaries taken as a whole (<U>provided</U> that, with respect to
this clause&nbsp;(i), Material Adverse Effect shall not be deemed to include the impact of (A) changes after the date hereof in
GAAP, (B) changes after the date hereof in Laws of general applicability to companies in the industries in which such party and
its Subsidiaries operate, (C) changes after the date hereof in global, national or regional political conditions (including the
outbreak of war or acts of terrorism) or in economic or market conditions affecting other companies in the industries in which
such part and its Subsidiaries operate (including changes in interest rates), (D) the announcement of this Agreement, including
the impact thereof on relationships with customers, employees and counterparts, (E) volcanoes, tsunamis, pandemics, earthquakes,
floods, storms, hurricanes, tornadoes or other natural disasters, (F) actions or omissions of Carbon or Oxygen taken at the written
request of the other party, or (G) a decline in the trading price of a party&rsquo;s common stock or the failure, in and of itself,
to meet earnings projections, but not, in either case, including the underlying causes thereof; except, with respect to clauses
(A), (B), (C) or (E), to the extent that the effects of such change are disproportionately adverse to the business, properties,
assets, liabilities, results of operations or financial condition of such party and its Subsidiaries, taken as a whole, as compared
to other companies in the industry in which such party and its Subsidiaries operate) or (ii) prevents or materially impairs the
ability of such party to timely consummate the transactions contemplated hereby. In addition, in the case of Oxygen, Material Adverse
Effect shall not be deemed to include the impact of any fact, change, event, occurrence, condition or development to the extent
the impact is reflected in the calculation of Final Gross Merger Consideration or to the extent Carbon will be compensated in respect
of the impact from the Holdback Amount.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Merger</U>&rdquo; shall have
the meaning set forth in the Recitals.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Merger Consideration Per Fully
Diluted Interest</U>&rdquo; shall have the meaning set forth in Section 1.7.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Merger Sub</U>&rdquo; shall
have the meaning set forth in the Preamble.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Multiemployer Plan</U>&rdquo;
shall have the meaning set forth in Section 3.11(f).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Multiple Employer Plan</U>&rdquo;
shall have the meaning set forth in Section 3.11(f).</P>


<!-- Field: Page; Sequence: 81 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-top: 6pt; padding-bottom: 6pt; border-bottom: Black 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->80<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 24pt 70%; text-align: left"><U>STRICTLY&nbsp;CONFIDENTIAL</U><BR>EXECUTION&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Net Merger Consideration</U>&rdquo;
shall have the meaning set forth in Section 1.7.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>New Benefit Plan</U>&rdquo;
shall have the meaning set forth in Section 6.3(b).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Non-Accredited Investor</U>&rdquo;
means any holder of Oxygen Common Interests (including Oxygen Interest Awards) or Oxygen Options who Carbon is unable to verify
to its reasonable satisfaction is an &ldquo;accredited investor&rdquo; (as such term is defined in Rule 501(a) under the Securities
Act) as of the Effective Time (it being understood that Carbon may deem any Oxygen Holder who does not complete and deliver an
Investor Questionnaire to the Exchange Agent prior to the fifth Business Day prior to the Closing Date as a Non-Accredited Investor).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Non-Accredited Investor Common
Interest Consideration</U>&rdquo; shall have the meaning set forth in Section 1.6(a).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Non-Accredited Investor Option
Consideration</U>&rdquo; shall have the meaning set forth in Section 1.6(a).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Notice of Disagreement</U>&rdquo;
shall have the meaning set forth in Section 1.7(c)(iii).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>NYSE</U>&rdquo; means the New
York Stock Exchange.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>OCC</U>&rdquo; means the Office
of the Comptroller of the Currency.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Option Cash Amount</U>&rdquo;
shall have the meaning set forth in Section 2.2(h).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Option Consideration</U>&rdquo;
shall have the meaning set forth in Section 1.7.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Option Holder</U>&rdquo; shall
have the meaning set forth in Section 1.6(a).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Option Withholding Amount</U>&rdquo;
shall have the meaning set forth in Section 2.2(h).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Organizational Documents</U>&rdquo;
means a Person&rsquo;s charter, articles of organization, certificate of incorporation, certificate of formation, limited liability
company agreement, trust documents, partnership agreement, by-laws or other similar organizational documents, as applicable, and
including in the case of Oxygen, the Oxygen LLC Agreement.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Out-of-the-Money Oxygen Option</U>&rdquo;
shall have the meaning set forth in Section 1.6(a).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Owned Real Property</U>&rdquo;
shall have the meaning set forth in Section 3.18(c).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Oxygen</U>&rdquo; shall have
the meaning set forth in the Preamble.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Oxygen Audited Financial Statements</U>&rdquo;
shall have the meaning set forth in Section 3.6(a).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Oxygen Audited Interim Balance
Sheet</U>&rdquo; shall have the meaning set forth in Section 1.7(c).</P>


<!-- Field: Page; Sequence: 82 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-top: 6pt; padding-bottom: 6pt; border-bottom: Black 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->81<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 24pt 70%; text-align: left"><U>STRICTLY&nbsp;CONFIDENTIAL</U><BR>EXECUTION&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Oxygen Audited Interim Financial
Statements</U>&rdquo; shall have the meaning set forth in Section 1.7(c).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Oxygen Bank</U>&rdquo; shall
have the meaning set forth in Section 1.12(a).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Oxygen Benefit Plans</U>&rdquo;
shall have the meaning set forth in Section 3.11(a).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Oxygen Budget</U>&rdquo; means
the 2014 Draft Forecast (with Haircuts ID 407).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Oxygen Common Interest</U>&rdquo;
means any &ldquo;Common Interest&rdquo; of Oxygen as such term is defined in the Oxygen LLC Agreement; <U>provided</U> that for
purposes of this Agreement, Oxygen Common Interest shall not include any Oxygen Converted Common Interest.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Oxygen Contract</U>&rdquo;
shall have the meaning set forth in Section&nbsp;3.13(a).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Oxygen Converted Common Interest</U>&rdquo;
means any &ldquo;Converted Common Interest&rdquo; of Oxygen as such term is defined in the Oxygen LLC Agreement.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Oxygen Disclosure Schedule</U>&rdquo;
shall have the meaning set forth in Section 9.6(a).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Oxygen ERISA Affiliate</U>&rdquo;
shall have the meaning set forth in Section 3.11(a).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Oxygen Financial Statements</U>&rdquo;
shall have the meaning set forth in Section 3.6(a).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Oxygen Holder</U>&rdquo; and
&ldquo;<U>Oxygen Holders</U>&rdquo; shall have the meaning set forth in Section&nbsp;1.1(b).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Oxygen Interest Award</U>&rdquo;
shall have the meaning set forth in Section 1.4(b).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Oxygen LLC Agreement</U>&rdquo;
shall mean the Third Amended and Restated Limited Liability Company Agreement of Oxygen.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Oxygen Loan</U>&rdquo; means
(i) any Loan owned in whole or in part by Oxygen or any of its Subsidiaries, including a Loan that has closed but has not funded,
and (ii) any Loan that, as of any time, Oxygen or any of its Subsidiaries owned and subsequently sold, transferred conveyed or
assigned.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Oxygen Option</U>&rdquo; means
an option granted by Oxygen to purchase Oxygen Common Interests that is outstanding and unexercised immediately prior to the Effective
Time.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Oxygen Profits Interest</U>&rdquo;
means any &ldquo;Profits Interest&rdquo; of Oxygen as such term is defined in the Oxygen LLC Agreement.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Oxygen Qualified Plans</U>&rdquo;
shall have the meaning set forth in Section 3.11(d).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Oxygen Registered Intellectual
Property</U>&rdquo; shall have the meaning set forth in Section 3.19(a).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Oxygen Regulatory Agreement</U>&rdquo;
shall have the meaning set forth in Section 3.14.</P>


<!-- Field: Page; Sequence: 83 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-top: 6pt; padding-bottom: 6pt; border-bottom: Black 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->82<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 24pt 70%; text-align: left"><U>STRICTLY&nbsp;CONFIDENTIAL</U><BR>EXECUTION&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Oxygen Unaudited Financial
Statements</U>&rdquo; shall have the meaning set forth in Section 3.6(a).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Patents</U>&rdquo; shall have
the meaning set forth in the definition of Intellectual Property.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Per Common Interest Merger
Consideration</U>&rdquo; shall have the meaning set forth in Section 1.4(a).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Per Interest Cash Consideration</U>&rdquo;
shall have the meaning set forth in Section 1.7.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Per Interest Stock Consideration</U>&rdquo;
shall have the meaning set forth in Section 1.7.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Per Option Cash Consideration</U>&rdquo;
shall have the meaning set forth in Section 1.7.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Per Option Merger Consideration</U>&rdquo;
shall have the meaning set forth in Section 1.6.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Per Option Stock Consideration</U>&rdquo;
shall have the meaning set forth in Section 1.7.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Permits</U>&rdquo; shall have
the meaning set forth in Section 3.12(a).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">&ldquo;<U>Permitted
Encumbrances</U>&rdquo; means (a) mechanics&rsquo;, materialmen&rsquo;s, warehousemen&rsquo;s, carriers&rsquo;, workers&rsquo;,
landlord&rsquo;s or repairmen&rsquo;s liens or other similar common law or statutory Liens arising or incurred in the ordinary
course of business, (b) Liens for Taxes, assessments and other governmental charges not yet due and payable, due but not delinquent,
or being contested in good faith by appropriate proceedings for which adequate reserves have been established and are reflected
on the most recent balance sheet included in the Oxygen Financial Statements, in each case in accordance with GAAP, (c) nonmonetary
Liens (other than leases or other occupancy agreements) that would not impair or restrict in any material respect the use, value
or free transferability of the real or tangible property in question based on the current use of such property</FONT>, (d) Liens
disclosed on the Oxygen Financial Statements, or notes thereto, (e) Liens arising or incurred in connection with any advance made
by any Federal Home Loan Bank permitted by the terms of this Agreement that are consistent in all material respects with the Liens
disclosed on the Oxygen Financial Statements, or notes thereto for such type of advances, (f) non-exclusive licenses or other similar
grants of rights to Intellectual Property to end-users or customers granted in the ordinary course of business and (g) such other
Liens or imperfections of title that do not, in any material respect, detract from the value or interfere with the present use
of the property subject thereto or affected thereby.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Person</U>&rdquo; means any
individual, corporation (including not&#45;for&#45;profit), savings association, bank, general or limited partnership, limited
liability company, joint venture, estate, trust, association, organization, Governmental Entity or other entity of any kind or
nature.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Pool</U>&rdquo; shall have
the meaning set forth in Section 3.23(f).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Preliminary Gross Merger Consideration</U>&rdquo;
means $3,410,894,310.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Premium Cap</U>&rdquo; shall
have the meaning set forth in Section 6.4(b).</P>


<!-- Field: Page; Sequence: 84 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-top: 6pt; padding-bottom: 6pt; border-bottom: Black 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->83<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 24pt 70%; text-align: left"><U>STRICTLY&nbsp;CONFIDENTIAL</U><BR>EXECUTION&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Previously Disclosed</U>&rdquo;
means information set forth by Oxygen or Carbon in the Oxygen Disclosure Schedule or Carbon Disclosure Schedule, as applicable;
<U>provided</U> that disclosure in any section of such schedule shall apply only to the corresponding Section of this Agreement
except to the extent that it is reasonably apparent on the face of such disclosure that such disclosure is relevant to another
Section of this Agreement.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Proceeding</U>&rdquo; means
any legal, administrative, arbitral or other proceeding, claim, actions or governmental or regulatory investigation of any nature.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Prohibited Practice</U>&rdquo;
shall have the meaning set forth in Section 3.8(b).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Prohibited Transaction</U>&rdquo;
shall have the meaning set forth in Section 3.8(b).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Real Property Lease</U>&rdquo;
shall have the meaning set forth in Section 3.18(b).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Regulatory Agencies</U>&rdquo;
shall have the meaning set forth in Section 3.5.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Released Holdback Amount</U>&rdquo;
shall have the meaning set forth in Exhibit A.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Released Parties</U>&rdquo;
shall have the meaning set forth in Section 6.18(d).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Representatives</U>&rdquo;
shall have the meaning set forth in Section 6.10(a).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Required Capital</U>&rdquo;
means the amount of Tangible Common Equity reflected on the Oxygen Audited Interim Balance Sheet up to the amount which results
in a 9% TCE/TA Ratio calculated based on the Tangible Common Equity and Tangible Assets reflected on the Oxygen Audited Interim
Balance Sheet.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Requisite Holders</U>&rdquo;
shall have the meaning set forth in Section 6.18(a).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Requisite Regulatory Approvals</U>&rdquo;
means the approval of the Federal Reserve and the OCC, in each case required to consummate the transactions contemplated by this
Agreement, including the Merger and the Bank Merger.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Retention Agreement</U>&rdquo;
shall have the meaning set forth in the Recitals.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Retention Amount</U>&rdquo;
shall mean $10,810,000.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Rolled Equity Award Amount</U>&rdquo;
shall have the meaning set forth in Section 1.7.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Securities Act</U>&rdquo; means
the Securities Act of 1933, as amended.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Selling Interestholder Restrictive
Covenant Agreements</U>&rdquo; shall have the meaning set forth in the Recitals.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Servicing Agreements</U>&rdquo;
shall have the meaning set forth in Section 3.13(a)(xiv).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Software</U>&rdquo; means (A)
computer programs, including any and all software implementations of algorithms, models and methodologies, whether in source code
or object</P>


<!-- Field: Page; Sequence: 85 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-top: 6pt; padding-bottom: 6pt; border-bottom: Black 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->84<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 24pt 70%; text-align: left"><U>STRICTLY&nbsp;CONFIDENTIAL</U><BR>EXECUTION&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt">code, (B) descriptions, flow-charts and other work product
used to design, plan, organize and develop any of the foregoing, screens, user interfaces, report formats, firmware, development
tools, templates, menus, buttons and icons and (C) all documentation, including user manuals and other training documentation,
related to any of the foregoing.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>SRO</U>&rdquo; means (i) any
&ldquo;self-regulatory organization&rdquo; as defined in Section&nbsp;3(a)(26) of the Exchange Act and (ii) any other United States
or foreign securities exchange, futures exchange, commodities exchange or contract market.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>State Act</U>&rdquo; shall
have the meaning set forth in Section 2.2(i).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Stock Consideration Amount</U>&rdquo;
has the meaning set forth in Section 1.7.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Stock Repurchase</U>&rdquo;
shall have the meaning set forth in Section 6.2(c).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Stockholders Agreement</U>&rdquo;
shall have the meaning set forth in the Recitals.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Subsidiary</U>&rdquo; means,
in respect of any Person, any entity of which (i) such Person directly or indirectly owns or controls at least a majority of the
securities or other interests having by their terms ordinary voting power to elect a majority of the board of directors or others
performing similar functions or (ii) such Person is or directly or indirectly has the power to appoint a general partner, manager
or managing member.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Surviving Bank</U>&rdquo; shall
have the meaning set forth in Section 1.12.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Surviving Company</U>&rdquo;
shall have the meaning set forth in the Recitals.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Takeover Statutes</U>&rdquo;
shall have the meaning set forth in Section 3.21.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Tangible Assets</U>&rdquo;
means Total Assets minus Goodwill and Intangibles.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Tangible Common Equity</U>&rdquo;
means Common Equity minus Goodwill and Intangibles.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Tapes</U>&rdquo; shall have
the meaning set forth in Section 3.24(d).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Tax</U>&rdquo; or &ldquo;<U>Taxes</U>&rdquo;
means all federal, state, local, and foreign income, excise, gross receipts, ad valorem, profits, gains, property, capital, sales,
transfer, use, license, payroll, employment, social security, severance, unemployment, withholding, duties, excise, windfall profits,
intangibles, franchise, backup withholding, value added, alternative or add-on minimum, estimated and other taxes, charges, levies
or like assessments together with all penalties and additions to tax and interest thereon.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Tax Analysis</U>&rdquo; shall
have the meaning set forth in Section 6.14(a).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Tax Analysis Objection</U>&rdquo;
shall have the meaning set forth in Section 6.14(a).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Tax Effected Transaction Expenses</U>&rdquo;
means (i) the Transaction Expenses <U>less</U> (ii) the Tax benefits in respect thereof determined in accordance with Section 6.14.</P>


<!-- Field: Page; Sequence: 86 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-top: 6pt; padding-bottom: 6pt; border-bottom: Black 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->85<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 24pt 70%; text-align: left"><U>STRICTLY&nbsp;CONFIDENTIAL</U><BR>EXECUTION&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Tax Return</U>&rdquo; means
any return, declaration, report, claim for refund, or information return or statement relating to Taxes, including any schedule
or attachment thereto, and including any amendment thereof, supplied or required to be supplied to a Governmental Entity.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>TCE/TA Ratio</U>&rdquo; means
Tangible Common Equity divided by Tangible Assets.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Termination Date</U>&rdquo;
shall have the meaning set forth in Section 8.1(c).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Total Assets</U>&rdquo; means
the amount set forth in the line item &ldquo;total assets&rdquo; on the Oxygen Audited Interim Balance Sheet, which amount as reflected
in the balance sheet included in the Oxygen Unaudited Financial Statements was $22,566,541,567.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Trade Secrets</U>&rdquo; shall
have the meaning set forth in the definition of Intellectual Property.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Transaction Expenses</U>&rdquo;
means the aggregate amount of (i) fifty percent (50%) of the amount of the FDIC Payments that Oxygen, Carbon or their respective
Subsidiaries make, incur or commit to make or incur that do not constitute a Burdensome Condition, if any, (ii) fifty percent (50%)
of the amount of the GSE Payments that Oxygen, Carbon or their respective Subsidiaries make, incur or commit to make or incur that
do not constitute a Burdensome Condition, if any, (iii) fees or other payments (other than payment of the Net Merger Consideration)
to any Oxygen Holder or their Affiliates in connection with this Agreement or the transactions contemplated by this Agreement,
if any, (iv) bonuses paid to employees of Oxygen or its Subsidiaries in connection with this Agreement or the transactions contemplated
by this Agreement, if any, (v) severance paid to Oxygen employees following the date hereof (excluding any severance (1) paid in
amounts and on terms consistent with Oxygen&rsquo;s past practice as set forth on Section 9.5(c) of the Oxygen Disclosure Schedule,
(2) paid pursuant to the agreements set forth on Section 9.5(c) of the Oxygen Disclosure Schedule or (3) that is mutually agreed
in writing with Carbon), (vi) fees or other payments to financial advisors, attorneys, accountants or other third party advisors
or representatives in connection with this Agreement or the transactions contemplated by this Agreement and (vii) the fees set
forth on Section 9.5(d) of the Oxygen Disclosure Schedule, in the case of (iii) through (vi) that are incurred by Oxygen or any
of its Subsidiaries at or prior to the Closing, whether payable before, at or after the Closing; <U>provided</U> that &ldquo;Transaction
Expenses&rdquo; shall not include any amounts incurred solely as a result of any change effected pursuant to Section 1.1(b), <U>provided</U>
<U>further</U> that, for the avoidance of doubt, &ldquo;Transaction Expenses&rdquo; shall not include any amounts to the extent
reflected as a liability on the Oxygen Audited Interim Financial Statements or to the extent incurred and paid prior to June 30,
2014; and, <U>provided</U> <U>further</U> that, for purposes of clarification, &ldquo;Transaction Expenses&rdquo; shall not include
any payments made pursuant to Section 5.07 of the Oxygen LLC Agreement.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>Transaction Tax Analysis</U>&rdquo;
shall have the meaning set forth in Section 6.14(a).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>USDA</U>&rdquo; means the United
States Department of Agriculture.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&ldquo;<U>VA</U>&rdquo; means the United
States Department of Veteran Affairs.</P>


<!-- Field: Page; Sequence: 87 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-top: 6pt; padding-bottom: 6pt; border-bottom: Black 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->86<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 24pt 70%; text-align: left"><U>STRICTLY&nbsp;CONFIDENTIAL</U><BR>EXECUTION&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><U><A NAME="a_Toc393714805"></A><A NAME="a_Toc391290269"></A><A NAME="a_Toc391290429"></A><A NAME="a_Toc391290541"></A></U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">9.6</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U> Disclosure Schedule</U><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><A NAME="a_Ref388724999"></A><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(a)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Before entry into this Agreement, Oxygen delivered to Carbon a schedule (a &ldquo;<U>Oxygen Disclosure Schedule</U>&rdquo;)
and Carbon delivered to Oxygen a schedule a (&ldquo;<U>Carbon Disclosure Schedule</U>&rdquo;), each of which sets forth, among
other things, items the disclosure of which is necessary or appropriate either in response to an express disclosure requirement
contained in a provision hereof or as an exception to one or more representations or warranties contained in Article III or Article
IV, respectively, or to one or more covenants contained herein; <U>provided</U> that notwithstanding anything in this Agreement
to the contrary, (i) no such item is required to be set forth as an exception to a representation or warranty if its absence would
not result in the related representation or warranty being deemed untrue or incorrect and (ii) the mere inclusion of an item as
an exception to a representation or warranty shall not be deemed an admission that such item represents a material<A NAME="PB_87_085543_6479"></A>
exception or material fact, event or circumstance or that such item has had or would be reasonably likely to have a Material Adverse
Effect.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><U><A NAME="a_Toc393714806"></A></U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">9.7</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Counterparts</U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">. This Agreement may be executed in counterparts,
all of which shall be considered one and the same agreement and shall become effective when counterparts have been signed by each
of the parties and delivered to the other parties, it being understood that all parties need not sign the same counterpart.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><U><A NAME="a_Toc393714807"></A></U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">9.8</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Entire Agreement</U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">. This Agreement (including the documents
and the instruments referred to herein) together with the Confidentiality Agreement constitutes the entire agreement among the
parties and supersedes all prior agreements and understandings, both written and oral, among the parties with respect to the subject
matter hereof.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><U><A NAME="a_Toc393714808"></A><A NAME="a_Ref347360194"></A></U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">9.9</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Governing Law; Jurisdiction</U><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(a)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>This Agreement shall be governed and construed in accordance with the Laws of the State of Delaware, without regard to any
applicable conflicts of Law.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><A NAME="a_Ref388725123"></A><FONT STYLE="font: 12pt Times New Roman, Times, Serif">(b)</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Each party agrees that it will bring any Proceeding in respect of any claim arising out of or related to this Agreement
or the transactions contemplated hereby exclusively in the Delaware Chancery Court, or in the event (but only in the event) that
such court does not have subject matter jurisdiction over such Proceeding, in the United States District Court for the District
of Delaware (such courts, the &ldquo;<U>Delaware Courts</U>&rdquo;), and, solely in connection with claims arising under this Agreement
or the transactions that are the subject of this Agreement, (i) irrevocably submits to the exclusive jurisdiction of the Delaware
Courts, (ii) waives any objection to laying venue in any such Proceeding in the Delaware Courts, (iii) waives any objection that
the Delaware Courts are an inconvenient forum or do not have jurisdiction over any party and (iv) agrees that service of process
upon such party in any such Proceeding will be effective if notice is given in accordance with Section&nbsp;9.4.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><U><A NAME="a_Toc393714809"></A><A NAME="a_Ref347370071"></A></U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">9.10</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Waiver of Jury Trial</U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">. </FONT><A NAME="a_Toc339473118"></A><A NAME="a_Toc339472926"></A><A NAME="a_Toc339472734"></A><A NAME="a_Toc339472542"></A><A NAME="a_Toc339472349"></A>Each
party acknowledges and agrees that any controversy which may arise under this Agreement is likely to involve complicated and difficult
issues, and therefore each such party hereby irrevocably and unconditionally waives, to the extent permitted by applicable Law
at the time of institution of the applicable litigation, any right such party may have to a trial by jury in respect of any litigation
directly or indirectly arising out </P>

<!-- Field: Page; Sequence: 88 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-top: 6pt; padding-bottom: 6pt; border-bottom: Black 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->87<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 24pt 70%; text-align: left"><U>STRICTLY&nbsp;CONFIDENTIAL</U><BR>EXECUTION&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt">of or relating to this Agreement or the transactions contemplated by this Agreement. Each party
certifies and acknowledges that: (i) no representative, agent or attorney of any other party has represented, expressly or otherwise,
that such other party would not, in the event of litigation, seek to enforce the foregoing waiver; (ii) each party understands
and has considered the implications of this waiver; (iii) each party makes this waiver voluntarily; and (iv) each party has been
induced to enter into this Agreement by, among other things, the mutual waivers and certifications in this Section&nbsp;9.10.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><U><A NAME="a_Toc393714810"></A><A NAME="a_Ref347359188"></A></U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">9.11</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Assignment; Third Party Beneficiaries</U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">. Neither this Agreement
nor any of the rights, interests or obligations shall be assigned by any of the parties hereto (whether by operation of Law or
otherwise) without the prior written consent of the other party. Any purported assignment in contravention hereof shall be null
and void. Subject to the preceding sentence, this Agreement will be binding upon, inure to the benefit of and be enforceable by
the parties and their respective successors and assigns. Except (a) as otherwise specifically provided in Section&nbsp;6.3(a) and
</FONT>(b) if the Effective Time occurs, the exclusive right of the Holder&rsquo;s Representative to enforce the provisions of
Section 6.17 on behalf of the Oxygen Holders who have irrevocably agreed to be bound by Section 6.18, this Agreement (including
the documents and instruments referred to herein) is not intended to confer upon any Person other than the parties hereto any rights
or remedies hereunder, including the right to rely upon the representations and warranties set forth herein.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><U><A NAME="a_Toc393714811"></A></U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">9.12</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Specific Performance</U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">. Each party hereto agrees that irreparable
damage would occur if any provision of this Agreement were not performed in accordance with its specific terms or were otherwise
breached or threatened to be breached. It is accordingly agreed that each party hereto shall be entitled to an injunction or injunctions
to prevent breaches of this Agreement and to enforce specifically the performance of the terms and provisions hereof (including
the parties&rsquo; obligation to consummate the Merger and the Bank Merger) in the Delaware Courts, without bond or other security
being required, this being in addition to any other right, remedy or cause of action to which such party is entitled at law or
in equity.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><U><A NAME="a_Toc393714812"></A></U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">9.13</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Delivery by Facsimile or Electronic Transmission</U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">. This Agreement
and any signed agreement or instrument entered into in connection with this Agreement, and any amendments or waivers hereto or
thereto, to the extent signed and delivered by means of a facsimile machine or by e&#45;mail delivery of a &ldquo;.pdf&rdquo; format
data file, shall be treated in all manner and respects as an original agreement or instrument and shall be considered to have the
same binding legal effect as if it were the original signed version thereof delivered in person. No party hereto or to any such
agreement or instrument shall raise the use of a facsimile machine or e&#45;mail delivery of a &ldquo;.pdf&rdquo; format data file
to deliver a signature to this Agreement or any amendment hereto or the fact that any signature or agreement or instrument was
transmitted or communicated through the use of a facsimile machine or e&#45;mail delivery of a &ldquo;.pdf&rdquo; format data file
as a defense to the formation of a contract and each party hereto forever waives any such defense.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><U><A NAME="a_Toc393714813"></A></U><FONT STYLE="font: 12pt Times New Roman, Times, Serif">9.14</FONT><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Valuation Dispute</U>. If Oxygen and Carbon are not initially in agreement with respect to the amount of an FDIC Payment
or GSE Payment that would be reflected as a Transaction Expense in the calculation of Net Merger Consideration assuming such FDIC
Payment or GSE Payment were paid by Oxygen as contemplated by Section 6.1(b) or 6.1(c), the</P>


<!-- Field: Page; Sequence: 89 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-top: 6pt; padding-bottom: 6pt; border-bottom: Black 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->88<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 24pt 70%; text-align: left"><U>STRICTLY&nbsp;CONFIDENTIAL</U><BR>EXECUTION&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt">parties shall seek in good faith to resolve their differences
and agree on an amount within ten (10) Business Days. If, at the end of such ten (10) Business Day period, such amount or amounts
still remain in dispute, then within two (2) Business Days following the end of such period, Carbon and Oxygen shall each submit
in writing to a nationally recognized independent valuation firm reasonably agreed by Oxygen and Carbon (the &ldquo;Independent
Valuation Firm&rdquo;) an amount that shall be its best and final offer as to the amount of such FDIC Payment or GSE Payment, as
applicable (as to each, its &ldquo;Final Offer&rdquo;). The Independent Valuation Firm shall be instructed to select the Final
Offer that is closest to the value of the FDIC Payment or GSE Payment, as the case may be, as determined by the Independent Valuation
Firm in accordance with the terms of this Agreement. The Final Offer selected by the Independent Valuation Firm shall serve as
the final, binding resolution of the amount of the FDIC Payment or GSE Payment, as applicable, that would be reflected as a Transaction
Expense if paid by Oxygen and such selection of a Final Offer by the Independent Valuation Firm shall be (i) in writing and signed
by the Independent Valuation Firm, (ii) furnished to Carbon and Oxygen as soon as practicable after the items in dispute have been
referred to the Independent Valuation Firm, which shall not be more than twenty (20) Business Days after such referral, and (iii)
conclusive and binding upon Carbon and Oxygen on the date of delivery of such written resolution (other than in the case of fraud).
Carbon and Oxygen agree to cooperate with the Independent Valuation Firm and to promptly provide all documents and information
reasonably requested by the Independent Valuation Firm so as to enable it to make its determination as quickly and as accurately
as possible. The fees and expenses of the Independent Valuation Firm shall be borne by the party whose Final Offer is not selected
by the Independent Valuation Firm; provided that any fees and expenses borne by Oxygen shall be Transaction Expenses.</P>

<P STYLE="font: italic 12pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"><A NAME="a_Ref392185926"></A>[Signature
Page Follows]</P>


<!-- Field: Page; Sequence: 90 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-top: 6pt; padding-bottom: 6pt; border-bottom: Black 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->89<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 24pt 70%; text-align: left"><U>STRICTLY&nbsp;CONFIDENTIAL</U><BR>EXECUTION&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">IN WITNESS WHEREOF, Carbon, Oxygen,
Merger Sub and the Holders&rsquo; Representative have caused this Agreement to be executed by their respective officers thereunto
duly authorized as of the date first above written.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 24pt 3in"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 24pt 3in">CIT GROUP INC.</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 3in">&nbsp;</TD>
    <TD STYLE="width: 0.5in"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">By:</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; border-bottom: Black 1pt solid"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">/s/ John A. Thain</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font: 12pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 12pt Times New Roman, Times, Serif">Name: John A. Thain</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 12pt Times New Roman, Times, Serif">Title: Chairman and Chief Executive Officer</FONT></TD></TR>
</TABLE>
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 24pt 3in">CARBON MERGER SUB LLC</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 3in; padding-right: 5.4pt">&nbsp;</TD>
    <TD STYLE="width: 0.5in; padding-right: 5.4pt"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">By:</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; border-bottom: Black 1pt solid"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">/s/ John A. Thain</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">Name: John A. Thain</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">Title: Chief Executive Officer</FONT></TD></TR>
</TABLE>
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 24pt 3in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 24pt 3in">IMB HOLDCO LLC</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 3in; padding-right: 5.4pt">&nbsp;</TD>
    <TD STYLE="width: 0.5in; padding-right: 5.4pt"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">By:</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; border-bottom: Black 1pt solid"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">/s/ Steven T. Mnuchin</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">Name: Steven T. Mnuchin</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">Title: Chief Executive Officer</FONT></TD></TR>
</TABLE>
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 3in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 3in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 3in">JCF III HOLDCO I L.P., as Holders&rsquo;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 3in">Representative</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 3in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 3in">By: JCF III AIV I GP L.P., its general partner</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 3in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 3in">By: JCF III AIV I GP Ltd., its general partner</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 24pt 3in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 3in; padding-right: 5.4pt">&nbsp;</TD>
    <TD STYLE="width: 0.5in; padding-right: 5.4pt"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">By:</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; border-bottom: Black 1pt solid"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">/s/ Sally Rocker</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">Name: Sally Rocker</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">Title: Authorized Person</FONT></TD></TR>
</TABLE>
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 24pt 3in">&nbsp;</P>



<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 24pt 3in"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 24pt 3in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><I>[Signature Page to Merger Agreement]</I></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 91 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-top: 6pt; padding-bottom: 6pt; border-bottom: Black 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->



</BODY>
</HTML>
</TEXT>
</DOCUMENT>
